| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 3001 |
Majority of Transformed Lymphomas Have High SUVs on PET Scanning Similar to Diffuse Large B Cell Lymphoma (DLBCL).
|
Noy, Ariela
|
|
|
110 |
11 |
p. 2614
|
article
|
| 3002 |
Malignant B Cells from Hairy Cell Leukemia Express an Innate Phenotype and Undergo IgD Class Switching in Response to Innate Environmental Factors, Including BAFF and APRIL.
|
Chiu, April
|
|
|
110 |
11 |
p. 4707
|
article
|
| 3003 |
Malignant B Cells Skew the Balance between Treg Cell and TH17 Cell Differentiation in B-Cell Non-Hodgkin Lymphoma (NHL).
|
Yang, Zhi-Zhang
|
|
|
110 |
11 |
p. 1347
|
article
|
| 3004 |
Management and Strategy of Thromboprophylaxis for Venous Thromboembolism in Pregnancy.
|
Corinaldesi, Giorgio
|
|
|
110 |
11 |
p. 3996
|
article
|
| 3005 |
Management of Hemophilia and Head Trauma: A Survey of Current Clinical Practice among Pediatric Hematology/Oncology Physicians.
|
Witmer, Char M.
|
|
|
110 |
11 |
p. 3967
|
article
|
| 3006 |
Management of High Haemorragic Risk Surgery: A Case of Acquired von Willebrand Disease (AVWD).
|
Mostarda, Giovanni
|
|
|
110 |
11 |
p. 3950
|
article
|
| 3007 |
Management of Pain Due to Vaso-Occlusive Crisis (VOC) in Adults with Sickle Cell Disease (SCD) in the Post-Guideline Era: A Retrospective Study in an Urban Medical Center Emergency Department (ED).
|
Solomon, Lawrence R.
|
|
|
110 |
11 |
p. 2267
|
article
|
| 3008 |
Manipulation of Oxygen Tension and Medium Composition To Enhance CD34+ Cell Numbers and Megakaryocytic Potential of Cord Blood Progenitors.
|
Kidd, Shannon M.
|
|
|
110 |
11 |
p. 772
|
article
|
| 3009 |
Mannose Labeled Liposome Containing DXR Administration Is Effective in Reversing Thrombocytopenia in the Model Mouse of Immune Thrombocytopenia.
|
Ishida, Yoji
|
|
|
110 |
11 |
p. 2109
|
article
|
| 3010 |
Mantle Cell Lymphoma Can Be Cured by Intensive Immunochemotherapy with In-Vivo Purged Stem-Cell Support; Final Report of the Nordic Lymphoma Group MCL2 Study.
|
Geisler, Christian H.
|
|
|
110 |
11 |
p. LB1
|
article
|
| 3011 |
MAPK-Activation in CD34+ CML Stem Cells Induced by Selective Abl-Inhibitors Is Not Observed Using the Combined Src/Abl-Inhibitor Dasatinib.
|
La Rosee, Paul
|
|
|
110 |
11 |
p. 652
|
article
|
| 3012 |
Mapping of Allosteric Modulator Effects in the Active Site of Factor IXa.
|
Villegas, Karla
|
|
|
110 |
11 |
p. 2695
|
article
|
| 3013 |
Marked Improvement in Short- and Long-Term Survival in Severe Aplastic Anemia Patients Treated with Immunosuppression in the Past 18 Years.
|
Scheinberg, Phillip
|
|
|
110 |
11 |
p. 1698
|
article
|
| 3014 |
Marked Improvement of Skin Involvement in Severe Progressive Systemic Sclerosis after Transplantation of Mesenchymal Stem Cells from an Allogeneic Haploidentical Related Donor.
|
Christopeit, Maximilian
|
|
|
110 |
11 |
p. 4865
|
article
|
| 3015 |
Marked Sensitivity of Chronic Lymphocytic Leukemia (CLL) to Apoptosis Induced by BCL2 Antagonist ABT-737.
|
Vogler, Meike
|
|
|
110 |
11 |
p. 3105
|
article
|
| 3016 |
Marked Therapeutic Efficacy of a Novel Polyethyleneglycol-SN38 Conjugate, EZN-2208, in Xenograft Models of Non-Hodgkin's Lymphoma.
|
Sapra, Puja
|
|
|
110 |
11 |
p. 1397
|
article
|
| 3017 |
Markers for Minimal Residual Disease (MRD) in B-Lineage Acute Lymphoblastic Leukemia (B-ALL): Analysis of IgH Gene Rearrangement Repertoire (AIRR) vs Conventional Strategy.
|
Morley, Alexander
|
|
|
110 |
11 |
p. 4243
|
article
|
| 3018 |
Markers of Responsiveness to ATG/CsA Therapy in Patients with Severe Aplastic Anemia.
|
Haddad, Abdo S.
|
|
|
110 |
11 |
p. 1699
|
article
|
| 3019 |
Marqibo (Vincristine Sulfate Liposomes Injection, OPTISOME™) Concentrates Vincristine in Tumor Tissue and Lymphoid Malignancy Oriented Tissues in Tumor-Bearing Mice.
|
Cullis, Pieter R.
|
|
|
110 |
11 |
p. 1403
|
article
|
| 3020 |
Marqibo (Vincristine Sulfate Liposomes Injection (OPTISOME™) Demonstrates Activity in Patients with Relapsed and Refractory Peripheral T-Cell Lymphoma.
|
Rodriguez, M. Alma
|
|
|
110 |
11 |
p. 4466
|
article
|
| 3021 |
Marrow-Derived Mesenchymal Stromal Cells Can Block an Antigen-Driven Humoral Response by Suppressing Plasma Cell Activity Via Production of CCL2.
|
Rafei, Moutih
|
|
|
110 |
11 |
p. 1350
|
article
|
| 3022 |
Massive Transfusion in Wartime: Experience from Northern Israel, Summer 2006.
|
Dann, Eldad J.
|
|
|
110 |
11 |
p. 4017
|
article
|
| 3023 |
Matching for 12 HLA Alleles Is Associated with a Significantly Superior Survival Due to a Lower Mortality in Recipients of Unrelated Donor Haematopoietic Cell Transplants for Early but Not Late Stage Leukaemia.
|
Shaw, B.E.
|
|
|
110 |
11 |
p. 3056
|
article
|
| 3024 |
Maternal Clonal Marrow Stromal Cells Expanded by “Subfractionation Culturing Method” Used for the Treatment of Refractory Chronic Graft Versus Host Disease of an Allogeneic Blood Stem Cell Recipient from an Unrelated Donor.
|
Kim, Chul Soo
|
|
|
110 |
11 |
p. 4910
|
article
|
| 3025 |
Mathematical Models To Identify Combined Protein and Clinical Biomarkers of Response to Induction Chemotherapy in Acute Myeloid Leukemia (AML).
|
Tibes, Raoul
|
|
|
110 |
11 |
p. 2399
|
article
|
| 3026 |
Matrilysin (MMP-7) Is a Novel Broadly Expressed Tumor Antigen Recognized by Antigen-Specific T Cells.
|
Grünebach, Frank
|
|
|
110 |
11 |
p. 1797
|
article
|
| 3027 |
Mature Conventional Human Dendritic Cells Express Indoleamine 2,3-Dioxygenase and Support the Relative Expansion of Autologous Regulatory T Cells.
|
Chung, David J.
|
|
|
110 |
11 |
p. 1804
|
article
|
| 3028 |
M2-10B4 Mesenchymal Stromal Cells Confer an In Vitro Protective Effect of Murine mCGPR/+ Acute Promyelocytic Leukemic Cells Against Chemotherapy.
|
Ramirez, Pablo A.
|
|
|
110 |
11 |
p. 2844
|
article
|
| 3029 |
MDR1 C3435T Polymorphism Is Highly Correlated with Early Response to Therapy and Outcome in Childhood Acute Lymphoblastic Leukaemia: Malaysia-Singapore 2003 ALL Study.
|
Kham, Shirley Kow Yin
|
|
|
110 |
11 |
p. 226
|
article
|
| 3030 |
MDS with Isolated Neutropenia or Thrombocytopenia. Incidence and Characteristics in the Groupe Francophone des Myélodysplasies (GFM) Registry.
|
Park, Sophie
|
|
|
110 |
11 |
p. 2456
|
article
|
| 3031 |
Measurement of Disease Severity in Patients with Sickle Cell Disease: A Systematic Review.
|
van den Tweel, Xandra W.
|
|
|
110 |
11 |
p. 2250
|
article
|
| 3032 |
Measurement of Urinary Hepcidin Levels by SELDI-TOF-MS in HFE-Hemochromatosis.
|
Bozzini, Claudia
|
|
|
110 |
11 |
p. 2668
|
article
|
| 3033 |
Measurement of Whole Blood Platelet Aggregation by Multiplate® Aggregometry Before and during Aspirin Treatment.
|
Pedersen, Susanne B.
|
|
|
110 |
11 |
p. 3895
|
article
|
| 3034 |
Measuring the Ability of Primary-Care Physicians To Diagnose and Manage Patients with Hematologic Malignancies.
|
Rosen, Peter J.
|
|
|
110 |
11 |
p. 3312
|
article
|
| 3035 |
Mechanism by Which Exogenous Administration of Flt3 Ligand (FL) Expands Natural Killer Cells In Vivo.
|
Guimond, Martin
|
|
|
110 |
11 |
p. 2310
|
article
|
| 3036 |
Mechanism for γ-Globin Induction by SCF Is Via PKCα/ERK1/2/Nrf2 Dependent Signal Pathway To Regulate Down-Stream Transcriptional Regulators NF-Y and COUP-TFII.
|
Aerbajinai, Wulin
|
|
|
110 |
11 |
p. 2194
|
article
|
| 3037 |
Mechanism of Action of MK-0457 Efficacy in Monotherapy and in Combination with Vorinostat in Wild Type and T315I Mutant BCR/ABL Positive Leukemia Cells.
|
Okabe, Seiichi
|
|
|
110 |
11 |
p. 1051
|
article
|
| 3038 |
Mechanism of Action of SNS-032, a Novel Cyclin Dependent Kinase Inhibitor, in Chronic Lymphocytic Leukemia: Comparison with Flavopiridol.
|
Chen, Rong
|
|
|
110 |
11 |
p. 3112
|
article
|
| 3039 |
Mechanism of Blood Coagulation by Non-Thermal Atmospheric Pressure Dielectric Barrier Discharge Plasma.
|
Nagaraj, Gayathri
|
|
|
110 |
11 |
p. 3162
|
article
|
| 3040 |
Mechanism of Reduction in Titers with Vectors Flanked by Chromatin Insulator Elements
|
Urbinati, Fabrizia
|
|
|
110 |
11 |
p. 3734
|
article
|
| 3041 |
Mechanism of Tetrandrine in Combination with Droloxifen To Reverse Multidrug Resistance in Leukemia.
|
Chen, Bao-An
|
|
|
110 |
11 |
p. 4172
|
article
|
| 3042 |
Mechanism of Thrombocytopenia in Hepatitis C as Determined by the Immature Platelet Fraction.
|
Zucker, Marjorie L.
|
|
|
110 |
11 |
p. 3199
|
article
|
| 3043 |
Mechanisms of 2-Methoxyestradiol-Induced Apoptosis on Myelodysplastic Syndrome MUTZ-1 Cell Lines.
|
Chen, Bao-An
|
|
|
110 |
11 |
p. 4590
|
article
|
| 3044 |
Mechanisms of Migration and Generation of Allo-Reactive Donor T Cells That Cause Organ Specific Acute GvHD in Allogeneic BMT Recipients.
|
Hossain, Mohammad S.
|
|
|
110 |
11 |
p. 3270
|
article
|
| 3045 |
Mechanisms Regulating CXCR4 Expression in Myeloma Cells.
|
Kim, Seong-Woo
|
|
|
110 |
11 |
p. 4748
|
article
|
| 3046 |
Mechanistic Paradigm for Combination Signal Transduction Inhibitor Therapy in Zap70+ CLL Involves Bicompartmental Functions of EZH2.
|
Hartman, Amy D.
|
|
|
110 |
11 |
p. 3099
|
article
|
| 3047 |
Medical Costs Analysis for Antifungal Prophylaxis in Neutropenic Patients with Hematological Malignancies: A Systematic Review Analysis.
|
Shintani, Takamichi
|
|
|
110 |
11 |
p. 3334
|
article
|
| 3048 |
Medical Costs of Adverse Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors: Canadian Perspective.
|
Newton, Nick
|
|
|
110 |
11 |
p. 5178
|
article
|
| 3049 |
Medical Visit Patterns in Cancer Chemotherapy Patients Receiving Erythropoiesis-Stimulating Agents in a Managed Care Setting.
|
McKenzie, Scott R.
|
|
|
110 |
11 |
p. 5156
|
article
|
| 3050 |
Megakaryocyte/Platelet-Restricted FVIII Expression Using a Platelet Factor 4 Promoter: Determination of Activation State and In Vivo Efficacy during Thrombocytosis.
|
Damon, Andrea L.
|
|
|
110 |
11 |
p. 1142
|
article
|
| 3051 |
Megakaryocytes and Functional Platelets Obtained from Human Subcutaneous Adipocytes in an In Vitro Differentiation System.
|
Saito, Emi
|
|
|
110 |
11 |
p. 3702
|
article
|
| 3052 |
Megakaryocytic Blast Phase (M-BP) of Chronic Myelogenous Leukemia (CML).
|
Quintás-Cardama, Alfonso
|
|
|
110 |
11 |
p. 4563
|
article
|
| 3053 |
MEIS1 Is a Promising New Target for Leukemia Therapy.
|
Kumar, Ashish
|
|
|
110 |
11 |
p. 872
|
article
|
| 3054 |
MEK Inhibitor AZD6244 Induces Cell Growth Arrest and Synergizes Nutlin-3a-Mediated Cell Death by Upregulating p53 and PUMA Levels in Acute Myelogenous Leukemia.
|
Zhang, Weiguo
|
|
|
110 |
11 |
p. 654
|
article
|
| 3055 |
MEL1 at 1p36.3 Is Fused to Several Partner Genes Including HOXA9 Located at Different Chromosomal Bands from 3q21.3 in t(1;3)(p36.3;q21.3)-Leukemia.
|
Xinh, Phan Thi
|
|
|
110 |
11 |
p. 3499
|
article
|
| 3056 |
Melphalan and Dexamethasone Is an Effective Therapy for Primary Systemic Amyloidosis.
|
Tan, Tow-Shung
|
|
|
110 |
11 |
p. 3608
|
article
|
| 3057 |
Melphalan-Prednisone-Thalidomide (MP-T) Demonstrates a Significant Survival Advantage in Elderly Patients ≥75 Years with Multiple Myeloma Compared with Melphalan-Prednisone (MP) in a Randomized, Double-Blind, Placebo-Controlled Trial, IFM 01/01.
|
Hulin, Cyrille
|
|
|
110 |
11 |
p. 75
|
article
|
| 3058 |
Melphalan-Prednisone-Thalidomide to Newly Diagnosed Patients with Multiple Myeloma: A Placebo Controlled Randomised Phase 3 Trial.
|
Waage, Anders
|
|
|
110 |
11 |
p. 78
|
article
|
| 3059 |
Membrane Microparticles from Patients with Steroid-Induced Avascular Necrosis of Femoral Head Increase the Expression of Fas in Endothelial Cells In Vitro.
|
Weng, Xi-sheng
|
|
|
110 |
11 |
p. 3903
|
article
|
| 3060 |
Membrane Type-Matrix Metalloproteinases (MT-MMPs) Are Expressed in Acute Myeloid Leukemia Cells and Are Upregulated by TNF-α.
|
Shirvaikar, Neeta
|
|
|
110 |
11 |
p. 2853
|
article
|
| 3061 |
Menin Regulates the Function of Lymphoid Progenitors and Hematopoietic Stem Cells.
|
Maillard, Ivan
|
|
|
110 |
11 |
p. 1257
|
article
|
| 3062 |
Mesenchymal Stem Cells and Fibroblasts Have Similar Immunoregulatory Properties In Vitro but Distinct Gene Expression Profiles: Implications for Cellular Therapy.
|
Haniffa, Muzlifah A.
|
|
|
110 |
11 |
p. 1930
|
article
|
| 3063 |
Mesenchymal Stem Cells as Suicide Gene Therapy Vehicles for Organ-Confined and Metastatic Prostate Cancer (PCa).
|
Martiniello-Wilks, Rosetta
|
|
|
110 |
11 |
p. 5148
|
article
|
| 3064 |
Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.
|
Jianyu, Weng
|
|
|
110 |
11 |
p. 4968
|
article
|
| 3065 |
Mesenchymal Stem Cells from Patients with Myelodysplastic Syndromes Are Functionally and Genomically Abnormal.
|
Villar, Olga López
|
|
|
110 |
11 |
p. 1916
|
article
|
| 3066 |
Mesenchymal Stem Cells Improve Wound Healing Via Early Activation of the Matrix Metalloproteinase-9 and Vascular Endothelial Growth Factor: Using a 3-Dimensional Collagen Gel Model.
|
Won, Jong-Ho
|
|
|
110 |
11 |
p. 3696
|
article
|
| 3067 |
Mesenchymal Stem Cells Promoted Long-Term Graft Survival of Xenogenic Mouse Islet Cells in Recipient Mice.
|
Tan, Guangxiao
|
|
|
110 |
11 |
p. 612
|
article
|
| 3068 |
Mesenchymal Stromal Cells Derived from Human Non-Small Cell Lung Cancer, Normal Lung Tissue, and Bone Marrow: Differences in Frequency, Cytogenetics, Proliferation Behavior, and Chemosensitivity - Implications for Cancer Therapy.
|
Gottschling, Sandra
|
|
|
110 |
11 |
p. 1925
|
article
|
| 3069 |
Mesenchymal Stromal Cells Engineered To Express IL-12 for Breast Cancer Cellular Immunotherapy.
|
Eliopoulos, Nicoletta
|
|
|
110 |
11 |
p. 5142
|
article
|
| 3070 |
Mesenchymal Stromal Cells Gene-Enhanced To Express Human Factor IX and Their In Vivo Use for Correction of Hemophilia B Phenotype in R333Q Mice.
|
Coutu, Daniel L.
|
|
|
110 |
11 |
p. 5136
|
article
|
| 3071 |
Mesenchymal Stromal Cells Genetically Engineered To Overexpress Insulin-Like Growth Factor-1 Provide Paracrine Support for Cell-Based Erythropoietin Therapy of Chronic Renal Failure-Induced Anemia.
|
Kucic, Terrence
|
|
|
110 |
11 |
p. 2598
|
article
|
| 3072 |
Mesenchymal Stromal Cells (MSCs) Acquire Cardiac-Specific Markers but Do Not Become Functional Cardiomyocytes and Retain the Stromal Phenotype.
|
Rose, Robert A.
|
|
|
110 |
11 |
p. 1920
|
article
|
| 3073 |
Mesodermal Patterning Activity of the Transcription Factor SCL.
|
Ismailoglu, Ismail
|
|
|
110 |
11 |
p. 1241
|
article
|
| 3074 |
Meta Analysis: Rituximab as Maintenance Therapy for Patients with Follicular Lymphoma.
|
Vidal, Liat
|
|
|
110 |
11 |
p. 3408
|
article
|
| 3075 |
Metalloproteinase Inhibitors Increase the Survival of Long-Term Refrigerated Platelets in Mice.
|
Josefsson, Emma C.
|
|
|
110 |
11 |
p. 419
|
article
|
| 3076 |
Methodologic Variations in the Determinations of Anti-Platelet Factor 4-Heparin Antibodies in Patients Suspected of Having Heparin Induced Thrombocytopenia: Diagnostic and Prognostic Implications.
|
Fareed, Jawed
|
|
|
110 |
11 |
p. 3206
|
article
|
| 3077 |
Methotrexate and/or Rituximab in a New Nude Rat Central Nervous System Lymphoma Model: Efficacy, Toxicity and Magnetic Resonance Imaging.
|
Jahnke, Kristoph
|
|
|
110 |
11 |
p. 4515
|
article
|
| 3078 |
Methylation of CpG Islands Was Involved in the Down-Regulation of DAZAP2 in Multiple Meyloma Cells.
|
Hu, Wei-Xin
|
|
|
110 |
11 |
p. 4157
|
article
|
| 3079 |
Methylation of the PTPNS1 Promoter Region in Pediatric Acute Promyelocytic Leukemia.
|
Hubeek, Isabelle
|
|
|
110 |
11 |
p. 4315
|
article
|
| 3080 |
Methylation Profiles of p16, p15 and p14 Genes in Korean Patients with Multiple Myeloma.
|
Kang, Seong-Ho
|
|
|
110 |
11 |
p. 1504
|
article
|
| 3081 |
Methylation Profiling of Apoptotic Genes in Leukemia Cell Lines and Patients.
|
EL Ahdab, Samih
|
|
|
110 |
11 |
p. 4147
|
article
|
| 3082 |
Methylation Status of Tumor Suppressor Genes BEX2, IGSF4, RARB and TIMP3 Is Indicative for AML with Translocations of the MLL Gene.
|
Quentmeier, Hilmar
|
|
|
110 |
11 |
p. 2115
|
article
|
| 3083 |
Methylen Blue Photoinactivated Plasma vs Fresh Frozen Plasma in Thrombotic Thrombocytopenic Purpura Treatment: A Multicentric Prospective Cohort Study.
|
Alvarez-Larrán, Alberto
|
|
|
110 |
11 |
p. 1318
|
article
|
| 3084 |
Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms of Both Donor and Recipient Can Modify the Rate of Recurrence in Allogeneic Hematopoietic Stem Cell Transplantation.
|
Oh, So Yeon
|
|
|
110 |
11 |
p. 4933
|
article
|
| 3085 |
Methylprednisolone-Treatment Induces Dephosphorylation of Syk in B-CLL Cells In Vitro.
|
Boelens, Jerina
|
|
|
110 |
11 |
p. 4693
|
article
|
| 3086 |
Methylseleninic Acid (MSA) Decreases DNA Synthesis, Induces Cell Death, and Sensitizes Both Rituximab Sensitive and Rituximab-Resistant Non-Hodgkin's Lymphoma Cell Lines to the Anti-Tumor Activity of Cisplatin and Gemcitabine.
|
Hernandez-Ilizaliturri, Francisco J.
|
|
|
110 |
11 |
p. 4517
|
article
|
| 3087 |
MHC-Matched Stem Cell Transplantation in Rhesus Macaques Using a Costimulation Blockade-Based Immunomodulation Platform.
|
Kean, Leslie S.
|
|
|
110 |
11 |
p. 1189
|
article
|
| 3088 |
Micafungin Does Not Influence the Concentration of Tacrolimus in Patients after Allogeneic Hematopoietic Stem Cell Transplantation.
|
Fukuoka, Noriyasu
|
|
|
110 |
11 |
p. 4938
|
article
|
| 3089 |
MICA Polymorphism Identified by Whole Genome Array Constitutes a Disease Predisposition Factor in T-Cell Large Granular Lymphocyte Leukemia.
|
Viny, Aaron D.
|
|
|
110 |
11 |
p. 3304
|
article
|
| 3090 |
Mice Engineered To Express a Form of Thrombin Favoring Protein C Are Resistant to S. aureus-Induced Sepsis.
|
Flick, Matthew J.
|
|
|
110 |
11 |
p. 267
|
article
|
| 3091 |
Mice Lacking Pleckstrin or Pleckstrin-2 Each Have Unique Platelet Secretion Defects.
|
Wang, Yanfeng
|
|
|
110 |
11 |
p. 134
|
article
|
| 3092 |
Microarray Analysis Detects Unique Expression Pattern for NPM1-Mutated AML with Normal Karyotype and Reveals Pathobiological Insights.
|
Haferlach, Torsten
|
|
|
110 |
11 |
p. 2382
|
article
|
| 3093 |
Microarray Analysis of PU.1-Induced Growth Arrest and Apoptosis of Myeloma Cell Lines.
|
Ueno, Shikiko
|
|
|
110 |
11 |
p. 2499
|
article
|
| 3094 |
Microarray Classification of Myelodysplastic Syndrome (MDS) Identifies Subgroups with Distinct Clinical Outcomes.
|
Mills, Ken I.
|
|
|
110 |
11 |
p. 2426
|
article
|
| 3095 |
Microarray Identification of Differentially Expressed Genes in AHI-1- Mediated Leukemic Transformation of Human Cutaneous T-Cell Lymphoma Cells.
|
Kennah, Erin
|
|
|
110 |
11 |
p. 2651
|
article
|
| 3096 |
Microenvironmental Up-Regulation of NF-kB Activity Via P65-Dependent and Independent Pathways in a Bioimaging Model of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
|
Tsai, Hui-Jen
|
|
|
110 |
11 |
p. 723
|
article
|
| 3097 |
Microfluidic Tools To Probe the Spatial Dynamics of Coagulation.
|
Kastrup, Christian J.
|
|
|
110 |
11 |
p. 3934
|
article
|
| 3098 |
Microparticle Levels Are High in Patients with Hemophilia A and Can Be Further Increased by DDAVP Administration.
|
Artoni, Andrea
|
|
|
110 |
11 |
p. 3139
|
article
|
| 3099 |
Microparticles as a Predictor of Acute Deep Venous Thrombosis in a Patient with Antiphospholipid Antibody Syndrome.
|
Cockrell, Erin
|
|
|
110 |
11 |
p. 3984
|
article
|
| 3100 |
Microparticles (platelet, Endothelial, and Leucocyte) Are Elevated in Patients with Myeloproliferative Disorders.
|
Lynch, Susan
|
|
|
110 |
11 |
p. 1552
|
article
|
| 3101 |
MicroRNA Analysis by In Situ Hibridization in Hodgkin Lymphoma.
|
Navarro, Alfons
|
|
|
110 |
11 |
p. 2271
|
article
|
| 3102 |
microRNA Control of Hematopoietic Stem Cell Fitness and Myelopoiesis.
|
Velu, Chinavenmeni S.
|
|
|
110 |
11 |
p. 373
|
article
|
| 3103 |
MicroRNA Expression Analysis in Multiple Myeloma Plasma Cells and Cell Lines by a Quantitative Real-Time PCR Approach.
|
Bakkus, Marleen
|
|
|
110 |
11 |
p. 2472
|
article
|
| 3104 |
MicroRNA Expression in Red Blood Cells from Patients with PNH.
|
Chi, Jen-Tsan Ashley
|
|
|
110 |
11 |
p. 3675
|
article
|
| 3105 |
MicroRNA Expression Profiles in Acute Myeloid Leukemia with Common Translocations.
|
Li, Zejuan
|
|
|
110 |
11 |
p. 3181
|
article
|
| 3106 |
MicroRNA Expression Profiling Characterize Diffuse Large B-Cell Lymphomas and Follicular Lymphomas.
|
Roehle, Anja
|
|
|
110 |
11 |
p. 3186
|
article
|
| 3107 |
MicroRNA Expression Signatures Accurately Discriminate Acute Lymphoblastic Leukemia from Acute Myeloid Leukemia.
|
Mi, Shuangli
|
|
|
110 |
11 |
p. 231
|
article
|
| 3108 |
MicroRNA-Mediated Down-Regulation of the Tumor Suppressor Gene PRDM1/Blimp-1 in Diffuse Large B-Cell Lymphomas.
|
Nie, Kui
|
|
|
110 |
11 |
p. 3187
|
article
|
| 3109 |
microRNA-Mediated Gene Regulation Effectively Restricts In Vivo Transgene Expression in Hematopoietic Stem Cell Progeny.
|
Papapetrou, Eirini P.
|
|
|
110 |
11 |
p. 193
|
article
|
| 3110 |
MicroRNA (miRNA)-29b Targets DNMT3A and B and Induces Re-Expression of the Hypermethylated ESR1 and p15 Genes in Acute Myeloid Leukemia (AML).
|
Garzon, Ramiro
|
|
|
110 |
11 |
p. 718
|
article
|
| 3111 |
MicroRNA Profiling of EVI1 Deregulated Myeloid Leukemia.
|
De Weer, An
|
|
|
110 |
11 |
p. 4146
|
article
|
| 3112 |
MicroRNA Profiling of Human Acute Myeloid Leukemia and Normal Hematopoietic Stem/Progenitor Cells Reveals a Leukemia Stem Cell Signature.
|
Park, Christopher Y.
|
|
|
110 |
11 |
p. 779
|
article
|
| 3113 |
MicroRNA-155 Promotes Myeloid Proliferation and Is Overexpressed in Acute Myeloid Leukemia.
|
Rao, Dinesh S.
|
|
|
110 |
11 |
p. 715
|
article
|
| 3114 |
MicroRNAs Act as Decoy Molecules To Restore Granulocytic Maturation of Differentiation-Arrested BCR/ABL+ Myeloid Precursors.
|
Eiring, Anna M.
|
|
|
110 |
11 |
p. 31
|
article
|
| 3115 |
MicroRNAs 155 and 451 as Possible Key Molecules for Human Erythroid Differentiation.
|
Umemura, Tsukuru
|
|
|
110 |
11 |
p. 4071
|
article
|
| 3116 |
MicroRNAs as the Target of Deletions on der(9) in Chronic Myeloid Leukemia.
|
Albano, Francesco
|
|
|
110 |
11 |
p. 2926
|
article
|
| 3117 |
MicroRNAs Specific for Immune-Privileged Diffuse Large B-Cell Lymphoma.
|
Robertus, JanLukas
|
|
|
110 |
11 |
p. 1566
|
article
|
| 3118 |
Microvascular Endothelial Cells Express Phosphatidylserine Receptor: A Functionally Active Receptor for Phosphatidylserine-Positive Erythrocytes.
|
Setty, Yamaja B.N.
|
|
|
110 |
11 |
p. 1720
|
article
|
| 3119 |
Microvesicle Information Transfer from Lung to Marrow Cells.
|
Aliotta, Jason
|
|
|
110 |
11 |
p. 437
|
article
|
| 3120 |
Mid-Treatment Evaluation of 18-FDG-Positron Emission Tomography/Computed Tomography (PET) as Predictive Value of Response Assessment in Aggressive Non Hodgkin Lymphoma (NHL).
|
Pregno, Patrizia
|
|
|
110 |
11 |
p. 2333
|
article
|
| 3121 |
Migration of Donor Cells from the Yolk Sac to Fetal Tissues after In Utero Transplantation of Early to Mid-Gestation Canine Fetuses.
|
Vaags, Andrea K.
|
|
|
110 |
11 |
p. 1201
|
article
|
| 3122 |
Minicircle Plasmid Containing the Human Manganese Superoxide Dismutase (MnSOD) Transgene Confers Radioprotection to Hematopoietic Progenitor Cell Line 32Dcl3.
|
Zhang, Xichen
|
|
|
110 |
11 |
p. 5138
|
article
|
| 3123 |
Minimal Residual Disease Detection by Four-Color Multidimensional Flow Cytometry Identifies Pediatric AML Patients at High Risk of Relapse.
|
Meshinchi, Soheil
|
|
|
110 |
11 |
p. 1429
|
article
|
| 3124 |
Minimal Residual Disease in High and Very High Risk ALL (HR/VHR-ALL) at the End of Induction (EOI) in FRALLE 2000 B and T Protocols.
|
Cayuela, Jean-Michel
|
|
|
110 |
11 |
p. 1427
|
article
|
| 3125 |
Minimal Residual Disease Monitoring by RQ-PCR in Core Binding Factor Positive AML Allows Risk-Stratification and Predicts Relapse: Results of the UK MRC AML-15 Trial.
|
Liu-Yin, John Ahman
|
|
|
110 |
11 |
p. 543
|
article
|
| 3126 |
Minimal Residual Disease (MRD) after Frontline Therapy in Adolescent and Young Adult (AYA) Patients with Acute Lymphoblastic Leukemia (ALL) Treated on Two Separate Regimens.
|
Rytting, Michael
|
|
|
110 |
11 |
p. 4344
|
article
|
| 3127 |
Minimal Residual Disease (MRD)-Oriented Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Results of Northern Italy Leukemia Group Study 09/00.
|
Bassan, Renato
|
|
|
110 |
11 |
p. 3497
|
article
|
| 3128 |
Minimal Residual Disease Status Is the Most Important Preditive Factor in Adults with Acute Lymphoblastic Leukemia. Prospective, Multicenter PALG 4-2002 MRD Study.
|
Holowiecki, Jerzy
|
|
|
110 |
11 |
p. 2821
|
article
|
| 3129 |
Mir-135a Expression Is Associated with Relapse in Hodgkin Lymphoma.
|
Navarro, Alfons
|
|
|
110 |
11 |
p. 2270
|
article
|
| 3130 |
Mirasol™ Pathogen Reduction of Packed Red Blood Cells (PRBCs) and Apheresis Platelet (Aplt) Concentrates Decreases Neutrophil Priming Activity Generated during Storage.
|
Ambruso, Daniel R.
|
|
|
110 |
11 |
p. 2893
|
article
|
| 3131 |
MiRNA-29b Targets MCL-1 and Is Down-Regulated in Chemotherapy-Resistant Acute Myeloid Leukemia (AML).
|
Garzon, Ramiro
|
|
|
110 |
11 |
p. 717
|
article
|
| 3132 |
miRNA Expression Profile of B-SLL Consistent with Normal Memory B Cells:BIC/miR–155 Specific Location in Proliferation Center.
|
Wang, Miao
|
|
|
110 |
11 |
p. 2081
|
article
|
| 3133 |
MiRNA Profiles in Acute Lymphoblastic Leukemia: Rather a Characteristic for the Leukemia Subtype Than a Reflection of Its Differentiation Status.
|
Schotte, Diana
|
|
|
110 |
11 |
p. 4144
|
article
|
| 3134 |
Mismatches in Low Expression HLA Class II Loci and MIC-A in Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT).
|
Patah, Poliana
|
|
|
110 |
11 |
p. 3050
|
article
|
| 3135 |
Missense Mutation of the Last Nucleotide of Exon 1 of β-globin Gene Interferes with the Expression of Wild Allele.
|
Agarwal, Neeraj
|
|
|
110 |
11 |
p. 1777
|
article
|
| 3136 |
Missplicing of Glycogen Synthase Kinase 3β: A Potential Mechanism of Blast Crisis Chronic Myeloid Leukemia Stem Cell Generation.
|
Abrahamsson, Annelie
|
|
|
110 |
11 |
p. 775
|
article
|
| 3137 |
Mitosis Is Not Required for Coordinated Changes in Iron Metabolism and High-Level Globin Gene Transcription in Erythropoietin-Responsive CD34+ Cells.
|
Bhupatiraju, Ajoy V.
|
|
|
110 |
11 |
p. 1776
|
article
|
| 3138 |
Mitoxantrone and Cytarabine Combination in Untreated Elderly Patients with Acute Myeloid Leukemia (AML): A Retrospective Single-Centre Analysis.
|
Marinakis, Theodore
|
|
|
110 |
11 |
p. 4372
|
article
|
| 3139 |
MKL1 Enhances Megakaryocytic Differentiation of Primary CD34+ Cells.
|
Renda, Matthew J.
|
|
|
110 |
11 |
p. 2218
|
article
|
| 3140 |
MKL1 Promotes Megakaryocytic Differentiation Via Stimulation of Serum Response Factor Target Genes.
|
Cheng, Ee-chun
|
|
|
110 |
11 |
p. 871
|
article
|
| 3141 |
MMY-3002: A Phase 3 Study Comparing Bortezomib-Melphalan-Prednisone (VMP) with Melphalan-Prednisone (MP) in Newly Diagnosed Multiple Myeloma.
|
Miguel, J.F. San
|
|
|
110 |
11 |
p. 76
|
article
|
| 3142 |
Mobilised Peripheral Blood Could Be a Suitable Source of Mesenchymal Stem Cells?.
|
Almici, Camillo
|
|
|
110 |
11 |
p. 4103
|
article
|
| 3143 |
Mobilization, Harvesting and Transplantation of Peripheral Blood Stem Cells in Patients with Severe Refractory Systemic Lupus Erythematosus - A Single Center Experience.
|
Xiao, Yi
|
|
|
110 |
11 |
p. 5107
|
article
|
| 3144 |
Mobilization of Normal Mouse Progenitors and Acute Promyelocytic Leukemia (APL) Cells with Inhibitors of CXCR4 and VLA-4 in Splenectomized and Unsplenectomized Mice.
|
Ramirez, Pablo A.
|
|
|
110 |
11 |
p. 2219
|
article
|
| 3145 |
Modified Topotecan Combination with Cyclophosphamide and Ara-C (CAT) for Patients with Refractory/Relapsed Leukemia.
|
Wu, Sui-jing
|
|
|
110 |
11 |
p. 4357
|
article
|
| 3146 |
Modulated Expression of BCL-xL and GATA-1 Genes Is a Common Feature in Myeloproliferative Disorders (MPD) Both in JAK2-V617F Positive and Negative Patients
|
Pozzi, Sarah
|
|
|
110 |
11 |
p. 1533
|
article
|
| 3147 |
Modulating Cholesterol Levels on Bone Marrow Cells Affects Endothelial and Hematopoietic Cell Mobilization and Differentiation.
|
Gomes, Ana
|
|
|
110 |
11 |
p. 1413
|
article
|
| 3148 |
Modulation of Arginase Pathway by Chloroquine and Its Congener May Underlie the Enhanced Cell Commitment towards Erythroid Differentiation.
|
Iyamu, Efemwonkiekie W.
|
|
|
110 |
11 |
p. 3394
|
article
|
| 3149 |
Modulation of CD20 Expression in Rituximab-Sensitive (RSCL) and Rituximab Resistant Cell Lines (RRCL) Using IL-4 and Bryostatin-1.
|
Tsai, Ping-Chiao
|
|
|
110 |
11 |
p. 2619
|
article
|
| 3150 |
Modulation of Fox-Regulated Alternative Splicing Events during Erythropoiesis.
|
Gallagher, Thomas L.
|
|
|
110 |
11 |
p. 142
|
article
|
| 3151 |
Modulation of Gene Expression Profile and In Vivo Anti-Myeloma Activity Induced by Valproic Acid, a Histone Deacytylase Inhibitor.
|
Neri, Paola
|
|
|
110 |
11 |
p. 4790
|
article
|
| 3152 |
Modulation of IRP Binding Activity by Oxygen in Primary Erythroid Cells.
|
Schranzhofer, Matthias
|
|
|
110 |
11 |
p. 2662
|
article
|
| 3153 |
Modulation of Platelet Function by Recombinant Thrombomodulin Hematologic Implications.
|
Adiguzel, Cafer
|
|
|
110 |
11 |
p. 3898
|
article
|
| 3154 |
Modulation of Responsiveness of Human CD34+ Cells to CXL12/SDF-1 through Desensitization of CXCR4 by CCR5 Chemokines: Possible Implications for Mobilization during Inflammation.
|
Basu, Sunanda
|
|
|
110 |
11 |
p. 2238
|
article
|
| 3155 |
Modulation of Tryptophan Catabolism by Acute Myeloid Leukemia Cells Acts as a General Mechanism of Immune Tolerance Via the Induction of T Regulatory Cells.
|
Curti, Antonio
|
|
|
110 |
11 |
p. 1345
|
article
|
| 3156 |
Molecular Allelo-Karyotyping of Adult T-Cell Leukemia Using High SNP Genotyping Microarrays.
|
Muto, Satsuki
|
|
|
110 |
11 |
p. 2385
|
article
|
| 3157 |
Molecular Analysis of WASP Gene - First Report from India.
|
Jacob, Rintu Rebecca
|
|
|
110 |
11 |
p. 3217
|
article
|
| 3158 |
Molecular and Clinical Features of B Cell Chronic Lymphocytic Leukemia (CLL) Carrying Stereotyped B Cell Receptors: An Italian Experience.
|
Bomben, Riccardo
|
|
|
110 |
11 |
p. 3089
|
article
|
| 3159 |
Molecular and Transcriptional Characterization of the Novel 17p11.2-p12 Chromosome Amplification in Multiple Myeloma.
|
Fabris, Sonia
|
|
|
110 |
11 |
p. 2486
|
article
|
| 3160 |
Molecular Background of “Smeary” von Willebrand Factor Multimers.
|
Schneppenheim, Reinhard
|
|
|
110 |
11 |
p. 2711
|
article
|
| 3161 |
Molecular Basis Explanation of Imatinib Resistance of Bcr-Abl Due to T315I and P-Loop Mutations from Molecular Dynamics Simulations.
|
Lee, Tai-Sung
|
|
|
110 |
11 |
p. 2917
|
article
|
| 3162 |
Molecular Characterization and Drug-Sensitivity of Pan Histone Deacetylase Inhibitor Resistant Human Acute Myeloid Leukemia Cells.
|
Fiskus, Warren
|
|
|
110 |
11 |
p. 807
|
article
|
| 3163 |
Molecular Characterization of a Prototype Family Harboring Two Genomic Instability Disorders: Ataxia Telangiectasia and Fanconi Anemia.
|
Balta, Gunay
|
|
|
110 |
11 |
p. 1680
|
article
|
| 3164 |
Molecular Characterization of Three New Mutant Enzymes of Pyrimidine 5′-Nucleotidase Causing Hereditary Hemolytic Anemia.
|
Chiarelli, Laurent R.
|
|
|
110 |
11 |
p. 1730
|
article
|
| 3165 |
Molecular Classifiers for Prediction of Minimal Residual Disease (MRD) and Event Free Survival (EFS) Improve Risk Assignment at Diagnosis in Pediatric High-Risk B Precursor Acute Lymphoblastic Leukemia (ALL): A Children's Oncology Group Study.
|
Kang, Huining
|
|
|
110 |
11 |
p. 1422
|
article
|
| 3166 |
Molecular Effects of Rituximab on CLL Cells In Vivo: Rapid Increase in Serum Interferon gamma, Induction of a Distinct Tumor Cell Gene Expression Signature and Loss of CD20 Expression.
|
Wiestner, Adrian
|
|
|
110 |
11 |
p. 2048
|
article
|
| 3167 |
Molecular Inversion Probes (MIPs) Identify Novel Areas of Allelic Imbalance in Childhood Leukemia.
|
Schiffman, Joshua D.
|
|
|
110 |
11 |
p. 1438
|
article
|
| 3168 |
Molecular Level of Minimal Residual Disease in Bone Marrow Before High-Dose Therapy and Autologous Stem Cell Transplantation Is a Prognostic Parameter in Patients with Multiple Myeloma.
|
Fenk, Roland
|
|
|
110 |
11 |
p. 1496
|
article
|
| 3169 |
Molecular Markers Predicting Clinical Outcome in Patients with Intermediate-Risk Acute Myeloid Leukemia Receiving Autologous Stem Cell Transplantation.
|
Esteve, Jordi
|
|
|
110 |
11 |
p. 604
|
article
|
| 3170 |
Molecular Mechanisms of Bortezomib Resistance in Acute Lymphoblastic Leukemia Cells in Comparison with Multiple Myeloma Cells.
|
Franke, Niels E.
|
|
|
110 |
11 |
p. 3469
|
article
|
| 3171 |
Molecular Mechanisms of Cell Density-Dependent Growth in Myeloid and Lymphoid Leukemia Cell Lines.
|
Murohashi, Ikuo
|
|
|
110 |
11 |
p. 4122
|
article
|
| 3172 |
Molecular Mechanisms of NF-kappaB Activation by the HTLV-I Oncoprotein Tax: Role of Post Translational Protein Modification.
|
Kfoury, Youmna
|
|
|
110 |
11 |
p. 4159
|
article
|
| 3173 |
Molecular Mechanisms of Spindle Checkpoint-Apoptosis Linkage and Karyotypic Stability in Stem Cells.
|
Mantel, Charlie
|
|
|
110 |
11 |
p. 3361
|
article
|
| 3174 |
Molecular Monitoring of ERG and BAALC as Minimal Residual Disease Markers in Patients with Acute Leukemia.
|
Najima, Yuho
|
|
|
110 |
11 |
p. 4249
|
article
|
| 3175 |
Molecular, Phenotypic and Clinical Predictors of Richter Syndrome (RS) in Chronic Lymphocytic Leukemia (CLL).
|
Rossi, Davide
|
|
|
110 |
11 |
p. 3086
|
article
|
| 3176 |
Molecular Prognostic Factors and Outcome among a Cohort of Patients with Monoclonal B-Cell Lymphocytosis (MBL).
|
Maddocks-Christianson, Kami
|
|
|
110 |
11 |
p. 748
|
article
|
| 3177 |
Molecular Quantification of Pre-Treatment Bone Marrow Clonal Cells in Multiple Myeloma Is a Novel Predictive Indicator of Remission Length.
|
Thulien, Kyle J.
|
|
|
110 |
11 |
p. 4757
|
article
|
| 3178 |
Molecular Remission in MLL/AF4-Positive Infant Leukemia Treated with the All Trans-Retinoic Acid Based MLL-Baby Protocol.
|
Tsaur, Grigory
|
|
|
110 |
11 |
p. 4254
|
article
|
| 3179 |
Molecular Response According to Type of Preexisting BCR-ABL Mutations after Second Line Dasatinib Therapy in Chronic Phase CML Patients.
|
Mueller, Martin C.
|
|
|
110 |
11 |
p. 319
|
article
|
| 3180 |
Molecular Signature of Distinct CD34+ Hematopoietic Stem and Progenitor Cell Subsets of Patients with CML in Chronic Phase.
|
Bruns, Ingmar
|
|
|
110 |
11 |
p. 3170
|
article
|
| 3181 |
Molecular Studies of Neutropenia in Barth Syndrome.
|
Aprikyan, Andrew A.
|
|
|
110 |
11 |
p. 3293
|
article
|
| 3182 |
Monitoring Endothelial Cell Activation In Vivo during Thrombus Formation.
|
Atkinson, Ben T.
|
|
|
110 |
11 |
p. 294
|
article
|
| 3183 |
Monitoring for HLA Antibodies in Cord Blood Transplantation.
|
Gutman, Jonathan A.
|
|
|
110 |
11 |
p. 2031
|
article
|
| 3184 |
Monitoring Immune Function in the Allogeneic Transplant Recipient: Predicting Graft vs Host Disease (GvHD) and Infection.
|
Anaissie, Elias J.
|
|
|
110 |
11 |
p. 1966
|
article
|
| 3185 |
Monitoring of Incipient Haematological Relapse by CD34+ Donor Chimerism Determination in Patients with Acute Myelogenous Leukaemia and Myelodysplastic Syndrome after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Low Dose TBI-Based Conditioning Regimens.
|
Niederwieser, Dietger W.
|
|
|
110 |
11 |
p. 5033
|
article
|
| 3186 |
Monitoring of Serum Hepcidin-25 in Multicentric Castleman's Disease Patients Treated with Tocilizumab, an Anti-Interleukin-6 Receptor Antibody.
|
Kawabata, Hiroshi
|
|
|
110 |
11 |
p. 3686
|
article
|
| 3187 |
Monoclonal B Cell Lymphocytosis as a Marker of Inherited Predisposition to Chronic Lymphocytic Leukemia.
|
Lanasa, Mark C.
|
|
|
110 |
11 |
p. 3090
|
article
|
| 3188 |
Monoclonal B Cell Lymphocytosis Exhibits Biologic Diversity Similar to Chronic Lymphocytic Leukemia.
|
Lanasa, Mark C.
|
|
|
110 |
11 |
p. 3084
|
article
|
| 3189 |
Monoclonal B-Cell Lymphocytosis (MBL) Is a Precursor State for Chronic Lymphocytic Leukemia (CLL) with 1% Progression Per Year.
|
Rawstron, Andy C.
|
|
|
110 |
11 |
p. 749
|
article
|
| 3190 |
Monoclonal Gammopathy of Undetermined Significance: Estimated Incidence and Duration Prior to Recognition.
|
Kyle, Robert A.
|
|
|
110 |
11 |
p. 246
|
article
|
| 3191 |
Monoclonal Gammopathy of Undetermined Significance with an IgE Paraprotein.
|
Ayto, Robert M.
|
|
|
110 |
11 |
p. 4744
|
article
|
| 3192 |
Monoclonal Immunoglobulins of Alpha-2 Mobility on Protein Electrophoresis: A Case Series.
|
Chari, Ajai
|
|
|
110 |
11 |
p. 4753
|
article
|
| 3193 |
Monosodium Urate Crystal as a Carrier for Idiotype Tumor Vaccine.
|
Sakamaki, Ippei
|
|
|
110 |
11 |
p. 4893
|
article
|
| 3194 |
Monosomy 7 Detected by FISH at Disease Presentation Is a Marker for Non-Response to Immunosuppression.
|
Sloand, Elaine
|
|
|
110 |
11 |
p. 1697
|
article
|
| 3195 |
More Rapid Outgrowth Kinetics of BCR-ABL Mutations in Advanced Versus Newly Diagnosed Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Clinical-Translational Evidence for a Contributory Role of Non-Mutational Resistance Mechanisms.
|
Pfeifer, Heike
|
|
|
110 |
11 |
p. 10
|
article
|
| 3196 |
Morphine Stimulates the Phosphorylation and Nuclear Translocation of EGFR in Lung Cancer Cells.
|
Nguyen, Julia
|
|
|
110 |
11 |
p. 4206
|
article
|
| 3197 |
Mortality Rate and Risk Factors among Males with Hemophilia Receiving Care in U.S. Hemophilia Treatment Centers (HTCs).
|
Larsen, Nina M.
|
|
|
110 |
11 |
p. 1143
|
article
|
| 3198 |
Motexafin Gadolinium (MGD) Induces Oxidant Stress and Downregulates Both Pro and Anti-Oxidant Genes in the Ramos Lymphoma Cell Line: Signaling through p53 Mediated Pathways.
|
Singh, Amareshwar T.K.
|
|
|
110 |
11 |
p. 4429
|
article
|
| 3199 |
Mouse Hematopoietic Stem Cells, Unlike Human and Mouse Embryonic Stem Cells, Exhibit Checkpoint-Apoptosis Coupling.
|
Rohrabaugh, Sara
|
|
|
110 |
11 |
p. 3357
|
article
|
| 3200 |
MOZ and MOZ-CBP Cooperate with NFκB To Induce Expression of NFκB-Dependent Genes.
|
Chan, Edward M.
|
|
|
110 |
11 |
p. 887
|
article
|
| 3201 |
MRD Kinetics in Adult Transplantation Recipients with Relapsed Acute Lymphoblastic Leukemia Depend on Initial Molecular Response to Front-Line Chemotherapy.
|
Brüggemann, Monika
|
|
|
110 |
11 |
p. 2799
|
article
|
| 3202 |
MTHFR 677CC/1298CC Genotypes Are Highly Associated with Chronic Myelogenous Leukemia: A Case-Control Study in Korea.
|
Moon, Hee Won
|
|
|
110 |
11 |
p. 4533
|
article
|
| 3203 |
MT1-MMP and RECK Inversely Regulate Hematopoietic Progenitor Cell Egress.
|
Avigdor, Abraham
|
|
|
110 |
11 |
p. 1259
|
article
|
| 3204 |
mTOR Inhibition for Relapsed or Refractory Hodgkin Lymphoma: Promising Single Agent Activity with Everolimus (RAD001).
|
Johnston, Patrick B.
|
|
|
110 |
11 |
p. 2555
|
article
|
| 3205 |
mTOR Inhibitor Rapamycin Interacts Synergistically with Farnesyltransferase Inhibitor FTI-277 To Induce Growth Inhibition in Human Leukemia Cells.
|
Cheong, June-Won
|
|
|
110 |
11 |
p. 1821
|
article
|
| 3206 |
Muc1 Expression Identifies Human Self-Renewing Stem/Progenitor Populations and Is Elevated in AML CD34+ Cells.
|
Fatrai, Szabolcs
|
|
|
110 |
11 |
p. 4040
|
article
|
| 3207 |
Multicenter Experience with Imatinib Mesylate in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients.
|
Carella, A.M.
|
|
|
110 |
11 |
p. 4554
|
article
|
| 3208 |
Multi-Center Phase II Study of CAMPATH-1H Dose De-Escalation Prior to Nonmyeloablative HLA-Identical Sibling Transplantation.
|
Chakraverty, Ronjon
|
|
|
110 |
11 |
p. 1055
|
article
|
| 3209 |
Multi-Center Phase II Study of Perifosine (KRX-0401) Alone and in Combination with Dexamethasone (dex) for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Promising Activity as Combination Therapy with Manageable Toxicity.
|
Richardson, Paul
|
|
|
110 |
11 |
p. 1164
|
article
|
| 3210 |
Multicenter Phase II Trial of Patients with Refractory or Recurrent Multiple Myeloma with Oral Treatment of Thalidomide Combined with Oral Cyclophosphamide, Idarubicin and Dexamethasone.
|
Glasmacher, Axel
|
|
|
110 |
11 |
p. 4825
|
article
|
| 3211 |
Multicenter Phase II Trial of 90Y-Ibritumomab Tiuxetan with High-Dose Chemotherapy (Busulfan/Cyclophosphamide/Etoposide) Followed by Autologous Stem Cell Transplantation in Relapsed, Refractoried, or High-Risk B-Cell NHL.
|
Kang, Byung Woog
|
|
|
110 |
11 |
p. 1914
|
article
|
| 3212 |
Multi-Center Prospective Trial on Conditioning with Treosulfan, Fludarabine and ATG Before Allogeneic HSCT from Unrelated Donors.
|
Michallet, Mauricette
|
|
|
110 |
11 |
p. 4949
|
article
|
| 3213 |
Multicenter, Randomized, Phase III Study Comparing Imatinib (Glivec) Standard Dose (400 mg/d) with Imatinib High Dose Induction (800 mg/d) Followed by Imatinib Maintenance (400 mg/d) in Patients with Pretreated Ph+/BCR-ABL+ CML in Chronic Phase - Results from the First Planned Interim Analysis (CELSG-CML 11 ISTAHIT Study).
|
Petzer, Andreas L.
|
|
|
110 |
11 |
p. 1048
|
article
|
| 3214 |
Multicytokine and Polyfunctional CMV-Specific T Cells Are Associated with Stem Cell Transplant Donor CMV Serostatus.
|
Zhou, Wendi
|
|
|
110 |
11 |
p. 4992
|
article
|
| 3215 |
Multidrug Resistance Gene (MDR1) Polymorphisms May Serve as Predictors of Resistance to Imatinib in Chronic Phase Chronic Myeloid Leukemia Patients.
|
Soverini, Simona
|
|
|
110 |
11 |
p. 1946
|
article
|
| 3216 |
Multi-Drug Resistant Leukemic Cells Highly Express HLA Class I Molecules and Single-Chain Fv Diabody Specific to HLA-A Overcomes Drug Resistance in These Cells.
|
Jalili, Ali
|
|
|
110 |
11 |
p. 2376
|
article
|
| 3217 |
Multimethod Clinical Assessment of Patterns and Prevalence of Nonadherence (NA) to Imatinib Treatment (IMRx) in Patients (Pts) with Chronic Myeloid Leukemia (CML): Results from the ADAGIO Study.
|
van Lierde, Marie-Anne
|
|
|
110 |
11 |
p. 5163
|
article
|
| 3218 |
Multiple Defects of Both Primitive and Definitive Erythrocytes in EKLF-Deficient Mice.
|
Pilon, Andre M.
|
|
|
110 |
11 |
p. 1234
|
article
|
| 3219 |
Multiple Erythroid Ankyrin Isoforms in the Mouse Cerebellum: Differential Localization in Purkinje Cells.
|
Birkenmeier, Connie B.
|
|
|
110 |
11 |
p. 1725
|
article
|
| 3220 |
Multiple Myeloma Cell-Osteoblast Interaction Results in Impaired Bone Formation.
|
Vallet, Sonia
|
|
|
110 |
11 |
p. 4764
|
article
|
| 3221 |
Multiple Myeloma in Manitoba: A Population Based Study.
|
Szwajcer, David
|
|
|
110 |
11 |
p. 3326
|
article
|
| 3222 |
Multiple Myeloma (MM) Is Characterized by Genomic Instability Regardless of Ploidy Categories and Degree of Karyotypic Complexity Is an Important Prognostic Factor.
|
Chng, Wee J.
|
|
|
110 |
11 |
p. 1476
|
article
|
| 3223 |
Multiple Myeloma with IGH-Involving del(14q): Report of 34 Cases.
|
Wlodarska, Iwona
|
|
|
110 |
11 |
p. 991
|
article
|
| 3224 |
Multiplex Analysis of Serum Cytokine Levels in Waldenström Macroglobulinemia Patients.
|
Elsawa, Sherine F.
|
|
|
110 |
11 |
p. 2616
|
article
|
| 3225 |
Multi-Scale Analysis of Granulopoiesis: A Bottoms-Up Approach.
|
Lee, Daniel W.
|
|
|
110 |
11 |
p. 3854
|
article
|
| 3226 |
Multisite Phosphorylation of NIPA at G2/M.
|
Illert, Anna L.
|
|
|
110 |
11 |
p. 3348
|
article
|
| 3227 |
Multi-Targeted Receptor Tyrosine Kinase Inhibitor, ABT-869, Induces Apoptosis and Inhibition of Proliferation of Ba/F3 FLT-3 ITD Mutant Cells.
|
Hernandez, Jenny E.
|
|
|
110 |
11 |
p. 1589
|
article
|
| 3228 |
Multivariate Analysis of Factors Influencing Stomatitis in Allogeneic Hematopoietic Stem Cell Transplantation.
|
Ohbayashi, Yumiko
|
|
|
110 |
11 |
p. 4937
|
article
|
| 3229 |
Multivariate Analysis Suggests That the Prognostic Impact of Poor Cytogenetics Is Potentially Underestimated in the IPSS.
|
Schanz, Julie
|
|
|
110 |
11 |
p. 248
|
article
|
| 3230 |
Multivariate Evaluation of the Prognostic and Therapeutic Relevance of Cytogenetics in a Merged European-American Cohort of 3860 Patients with MDS.
|
Haase, Detlef
|
|
|
110 |
11 |
p. 247
|
article
|
| 3231 |
Mutant TIRAP Gene Polymorphism Is Associated with Outcomes in HLA Genoidentical Bone Marrow Transplants Recipients with Leukemia.
|
Rocha, Vanderson
|
|
|
110 |
11 |
p. 327
|
article
|
| 3232 |
Mutated IGHV 1-69 B-CLL Patients Have Indolent Disease and Short CDR3 Sequences.
|
Galligan, Leeona
|
|
|
110 |
11 |
p. 4695
|
article
|
| 3233 |
Mutational Analysis of Chronic Myeloid Leukemia (CML) Clones Reveals Heightened BCR-ABL1 Genetic Instability and Wild-Type BCR-ABL1 Exhaustion in Patients Failing Sequential Imatinib and Dasatinib Therapy.
|
Quintás-Cardama, Alfonso
|
|
|
110 |
11 |
p. 1938
|
article
|
| 3234 |
Mutational Analysis of Thrombopietin, c-MPL and Jak2 Genes in Essential Thrombothethymia Patients - Identification of Concurrent Mutations of c-MPL and Jak2.
|
Ding, Jianmin
|
|
|
110 |
11 |
p. 4658
|
article
|
| 3235 |
Mutational Loss of PTEN Induces Resistance to NOTCH1 Inhibition in T-ALL.
|
Ferrando, Adolfo
|
|
|
110 |
11 |
p. 5
|
article
|
| 3236 |
Mutation and Methylation Analysis of WWOX and CYLD on 16q; Potential Tumor Suppressor Genes in Myeloma.
|
Walker, Brian A.
|
|
|
110 |
11 |
p. 2473
|
article
|
| 3237 |
Mutation of the Wilms' Tumor 1 Gene Is a Poor Prognostic Factor Associated with Chemoresistance in Normal Karyotype Acute Myeloid Leukemia.
|
Virappane, Priya
|
|
|
110 |
11 |
p. 361
|
article
|
| 3238 |
Mutation Screening of GPIIb and GPIIIa Exons by Conformation Sensitive Gel Electrophoresis.
|
Kannan, Meganathan
|
|
|
110 |
11 |
p. 3218
|
article
|
| 3239 |
Mutations in Specific NOTCH1 Domains Convey a Distinct Phenotype in Adult Acute T-Lymphoblastic Leukemia.
|
Thibaut, Julia
|
|
|
110 |
11 |
p. 152
|
article
|
| 3240 |
Mutations in the Catalytic Subunit of Class IA PI3K Are Leukemogenic In Vivo.
|
Horn, Stefan
|
|
|
110 |
11 |
p. 875
|
article
|
| 3241 |
Mutations in the Exon 12 of the JAK2 Gene Appeared To Be a Rare Event Essentially Clustered in V617F JAK2 Negative PV Patients.
|
Kouroupi, Eirini
|
|
|
110 |
11 |
p. 2534
|
article
|
| 3242 |
Mutations of the Genes for Ribosomal Proteins L5 and L11 Are a Common Cause of Diamond-Blackfan Anemia.
|
Gazda, Hanna T.
|
|
|
110 |
11 |
p. 421
|
article
|
| 3243 |
Mutations That Cooperate with Nf1 Inactivation in Leukemogenesis Influence Therapeutic Response to MEK Inhibition.
|
Lauchle, Jennifer O.
|
|
|
110 |
11 |
p. 594
|
article
|
| 3244 |
Mutations within BCR-ABL1 295–312 Define a Novel Region Associated with Poor Prognosis in Patients with Chronic Myelogenous Leukemia (CML) Resistant to Imatinib.
|
Quintás-Cardama, Alfonso
|
|
|
110 |
11 |
p. 1936
|
article
|
| 3245 |
Mutual Regulatory Loop between miR-155 and PU.1 Is a Candidate Pathogenesis Factor in CLL.
|
Stopka, Tomas
|
|
|
110 |
11 |
p. 1130
|
article
|
| 3246 |
Myc Induces Acute Myeloid Leukemia by Conferring Self-Renewal Activity to Committed Myeloid Progenitor Cells That Resist Apoptosis Via Endogenous Mcl-1.
|
Luo, Hui
|
|
|
110 |
11 |
p. 2634
|
article
|
| 3247 |
Mycophenolic Acid Causes Dysfunction of Human Polymorphonuclear Neutrophils and Dendritic Cells during the Interaction with Aspergillus fumigatus.
|
Loeffler, Juergen
|
|
|
110 |
11 |
p. 3849
|
article
|
| 3248 |
Mycosis Fungoide: Immunochemistry Analysis of Lymphoid and Microenvironment Cells by Macrotissue Array.
|
del Agua, Celia
|
|
|
110 |
11 |
p. 4400
|
article
|
| 3249 |
Myeloablative Intravenous Busulfan/Fludarabine Conditioning Does Not Facilitate Reliable Engraftment of Dual Umbilical Cord Blood Grafts in Adult Recipients.
|
Horwitz, Mitchell
|
|
|
110 |
11 |
p. 2007
|
article
|
| 3250 |
Myelodisplastic Syndrome: Is It Associated or Is It a Precursor of Myeloid Malignancies?.
|
Corinaldesi, Giorgio
|
|
|
110 |
11 |
p. 4592
|
article
|
| 3251 |
Myelodysplastic Syndrome: A Study of VA Population.
|
Matacia-Murphy, Gina M.
|
|
|
110 |
11 |
p. 2470
|
article
|
| 3252 |
Myelodysplastic Syndrome in Fanconi Anemia: Morphologic and Cytogenetic Findings Are Strongly Correlated.
|
Cioc, Adina M.
|
|
|
110 |
11 |
p. 2458
|
article
|
| 3253 |
Myelodysplastic Syndrome (MDS) Displays Profound and Functionally Significant Epigenetic Deregulation Compared to Acute Myeloid Leukemia (AML) and Normal Bone Marrow Cells.
|
Figueroa, Maria E.
|
|
|
110 |
11 |
p. 345
|
article
|
| 3254 |
Myelodysplastic Syndromes and Acute Myeloid Leukemia with t(6;9)(p23;q34).
|
Delmonte Jr., John
|
|
|
110 |
11 |
p. 3502
|
article
|
| 3255 |
Myelodysplastic Syndromes and Philadelphia Negative Chronic Myeloproliferative Diseases Show an Overlapping Pattern of Cytogenetic Aberrations.
|
Haferlach, Claudia
|
|
|
110 |
11 |
p. 1553
|
article
|
| 3256 |
Myelofibrosis and Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RISCT).
|
Popat, Uday R.
|
|
|
110 |
11 |
p. 3062
|
article
|
| 3257 |
Myeloid-Associated Antigen Expression Is an Adverse Factor for Complete Remission Following Induction Chemotherapy of Adult Precursor T-Lymphoblastic Leukemia/Lymphoma (T-ALL).
|
Al-Khabori, Murtadha
|
|
|
110 |
11 |
p. 4228
|
article
|
| 3258 |
Myeloid Derived Dendritic Cells Inhibit CD8+ T Cell Responses by Down-Modulating NKG2D and 4–1BB Expression.
|
Kim, Young-June
|
|
|
110 |
11 |
p. 315
|
article
|
| 3259 |
Myeloid Dyspoiesis as Determined by Flow Cytometry Is a More Powerful Predictor of Post-Transplant Relapse with MDS Than the Marrow Myeloblast Count.
|
Wells, Denise A.
|
|
|
110 |
11 |
p. 1656
|
article
|
| 3260 |
Myeloid Gene Activation and T Cell/Natural Killer Cell Gene Repression in Cells Expressing Two Distinct PU.1 Concentrations.
|
Kamath, Meghana
|
|
|
110 |
11 |
p. 1242
|
article
|
| 3261 |
Myeloma International Staging System Retains Its Prognostic Value at Disease Relapse.
|
Verma, Rajanshu
|
|
|
110 |
11 |
p. 1474
|
article
|
| 3262 |
Myeloma with AL Amyloidosis: 10 Years Experience with Stem Cell Transplant.
|
De Padua Silva, Leandro
|
|
|
110 |
11 |
p. 5112
|
article
|
| 3263 |
Myeloperoxidase Is Required for the Combined Apoptotic Effects of Arsenic Trioxide with Ascorbic Acid or Epigallocatechin-3-Gallate in Myeloid Leukemia Cells.
|
Xia, Lijuan
|
|
|
110 |
11 |
p. 3474
|
article
|
| 3264 |
NALP7 and NALP11 Differential Expression Correlates with Glucocorticoid Sensitivity in Multiple Myeloma Cell Lines.
|
Ma, Shuo
|
|
|
110 |
11 |
p. 2366
|
article
|
| 3265 |
Nasal Epithelial Cells of Donor Origin after Allogeneic HCT.
|
Khan, Faisal
|
|
|
110 |
11 |
p. 1101
|
article
|
| 3266 |
Nasal NK/T Cell Lymphoma: Dramatic Response to Pegaspargase in Two Patients.
|
Chasky, Moshe C.
|
|
|
110 |
11 |
p. 4467
|
article
|
| 3267 |
Nasal Type NK/T Cell Lymphoma with Cutaneous and Ocular Involvement: A Case Report.
|
Lee, Ho Sup
|
|
|
110 |
11 |
p. 4434
|
article
|
| 3268 |
Natural History of 33 Patients with Upshaw-Schulman Syndrome Has Revealed That All the Gravida Develop Thrombocytopenia, Often Followed by Thrombotic Microangiopathy with Stillbirth.
|
Fujimura, Yoshihiro
|
|
|
110 |
11 |
p. 3211
|
article
|
| 3269 |
Natural History of Transfusion-Independent Non-Severe Aplastic Anemia in Children.
|
Nishio, Nobuhiro
|
|
|
110 |
11 |
p. 1693
|
article
|
| 3270 |
Naturally Occurring Regulatory T Cells Modulate Immune Responses Against Exogenous Factor VIII in Hemophilic Balb/c Mice but Not in C57BL/6J Mice.
|
Hausl, Christina
|
|
|
110 |
11 |
p. 1160
|
article
|
| 3271 |
N-Cadherin and Cadherin-11 Play Vital Roles in the Cell-Cell Contact between Hematopoietic Progenitor Cells and Mesenchymal Stromal Cells.
|
Wagner, Wolfgang
|
|
|
110 |
11 |
p. 1406
|
article
|
| 3272 |
N-cadherin Expression Level Distinguishes Reserved Versus Primed States of Hematopoietic Stem Cells.
|
Haug, Jeffrey S.
|
|
|
110 |
11 |
p. 1268
|
article
|
| 3273 |
NCRI CLL201 Trial: A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) with or without Rituximab in Previously Treated CLL.
|
Hillmen, Peter
|
|
|
110 |
11 |
p. 752
|
article
|
| 3274 |
Nedd9 Over-Expression Leads to Imatinib Resistance in Gastrointestinal Stromal Tumor Cells.
|
Le Ba, Thao
|
|
|
110 |
11 |
p. 4212
|
article
|
| 3275 |
Negative Paracrine Effect of Platelet Factor 4 on Megakaryopoiesis Occurs through Lipoprotein Related Protein Receptor-1 on Megakaryocytes.
|
Lambert, Michele P.
|
|
|
110 |
11 |
p. 97
|
article
|
| 3276 |
Negative Regulation of Cell Cycle Kinetics of Human Hematopoietic Cells by the Transcription Factor Dmtf1.
|
Kobayashi, Michihiro
|
|
|
110 |
11 |
p. 3359
|
article
|
| 3277 |
Neither DNA Hypomethylation or Changes in the Kinetics of Erythroid Differentiation Account for 5-Azacytidine's Ability To Induce Human Fetal Hemoglobin.
|
Mabaera, Rodwell
|
|
|
110 |
11 |
p. 572
|
article
|
| 3278 |
Neither Serum Ferritin Nor Number of Red Blood Cell Transfusions Affect Overall Survival in Refractory Anemia with Ringed Sideroblasts.
|
Chee, Cheng E.
|
|
|
110 |
11 |
p. 2454
|
article
|
| 3279 |
Neurocognitive Impairment Following Recovery from ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP).
|
Lewis, Qurana F.
|
|
|
110 |
11 |
p. 1311
|
article
|
| 3280 |
Neurological Manifestations in Gaucher Disease Patients and Relatives.
|
Giraldo, Pilar
|
|
|
110 |
11 |
p. 3838
|
article
|
| 3281 |
Neuropathy in Multiple Myeloma Patients Treated with Bortezomib: A Multicenter Experience.
|
Caravita, Tommaso
|
|
|
110 |
11 |
p. 4823
|
article
|
| 3282 |
Neuropsychological (NP) Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adult Patients with Sickle Cell Disease (SCD).
|
Vichinsky, Elliott
|
|
|
110 |
11 |
p. 428
|
article
|
| 3283 |
Neurotrophin Receptors and Ligands Are Highly Expressed in Acute Leukemia and Promote Leukemogenesis.
|
Li, Zhixiong
|
|
|
110 |
11 |
p. 696
|
article
|
| 3284 |
Neutralization of Macrophage Migration Inhibitory Factor (MIF) Reduces GVHD but Preserves GVL.
|
Miklos, Sandra
|
|
|
110 |
11 |
p. 3234
|
article
|
| 3285 |
Neutralization of Tumor-Derived Soluble Glucocorticoid-Induced TNF-Related Protein (GITR) Ligand Present in Cancer Patient Sera Increases Anti-Tumor Reactivity of NK Cells.
|
Baltz, Katrin M.
|
|
|
110 |
11 |
p. 314
|
article
|
| 3286 |
Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Thalassemia Intermedia: Lack of Association with Erythropoiesis, Iron Metabolism, Renal Dysfunction and Inflammation.
|
Papassotiriou, Ioannis
|
|
|
110 |
11 |
p. 3814
|
article
|
| 3287 |
Newborn Haemoglobinopathy Carrier Screening: Towards Comprehensive and Improved Patient Care of Sickle Cell Disease in Oman, a Cost Effective Analysis.
|
Alkindi, Salam
|
|
|
110 |
11 |
p. 5155
|
article
|
| 3288 |
Newborns Are Hyperfibrinolytic at Physiologic tPA Concentrations and the Increased Fibrinolysis Is Related to Decreased Apparent TAFIa.
|
Mitchell, Lesley G.
|
|
|
110 |
11 |
p. 1756
|
article
|
| 3289 |
New Classification of Chronic Graft Versus Host Disease: Added Clarity from the Consensus Diagnoses.
|
Arora, Mukta
|
|
|
110 |
11 |
p. 41
|
article
|
| 3290 |
New Compound Heterozygous Mutations of GPIIb in Patient with Glanzmann Thrombasthenia.
|
Yu, Ziqiang
|
|
|
110 |
11 |
p. 3921
|
article
|
| 3291 |
Newly Diagnosed Multiple Myeloma Patients with 1q21 Amplification Treated by Autologous Stem Cell Transplantation Have Shorter Progression-Free Survival Interval.
|
Nemec, Pavel
|
|
|
110 |
11 |
p. 4758
|
article
|
| 3292 |
New Pulmonary Embolism Diagnostic Algorythm and the Thromboprophylaxis in a Hungarian Teaching Hospital.
|
Egyed, Miklos
|
|
|
110 |
11 |
p. 4000
|
article
|
| 3293 |
New Zealand (NZ) Pacific Peoples and Maori Have a Higher Risk of Developing Multiple Myeloma Than Other New Zealanders.
|
Phillips, Julia K.
|
|
|
110 |
11 |
p. 4760
|
article
|
| 3294 |
NFκB-Mediated Up-Regulation of Transcription Factors Related to More Primitive State of Hematopoietic Progenitor Cells.
|
Panepucci, Rodrigo A.
|
|
|
110 |
11 |
p. 1246
|
article
|
| 3295 |
NF-E2 Overexpression Delays Erythroid Differentiation and Increases Erythrocyte Production
|
Mutschler, Manuel
|
|
|
110 |
11 |
p. 1546
|
article
|
| 3296 |
NF-kappa B Plays a Key Role in the Hematopoietic Niche Function of Osteoblast after Ionizing Radiation.
|
Xiao, Mang
|
|
|
110 |
11 |
p. 4091
|
article
|
| 3297 |
NF-kB as a Regulator of FA/BRCA Gene Expression in Multiple Myeloma.
|
Oliveira, Vasco A.
|
|
|
110 |
11 |
p. 3508
|
article
|
| 3298 |
NF1 Microdeletions in Pediatric MLL-Rearranged AML and T-ALL: A Novel Mechanism for RAS Activation.
|
Balgobind, Brian V.
|
|
|
110 |
11 |
p. 757
|
article
|
| 3299 |
Nilotinib in Patients (pts) with Philadelphia Chromosome-Positive (Ph+) Chronic Myelogenous Leukemia in Blast Crisis (CML-BC) Who Are Resistant or Intolerant to Imatinib.
|
Giles, Francis J.
|
|
|
110 |
11 |
p. 1025
|
article
|
| 3300 |
Nilotinib in Patients (pts) with Relapsed/Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Who Are Resistant or Intolerant to Imatinib.
|
Ottmann, Oliver G.
|
|
|
110 |
11 |
p. 2815
|
article
|
| 3301 |
Nilotinib Is Associated with Minimal Cross Intolerance to Imatinib in Patients with Imatinib-Intolerant Philadelphia-Positive (Ph+) Chronic Myelogenous Leukemia (CML) in Either Chronic Phase (CP) or Accelerated Phase (AP).
|
Cortes, Jorge
|
|
|
110 |
11 |
p. 1040
|
article
|
| 3302 |
Nilotinib Is Highly Active and Safe in Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Patients with Imatinib-Resistance or Intolerance.
|
Kantarjian, Hagop M.
|
|
|
110 |
11 |
p. 735
|
article
|
| 3303 |
Nilotinib Is Safe and Effective in Accelerated Phase Chronic Myelogenous Leukemia (CML-AP) Patients with Imatinib Resistance or Intolerance.
|
le Coutre, Philipp
|
|
|
110 |
11 |
p. 471
|
article
|
| 3304 |
Nilotinib Therapy after Dasatinib Failure in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP), Accelerated Phase (AP) or Blast Crisis (BC).
|
Giles, Francis J.
|
|
|
110 |
11 |
p. 1029
|
article
|
| 3305 |
Nitric Oxide from Mesenchymal Stem Cells Regulated T-Cells through Inhibiting Expression of the T-bet.
|
Liu, Gexiu
|
|
|
110 |
11 |
p. 4110
|
article
|
| 3306 |
NK and T-Cell Status as Well as Their Perforin Expression Is Related to Clinical Severity and Outcome in Difuse Large Cell Lymphoma.
|
Gutierrez, Antonio
|
|
|
110 |
11 |
p. 1574
|
article
|
| 3307 |
NK-Cell Reconstitution after HLA-Identical Blood and Marrow Transplantations for CML: The Recovery of NKG2D Is Inversely Correlated with NKG2A and It Promotes the GVL Effect.
|
Tong, Juan
|
|
|
110 |
11 |
p. 4879
|
article
|
| 3308 |
NK-Cell Recovery and Immune Reconstitution after Haploidentical Hematopoietic Cell Transplantation Using Either CD34 Selected Grafts and Adoptive NK-Cell Transfer or CD3/CD19 Depleted Grafts: Comparison of Two Strategies for NK Cell Based Immunotherapy.
|
Gentilini, Chiara
|
|
|
110 |
11 |
p. 2988
|
article
|
| 3309 |
NK Cells Derived from Human Embryonic Stem Cells Demonstrate More Effective In Vivo Clearance of Xenografted Human Tumor Cells Compared to NK Cells Derived from Cord Blood.
|
Woll, Petter S.
|
|
|
110 |
11 |
p. 2745
|
article
|
| 3310 |
NK Cells Induce Alloreactive Donor T Cell Apoptosis and Decrease Proliferation in GVHD Induction.
|
Olson, Janelle A.
|
|
|
110 |
11 |
p. 2162
|
article
|
| 3311 |
NKG2D-Mediated Marrow Injury in Paroxysmal Nocturnal Hemoglobinuria and Its Related Disorders.
|
Hanaoka, Nobuyoshi
|
|
|
110 |
11 |
p. 3674
|
article
|
| 3312 |
NKT Cells Are Potent Regulators of GVHD Following Adoptive Transfer in Allogeneic BMT.
|
Leveson-Gower, Dennis B.
|
|
|
110 |
11 |
p. 353
|
article
|
| 3313 |
NM23-H2 Is a Tumor Associated Antigen (TAA) in Chronic Myeloid Leukemia (CML).
|
Tschiedel, Sabine
|
|
|
110 |
11 |
p. 2932
|
article
|
| 3314 |
No Correlation between Thromboxane A2 Synthesis and Platelet Activation in Aspirin Treated Patients Undergoing Coronary Artery Bypass Graft Surgery.
|
Favreau, Frederic
|
|
|
110 |
11 |
p. 924
|
article
|
| 3315 |
NOD2/CARD15 Genotype and HLA-DPB1 Matching Status Can Be Used To Predict Disease Relapse in Recipients of an Unrelated Donor Haematopoietic Stem Cell Transplant for Acute Leukaemia.
|
Madrigal, J. Alejandro
|
|
|
110 |
11 |
p. 830
|
article
|
| 3316 |
No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.
|
Lijfering, Willem M.
|
|
|
110 |
11 |
p. 130
|
article
|
| 3317 |
No Difference in Survival or Long-Term Disease Outcomes in Palifermin-Treated Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation.
|
Spielberger, Ricardo
|
|
|
110 |
11 |
p. 1664
|
article
|
| 3318 |
No Effect of Etodolac, a COX Inhibitor, on Platelet Function in Healthy Volunteers.
|
Korte, Wolfgang C.
|
|
|
110 |
11 |
p. 2098
|
article
|
| 3319 |
No Immunogenicity Found to Antithrombin alfa in Human Clinical Studies.
|
Frieling, Johan
|
|
|
110 |
11 |
p. 3197
|
article
|
| 3320 |
Non-Classical Anti-Factor VIII C2 Domain Inhibitors Are Present in the Plasmas of Most Factor VIII Inhibitor Patients.
|
Meeks, Shannon L.
|
|
|
110 |
11 |
p. 786
|
article
|
| 3321 |
Non-Clinical Pharmacology of Anti-CD22 Antibody Drug Conjugates.
|
Xie, Dong
|
|
|
110 |
11 |
p. 2363
|
article
|
| 3322 |
Non-Compliance Is the Predominant Cause of Aspirin Resistance.
|
Schwartz, Kenneth A.
|
|
|
110 |
11 |
p. 932
|
article
|
| 3323 |
Nongastric Marginal Zone B-Cell Lymphoma: A Prognostic Model from a Retrospective Multicenter Study.
|
Oh, Sung Yong
|
|
|
110 |
11 |
p. 1361
|
article
|
| 3324 |
Nonhematological Tumor Metastasis in the Bone Marrow: An Analysis of 10112 Unselected Plastic-Embedded Biopsy Sections.
|
Li, Xiao
|
|
|
110 |
11 |
p. 5154
|
article
|
| 3325 |
Non Hodgkin Lymphoma (NHL) Distribution and Clinical Characteristics in a Mexican Registry with High Frequency of T Cell NHL: A Descriptive Study on Behalf of Mexican Hematology Study Group (MHSG).
|
Ignacio, Gregorio
|
|
|
110 |
11 |
p. 4407
|
article
|
| 3326 |
Non Hodgkin's Lymphoma (NHL) and Deep Vein Thrombosis (DVT): A Dangerous Liaison Still Unexplored.
|
Giordano, Giulio
|
|
|
110 |
11 |
p. 3990
|
article
|
| 3327 |
Non-Hodgkin's Lymphoma Refractory to First Line Therapy: Incidence, Associated Clinical and Histological Factors, and Outcome among 503 Newly Diagnosed Patients.
|
Gueli, Angela
|
|
|
110 |
11 |
p. 1373
|
article
|
| 3328 |
Non-Hodgkin's (NHL) Lymphoma Patients(pts) in the VA Population: Clinical Characteristics and Survival Predictors.
|
Cholankeril, Michelle
|
|
|
110 |
11 |
p. 4435
|
article
|
| 3329 |
Non-Inferiority of Anagrelide Compared to Hydroxyurea in Newly Diagnosed Patients with Essential Thrombocythemia: The ANAHYDRET-Study.
|
Gisslinger, Heinz
|
|
|
110 |
11 |
p. 3547
|
article
|
| 3330 |
Non-Integrating Gene Transfer To Redirect Specificity of Lymphocytes towards Pediatric CD19+ Malignancies
|
Yuen, Carrie H.
|
|
|
110 |
11 |
p. 3739
|
article
|
| 3331 |
Non Myeloablative Allogeneic Related Transplant in Patients with Aggressive B Cell Lymphoma: Results of Two Multicenter Spanish Trials. The GELTAMO Group.
|
Caballero, M.D.
|
|
|
110 |
11 |
p. 5053
|
article
|
| 3332 |
Non-Myeloablative Allogeneic Stem Cell Transplantation in 154 Patients (pts) with Chronic Myeloid Leukaemia (CML).
|
Benakli, Malek
|
|
|
110 |
11 |
p. 4975
|
article
|
| 3333 |
Non-Myeloablative Allogeneic Stem Cell Transplantation (NMT) Overcomes the Adverse Effects of Treatment Resistance and High Beta-2-Microglobulin in Patients with Mantle Cell Lymphoma (MCL): An Analysis of 123 Transplantations at the MD Anderson Cancer Center.
|
Tam, Constantine S.
|
|
|
110 |
11 |
p. 484
|
article
|
| 3334 |
Non-Myeloablative Allogeneic Transplantation for Hodgkin's and Non-Hodgkin's Lymphoma: Evidence for a Graft-Versus-Lymphoma Effect and Relevance of Chimerism.
|
Armand, Philippe
|
|
|
110 |
11 |
p. 3041
|
article
|
| 3335 |
Nonmyeloablative Allogeneic Transplantation in the Imatinib Era: Three Chances To Achieve Molecular Remission in CML.
|
Champlin, Richard E.
|
|
|
110 |
11 |
p. 1028
|
article
|
| 3336 |
Nonmyeloablative Allogeneic Transplantation (NMT) for Relapsed Follicular Lymphoma (FL): Continuous Complete Remission with Longer Follow-Up.
|
Khouri, Issa F.
|
|
|
110 |
11 |
p. 485
|
article
|
| 3337 |
Non-Myeloablative Conditioning Regimen (NMCR) for Allogeneic Bone Marrow Transplantation (BMT) in Patients with Severe Aplastic Anemia (SAA).
|
Rosenthal, Joseph
|
|
|
110 |
11 |
p. 4943
|
article
|
| 3338 |
Nonmyeloablative Peripheral Blood Stem Cell Transplantation for Chronic Myeloid Leukemia in Chronic and Advanced Phases.
|
Ding, Jia-Hua
|
|
|
110 |
11 |
p. 5041
|
article
|
| 3339 |
Non-Myeloablative T-Cell Depleted (TCD) Haploidentical Hematopoietic Cell Transplantation (HCT) Followed by Donor Leukocyte Infusion(s) for Hematologic Malignancies: The MGH Experience.
|
Dey, Bimalangshu R.
|
|
|
110 |
11 |
p. 5088
|
article
|
| 3340 |
Non-Pegylated Lyposomal Doxorubicin, Cyclophosphamide, Vincristine, Prednisone and Rituximab (R-COMP) as Initial Treatment for Patients with Splenic Marginal Zone Lymphoma (SMZL). A GISL Study
|
Iannitto, Emilio
|
|
|
110 |
11 |
p. 1293
|
article
|
| 3341 |
Non-Relapse Mortality Associated with Autologous Stem Cell Transplant (ASCT).
|
Stotler, Christy
|
|
|
110 |
11 |
p. 1671
|
article
|
| 3342 |
Nonsense-Mediated mRNA Decay Is Essential for the Hematopietic Compartement.
|
Weischenfeldt, Joachim
|
|
|
110 |
11 |
p. 506
|
article
|
| 3343 |
Non Synonymous SNP-Array-Based Disease Association Analysis in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria.
|
Serio, Bianca
|
|
|
110 |
11 |
p. 3681
|
article
|
| 3344 |
Nordic CML Study Group Quality and Standardization Rounds for Quantitative RT-PCR of BCR-ABL To Facilitate Reporting on the International Scale.
|
Boström, Hans
|
|
|
110 |
11 |
p. 4559
|
article
|
| 3345 |
No Reversal of Demethylation after Azacitidine Treatment in Concordance with Poor Clinical Response.
|
Tran, Huong Thi Thanh
|
|
|
110 |
11 |
p. 4629
|
article
|
| 3346 |
Normal Initial Response to Erythropoietin but Impaired Proliferation in 2-Phase Erythroid Culture in Diamond Blackfan Anemia.
|
Ball, Sarah
|
|
|
110 |
11 |
p. 1685
|
article
|
| 3347 |
Normal Presence of Tissue Inhibitors of Matrix Metalloproteinases in Platelets of Patients with the Gray Platelet Syndrome Suggests a Novel Organization for These Secreted Proteins.
|
Villeneuve, Julien
|
|
|
110 |
11 |
p. 2104
|
article
|
| 3348 |
Normal Response to Aspirin in Healthy Individuals: Cross-Comparison of Light Transmission Aggregometry, VerifyNow™ System, Platelet Count Drop, Thrombelastography (TEG®) and Urinary 11-dehydrothromboxane B2.
|
Blais, Normand
|
|
|
110 |
11 |
p. 934
|
article
|
| 3349 |
Normal Short-Term but Reduced Long-Term Engraftment Capacity of CML Hematopoietic Cells with Skewed Myeloid Lineage Differentiation Is Seen in an Improved Mouse Model of Human Hematopoiesis.
|
Tauer, Jeff
|
|
|
110 |
11 |
p. 3383
|
article
|
| 3350 |
No Significance of Derivative Chromosome 9 Deletion on the Clearance Kinetics of BCR/ABL Fusion Transcripts, Cytogenetic or Molecular Response, Loss of Response or Treatment Failure to Imatinib Mesylate Therapy for Chronic Myeloid Leukemia.
|
Kim, Dong Hwan (Dennis)
|
|
|
110 |
11 |
p. 1950
|
article
|
| 3351 |
No Significant Clinical Benefit of First Line Therapy with Fludarabine (F) in Comparison to Chlorambucil (Clb) in Elderly Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Results of a Phase III Study of the German CLL Study Group (GCLLSG).
|
Eichhorst, Barbara F.
|
|
|
110 |
11 |
p. 629
|
article
|
| 3352 |
No Significant Expression of Wt1 Gene in Multiple Myeloma Patients at Diagnosis: Is Wt1 Gene Expression Useful Marker for Minimal Residual Disease in Multiple Myeloma?.
|
Ozkul, Yusuf
|
|
|
110 |
11 |
p. 4761
|
article
|
| 3353 |
Notch Signaling Induces Megakaryocytic Cell Fate.
|
Mercher, Thomas
|
|
|
110 |
11 |
p. 200
|
article
|
| 3354 |
Notch Signaling Pathway in Hematopoietic Stem Cells Is Activated through Interactive Communication with Mesenchymal Stem Cells.
|
Kikuchi, Yuji
|
|
|
110 |
11 |
p. 1408
|
article
|
| 3355 |
Novel C-KIT Transcripts Identified in Mast Cell Leukemia: An Update of the Full Transcript and It's Distribution.
|
Ozer, Ozden
|
|
|
110 |
11 |
p. 2396
|
article
|
| 3356 |
Novel Concentration-Dependent Roles for Heparin in Modifying LPS-Induced Activation of Mononuclear Cells in Whole Blood.
|
Hochart, Helene
|
|
|
110 |
11 |
p. 927
|
article
|
| 3357 |
Novel Deuterated Gemini-Vitamin D3 Analogs Have Potent Antitumor Activity.
|
Okamoto, Ryoko
|
|
|
110 |
11 |
p. 4210
|
article
|
| 3358 |
Novel Direct Evidence That Adult Bone Marrow-Derived Very Small Embryonic Like (VSEL) Stem Cells Are Mobilized into Peripheral Blood - Leukopheresis as a Potential Tool To Isolate Pluripotent Stem Cells for Therapeutic Pruposes.
|
Kucia, Magda
|
|
|
110 |
11 |
p. 1205
|
article
|
| 3359 |
Novel Efficient Primary Human Peripheral Blood Progenitor Cell-Targeted Recombinant Adeno-Associated Viral Vectors.
|
Veldwijk, Marlon R.
|
|
|
110 |
11 |
p. 5144
|
article
|
| 3360 |
Novel Findings Support a Patophysiological Role of the Arachidonic Cascade in Hodgkin Lymphoma.
|
Sjoberg, Jan
|
|
|
110 |
11 |
p. 2269
|
article
|
| 3361 |
Novel Function of FGFR1 in Hematopoietic Stem Cell Stress Response.
|
Ross, Jason T.
|
|
|
110 |
11 |
p. 2200
|
article
|
| 3362 |
Novel Functions for a Fibrinolytic Pathway in Controlling Hematopoiesis.
|
Hattori, Koichi
|
|
|
110 |
11 |
p. 86
|
article
|
| 3363 |
Novel Heritable Mutation of the Transcription Factor RUNX1 as a Cause of Autosomal Dominant Familial Platelet Disorder with Predisposition to Acute Myeloid Leukemia (FPD/AML).
|
Patton, William N.
|
|
|
110 |
11 |
p. 4244
|
article
|
| 3364 |
Novel Human CD4+ T Lymphocyte Subpopulations Defined by CD300a/c Molecule Expression.
|
Hart, Derek N.J.
|
|
|
110 |
11 |
p. 2304
|
article
|
| 3365 |
Novel Link between PI 3′ Kinase/p38 Map Kinase Pathway in Dasatinib (BMS354825) Mediated Effect in BCR-ABL Expressing Cells.
|
Lumby, Crystal
|
|
|
110 |
11 |
p. 4538
|
article
|
| 3366 |
Novel Mll-AF9 Cooperating Genes Identified in a Leukemogenesis Screen Using Retroviral Mutagenesis.
|
Bergerson, Rachel J.
|
|
|
110 |
11 |
p. 825
|
article
|
| 3367 |
Novel Mouse Anti-Mouse β3 Integrin Monoclonal Antibodies: Development and Characterization of New Reagents for Research in Thrombosis and Thrombocytopenia.
|
Zhu, Guangheng
|
|
|
110 |
11 |
p. 2107
|
article
|
| 3368 |
Novel Mutations in Types 2 & 3 von Willebrand Disease and Correlation with von Willebrand Factor Multimer Patterns.
|
Titapiwatanakun, Ruetima
|
|
|
110 |
11 |
p. 2136
|
article
|
| 3369 |
Novel Mutations of the JAK2 Gene and Erythropoietin Receptor Gene in Japanese Chronic Myeloproliferative Diseases.
|
Inami, Mitsuharu
|
|
|
110 |
11 |
p. 2535
|
article
|
| 3370 |
Novel Nanoparticle-Based Approaches To Target B-Cell Malignancies.
|
Weaver, James A.
|
|
|
110 |
11 |
p. 4903
|
article
|
| 3371 |
Novel, 2ND Generation Histone Deacetylase (HDAC) Inhibitor JNJ-26481585 Exhibits Potent Antitumor Activity Against Chronic Lymphocytic Leukemia Cells In-Vitro and Ex-Vivo.
|
Bommert, Kurt
|
|
|
110 |
11 |
p. 4679
|
article
|
| 3372 |
Novel Spliced MLL Fusions Have Been Identified Involving the MLL Partner Genes ELL, EPS15, MLLT3, and SEPT5.
|
Meyer, Claus
|
|
|
110 |
11 |
p. 978
|
article
|
| 3373 |
Novel Synthetic Histone Deacetylase Inhibitor, SK-7041, Has Potent Anti-Proliferative Activity in Acute Myeloid Leukemia Cell Lines.
|
Yoon, Sung-Soo
|
|
|
110 |
11 |
p. 2854
|
article
|
| 3374 |
Novel Treatment Approaches in Combination with Rituximab for Immune Tolerance Induction in Severe Hemophilia B.
|
Brandow, Amanda M.
|
|
|
110 |
11 |
p. 3975
|
article
|
| 3375 |
Novel Tumor Suppressor Protein Programmed Cell Death 4 (PDCD4) Suppresses Activity of PI3K/Akt Pathway and Regulates Expression of p27 (Kip1) and c-myc, DAP5 and Willm's Tumor (WT1) in Acute Myeloid Leukemia.
|
Ozpolat, Bulent
|
|
|
110 |
11 |
p. 2656
|
article
|
| 3376 |
Novel VWF Sequence Variations Identified in Normal Controls and Index Cases Enrolled in the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB-VWD).
|
Bellissimo, Daniel B.
|
|
|
110 |
11 |
p. 709
|
article
|
| 3377 |
NPM-ALK Induces Tumour Development in a Murine Model of Anaplastic Large Cell Lymphoma (ALCL) Independently of Bcl-3 Expression.
|
Gruber, Charlotte
|
|
|
110 |
11 |
p. 460
|
article
|
| 3378 |
NPM1 Mutations Are Valid Minimal Residual Disease Parameters Following Allogeneic Stem Cell Transplantation: A Study on 116 AML Patients.
|
Bacher, Ulrike
|
|
|
110 |
11 |
p. 1655
|
article
|
| 3379 |
ΔNp73 /TAp73 Expression Ratio Is Associated with Ara-C-Induced Apoptosis Resistance in Acute Myeloid Leukemia.
|
Araújo, Antonio Roberto L.
|
|
|
110 |
11 |
p. 4148
|
article
|
| 3380 |
NR2F6, the Mammalian Homologue of Drosophila Seven Up, Can Initiate Myelodysplasia and Acute Leukemia.
|
Ichim, Christine V.
|
|
|
110 |
11 |
p. 400
|
article
|
| 3381 |
Nucleophosmin Gene Mutations Exhibit High Spontaneous Apoptosis and Favorable Prognosis in Acute Myeloid Leukemia.
|
Del Poeta, Giovanni
|
|
|
110 |
11 |
p. 3480
|
article
|
| 3382 |
Nucleophosmin Gene Mutations Identify a Favorable Risk Group in Childhood Acute Myeloid Leukemia with a Normal Karyotype.
|
Hollink, Iris H.
|
|
|
110 |
11 |
p. 366
|
article
|
| 3383 |
Nucleotidase Activity of CD39/NTPDase1 Is Dependent on Internal Proteolytic Cleavage Which Contributes to Lipid Raft Localization.
|
Olson, Kim E.
|
|
|
110 |
11 |
p. 3634
|
article
|
| 3384 |
Number of Prior Chemotherapy Regimens: Important Prognositic Factor of All-Cause Mortality after Allogeneic Hematopoietic Cell Transplantation.
|
Kiyokawa, Tetsuyuki
|
|
|
110 |
11 |
p. 1104
|
article
|
| 3385 |
Numbers of Lymphoma Associated Macrophages (LAMS) and Regulatory T-Cells (Tregs) in Follicular Lymphoma (FL) Patients (pts) Treated with and without Monoclonal Antibody (MoAb)-Containing Therapy Do Not Correlate with Overall Survival (OS): A Study from the Southwest Oncology Group (SWOG).
|
Sweetenham, John William
|
|
|
110 |
11 |
p. 2602
|
article
|
| 3386 |
Numerous Genomic Abnormalities in AML with Normal Karyotype.
|
Akagi, Tadayuki
|
|
|
110 |
11 |
p. 1811
|
article
|
| 3387 |
Nutritional Deficiencies in Chronically Transfused Hemoglobinopathy Patients.
|
Claster, Susan
|
|
|
110 |
11 |
p. 1735
|
article
|
| 3388 |
Obesity Does Not Impact Outcome in Patients with AML/MDS Undergoing Allogeneic Transplantation.
|
De Padua Silva, Leandro
|
|
|
110 |
11 |
p. 1989
|
article
|
| 3389 |
Oblimersen (OBL; Genasense®), a Phosphorothioate (PS) Bcl-2 Antisense Oliogonucleotide (ASO), Can Be Safely Administered by Bolus Subcutaneous (SC) Injection and Brief IV Infusion.
|
Tolcher, Anthony
|
|
|
110 |
11 |
p. 4724
|
article
|
| 3390 |
Oct4 and Its Pseudogenes Confuse Stem Cell Research.
|
Liedtke, Stefanie
|
|
|
110 |
11 |
p. 3700
|
article
|
| 3391 |
Ocular Adnexal Marginal Zone B Cell Lymphoma Has Characteristic Deletion at Chromosome Band 6q23.3-24.1 Whose Target Is TNFAIP3.
|
Honma, Keiichiro
|
|
|
110 |
11 |
p. 2643
|
article
|
| 3392 |
OFD1-Mediated T Cell Responses in MGUS Patients: Implications for Immunotherapy.
|
Blotta, Simona
|
|
|
110 |
11 |
p. 1488
|
article
|
| 3393 |
Oligonucleotide Array CGH Studies in Myeloproliferative Neoplasms and Comparison with Conventional Cytogenetic Analysis
|
Tefferi, Ayalew
|
|
|
110 |
11 |
p. 1550
|
article
|
| 3394 |
Omega-3 Fatty Acid Deficiency in Sickle Cell Disease Correlates with Clinical Severity and Has Therapeutic Implications.
|
Okpala, Iheanyi
|
|
|
110 |
11 |
p. 3781
|
article
|
| 3395 |
Once Daily Busulfan and Fludarabine Is Well Tolerated and Effective in Older Heavily Treated Patients Prior to Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplant.
|
Potter, Grant W.
|
|
|
110 |
11 |
p. 4950
|
article
|
| 3396 |
Once Daily Busulfan Cyclophosphamide Is Well Tolerated and Effective Prior to Allogeneic Hematopoietic Stem Cell Transplantation.
|
LeMaistre, Julia A.
|
|
|
110 |
11 |
p. 1996
|
article
|
| 3397 |
Once Daily YM150, an Oral Direct Factor Xa Inhibitor, for Prevention of Venous Thromboembolism in Patients Undergoing Elective Primary Hip Replacement.
|
Eriksson, Bengt I.
|
|
|
110 |
11 |
p. 309
|
article
|
| 3398 |
Oncogenic NK-Like Homeodomain Proteins Inhibit Etoposide-Induced Apoptosis in T-ALL Cell Lines by Activation of the Polycistronic miR-17-92 Transcript.
|
Nagel, Stefan
|
|
|
110 |
11 |
p. 2787
|
article
|
| 3399 |
Oncogenic Transformation of NIH 3T3 Fibroblasts by BCR-ABL Oncoprotein Requires the IL-3 Receptor.
|
Tao, Wenjing
|
|
|
110 |
11 |
p. 3370
|
article
|
| 3400 |
One-Mutation Model Can Explain Age Incidence in AML Carrying Nucleophosmin (NPM1) Mutations.
|
Liso, Arcangelo
|
|
|
110 |
11 |
p. 4312
|
article
|
| 3401 |
Ongoing Strong Improvement in Survival after Diagnosis with Childhood Hematologic Malignancies.
|
Pulte, Dianne
|
|
|
110 |
11 |
p. 3313
|
article
|
| 3402 |
Ongoing Strong Improvement in Treatment Outcomes for Patients Diagnosed with Non-Hodgkin Lymphoma from the 1990s to the Early 21st Century.
|
Pulte, Dianne
|
|
|
110 |
11 |
p. 3314
|
article
|
| 3403 |
Onset of Cardiac Iron Loading in Pediatric Patients.
|
Wood, John C.
|
|
|
110 |
11 |
p. 2765
|
article
|
| 3404 |
Operationalizing the Concept of “Immobility” for Better Targeting of Thromboprophylaxis in Medical Patients: How the Literature Falls Short.
|
Desrosiers, Laura
|
|
|
110 |
11 |
p. 968
|
article
|
| 3405 |
Optimal Treatment for Patients after Dasatinib or Nilotinib: Comparison of Preclinical Activities of Approved and Promising Investigational Kinase Inhibitors Against BCR-ABL Kinase Domain Mutations That Confer Clinical Resistance to Dasatinib or Nilotinib.
|
Kasap, Corynn
|
|
|
110 |
11 |
p. 4589
|
article
|
| 3406 |
Optimization of a Cytokine Cocktail for the Expansion of Cord Blood CD34+ Cells into Megakaryocytes Progenitors.
|
Boyer, Lucie
|
|
|
110 |
11 |
p. 4041
|
article
|
| 3407 |
Optimization of One-Stage Coagulation Factor Assays: Improved Accuracy and Precision over an Extended Linear Range.
|
Polgar, Janos
|
|
|
110 |
11 |
p. 3933
|
article
|
| 3408 |
Optimizing Culture Conditions for Ex Vivo Expansion of Virus Specific T Cells.
|
Borelli, Gabriel
|
|
|
110 |
11 |
p. 4863
|
article
|
| 3409 |
Oral Acyclovir Is an Effective in Decreasing the Incidence of Bortezomib Associated Herpes Zoster in Patients with Multiple Myeloma.
|
DePaolo, Dawn
|
|
|
110 |
11 |
p. 4844
|
article
|
| 3410 |
Oral Anticoncipient Induced Angiosarcomatosis and Disseminated Intravascular Coagulation.
|
Pfliegler, George P.
|
|
|
110 |
11 |
p. 3946
|
article
|
| 3411 |
Oral Deferasirox (Exjade®, ICL670) Is Effective, with a Clinically Manageable Safety Profile, in Pediatric β-Thalassemia Patients with High Iron Burden.
|
Taher, Ali
|
|
|
110 |
11 |
p. 2779
|
article
|
| 3412 |
Oral Mucositis Measured by the Oral Mucositis Assessment Scale (OMAS), but Not by the World Health Organization (WHO) Scoring System, Correlates with Nutritional Changes after Autologous Peripheral Blood Stem Cell Transplantation.
|
Toro, Juan J.
|
|
|
110 |
11 |
p. 4944
|
article
|
| 3413 |
Oral Rivaroxaban Compared with Subcutaneous Enoxaparin for Extended Thromboprophylaxis after Total Hip Arthroplasty: The RECORD1 Trial.
|
Eriksson, Bengt I.
|
|
|
110 |
11 |
p. 6
|
article
|
| 3414 |
Oral Treatment with PBI-1402 Increases Hemoglobin Level and Red Blood Cell Count: A Novel Approach to Treating Chemotherapy-Induced Anemia.
|
Gagnon, Lyne
|
|
|
110 |
11 |
p. 2211
|
article
|
| 3415 |
Organ-Specific T Cell Receptor Repertoire in Target Organs of Murine Graft-Versus-Host after Haploidentical Bone Marrow Transplantation.
|
Fu, Yue Wen
|
|
|
110 |
11 |
p. 4859
|
article
|
| 3416 |
Osteonecrosis of the Jaw in Multiple Myeloma Patients (the IFM Registry).
|
Fuzibet, Jean Gabriel
|
|
|
110 |
11 |
p. 4809
|
article
|
| 3417 |
Osteonecrosis of the Jaw Related to Bisphosphonates Therapy in Multiple Myeloma and Metastatic Prostate Cancer Patients. A Latin American Report: An Adverse Event To Look For!!.
|
Beltran, Brady
|
|
|
110 |
11 |
p. 5162
|
article
|
| 3418 |
Osteopenia Is Commonly Present in Prepubertal Children with Severe Hb E/βthalassemia Despite Adequate Transfusion and Iron Chelation Therapy.
|
Viprakasit, Vip
|
|
|
110 |
11 |
p. 3830
|
article
|
| 3419 |
Osteopontin in Hemophilic Synovitis.
|
Hakobyan, Narine
|
|
|
110 |
11 |
p. 1147
|
article
|
| 3420 |
Other Tumours in Primary Cutaneous Lymphomas.
|
Rupoli, Serena
|
|
|
110 |
11 |
p. 4417
|
article
|
| 3421 |
Outcome after Autologous Stem Cell Transplantation for Multiple Myeloma in Patients with Preceeding Plasma Cell Disorders.
|
Kumar, Shaji
|
|
|
110 |
11 |
p. 945
|
article
|
| 3422 |
Outcome Following Hematopoietic Cell Transplantation for Patients with AML-CR1: Comparison between Matched-Sibling and Unrelated Allografts.
|
Pagel, John M.
|
|
|
110 |
11 |
p. 330
|
article
|
| 3423 |
Outcome of Acute Promyelocytic Leukemia (APL) with Very High WBC Counts Treated with ATRA and Chemotherapy (CT): The European Group Experience.
|
Kelaidi, C.
|
|
|
110 |
11 |
p. 1845
|
article
|
| 3424 |
Outcome of Allogeneic Stem Cell Transplantation after Hypomethylating Therapy with 2′-Deoxy-5 Azacytidine for Patients with Myelodysplastic Syndrome.
|
De Padua Silva, Leandro
|
|
|
110 |
11 |
p. 1468
|
article
|
| 3425 |
Outcome of Diffuse Large B Cell Lymphoma in the United States: Review of SEER Data.
|
Komrokji, Rami S.
|
|
|
110 |
11 |
p. 1567
|
article
|
| 3426 |
Outcome of Hematopoietic Cell Transplantation in Children with Sickle Cell Disease, a Single Center's Experience.
|
Majumdar, Suvankar
|
|
|
110 |
11 |
p. 1112
|
article
|
| 3427 |
Outcome of Hematopoietic Cell Transplant from HLA-Matched Siblings Compared to a Volunteer Unrelated Donors Matched for HLA-A, B, C, DRB1, and DQB1 Alleles.
|
Woolfrey, Ann
|
|
|
110 |
11 |
p. 170
|
article
|
| 3428 |
Outcome of Limited-Stage Peripheral T-Cell Lymphoma: Results from the Nebraska Lymphoma Study Group.
|
Bierman, Philip
|
|
|
110 |
11 |
p. 3451
|
article
|
| 3429 |
Outcome of Patients with Chronic Myeloid Leukemia Who Recieved an Intermittent Imatinib Therapy.
|
Goh, Hyun-Gyung
|
|
|
110 |
11 |
p. 1034
|
article
|
| 3430 |
Outcome of Patients with T-Cell Lymphoblastic Leukemia or Lymphoma: The GRAALL Experience.
|
Leprètre, Stéphane
|
|
|
110 |
11 |
p. 2818
|
article
|
| 3431 |
Outcome of Relapse after Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) - The Effect of the Underlying Disease on Survival Following Relapse.
|
Singhal, Seema
|
|
|
110 |
11 |
p. 5020
|
article
|
| 3432 |
Outcome of Relapsed AML Patients Aged between 50 and 70: The ALFA Group Experience (ALFA 9801 Study).
|
Merabet, F.
|
|
|
110 |
11 |
p. 1857
|
article
|
| 3433 |
Outcome of Relapsed Philadelphia Chromosome Positive Chronic Myeloid Leukemia (Ph+ CML) after Allogeneic Hematopoietic Cell Transplantation (HCT).
|
Heyn, Simone
|
|
|
110 |
11 |
p. 3230
|
article
|
| 3434 |
Outcome of Sibling Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantations in Low-Grade B Cell Lymphoproliferative Disorders. A Single Centre Experience.
|
Desmond, Ronan
|
|
|
110 |
11 |
p. 5059
|
article
|
| 3435 |
Outcome of Thalassemia Intermedia Mothers and Newborns in Two Tertiary Care Centers, Beirut and Milan.
|
Taher, A.
|
|
|
110 |
11 |
p. 3827
|
article
|
| 3436 |
Outcome, Prognostic Factors and Long-Term Follow-Up in 207 Chronic Phase CML Patients Receiving Front-Line Imatinib 400 mg at a Single Institution.
|
de Lavallade, Hugues
|
|
|
110 |
11 |
p. 1045
|
article
|
| 3437 |
Outcomes after Autologous Stem Cell Transplantation for Mantle Cell Lymphoma Based on Remission Status and Induction Chemotherapy Regimen.
|
Till, Brian G.
|
|
|
110 |
11 |
p. 1905
|
article
|
| 3438 |
Outcomes for B-Precursor Patients in Legacy Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) Studies in Childhood Acute Lymphoblastic Leukemia (ALL): A Children's Oncology Group (COG) Report.
|
Gaynon, Paul S.
|
|
|
110 |
11 |
p. 847
|
article
|
| 3439 |
Outcomes for Patients Who Fail High Dose Chemoradiotherapy and Autologous Stem Cell Rescue for Relapsed and Primary Refractory Hodgkin Lymphoma.
|
Moskowitz, Alison
|
|
|
110 |
11 |
p. 1649
|
article
|
| 3440 |
Outcomes in the Recent Seattle Cord Blood Experience: Low TRM and Relapse; High Mild Acute GVHD and CMV Reactivation.
|
Gutman, Jonathan A.
|
|
|
110 |
11 |
p. 2019
|
article
|
| 3441 |
Outcomes of Allogeneic Hematopoietic Cell Transplantation (HCT) after Non-Myeloablative Conditioning in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL).
|
Rezvani, Andrew R.
|
|
|
110 |
11 |
p. 3037
|
article
|
| 3442 |
Outcomes of Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).
|
Dickinson, John D.
|
|
|
110 |
11 |
p. 3045
|
article
|
| 3443 |
Outcomes of MDS Patients with Chromosome 7 Abnormalities Treated with 5-Azacytidine.
|
Lim, ZiYi
|
|
|
110 |
11 |
p. 1449
|
article
|
| 3444 |
Outcomes of Relapsed/Refractory B-Cell Lymphoma Is Improved by Salvage Chemotherapy Consisting of Two to Three Cycles of Dexamethasone (D), High Dose Ara-C (HA) and Carboplatin (DHAC) with or without Rituximab (R) Followed by Autologous Stem Cell Transplantation.
|
Padmanabhan, Swaminathan
|
|
|
110 |
11 |
p. 5130
|
article
|
| 3445 |
Outcome with Hyper-CVAD/MTX-Ara-C, a Dose-Intensive Regimen, in Acute Lymphocytic Leukemia and Highly Aggressive Lymphoma in China.
|
Niu, Ting
|
|
|
110 |
11 |
p. 4328
|
article
|
| 3446 |
Outgrowing Endothelial Cells That Are Derived from Human Umbilical Cord Blood Improve Neovascularization in Hind-Limb Ischemia.
|
Yoo, Eun-Sun
|
|
|
110 |
11 |
p. 3697
|
article
|
| 3447 |
Outpatient Busulfan (BU)/Cytoxan (CY)/VP-16 and Autologous Stem Cell Transplant (ASCT) for Non-Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD): Comprehensive Supportive Care Program Associated with Low Treatment Related Mortality and Hospital Utilization.
|
Solomon, Scott R.
|
|
|
110 |
11 |
p. 1908
|
article
|
| 3448 |
Outpatient Management of Both Myeloablative and Reduced-Intensity Allogeneic HCT Results in Low Non-Relapse Mortality Irrespective of HCT-CI.
|
Bashey, Asad
|
|
|
110 |
11 |
p. 3022
|
article
|
| 3449 |
Overactivation of STAT Pathways and Overexpression of Survivin Confer Resistance to FLT3 Inhibitors and Could Be Therapeutic Targets in AML.
|
Zhou, Jianbiao
|
|
|
110 |
11 |
p. 2367
|
article
|
| 3450 |
Overall Survival in Erythrodermic Cutaneous T-Cell Lymphoma: An Analysis of Prognostic Factors in a Cohort of Erythrodermic Cutaneous T-Cell Lymphoma Patients.
|
Vidulich, Kelley A.
|
|
|
110 |
11 |
p. 3574
|
article
|
| 3451 |
Overcoming Graft Rejection in Adult Patients with High-Risk Severe Aplastic Anemia Using Supplemental CD34+-Enriched PBSC in Combination with BM.
|
Cho, Byung-Sik
|
|
|
110 |
11 |
p. 1111
|
article
|
| 3452 |
Overexpression of APC Reduces Stem Cell Capacity and Leukemogenic Potential of PLZF/RAR-Positive Leukemic Stem Cells.
|
Seshire, Anita
|
|
|
110 |
11 |
p. 874
|
article
|
| 3453 |
Overexpression of JAK2 mRNA in Chronic Myeloproliferative Disease and Its Implication on Mutation Testing and Biology of Disease.
|
Ma, Wanlong
|
|
|
110 |
11 |
p. 2554
|
article
|
| 3454 |
Overexpression of Rheb2 Has Diverse Effects on Hematopoietic Progenitor and Stem Cell Functions.
|
Campbell, Timothy B.
|
|
|
110 |
11 |
p. 1274
|
article
|
| 3455 |
Overexpression of the Plasma Lysophospholipase D Autotaxin Reveals a Novel Pathway for Regulation of Hemostasis in Mice.
|
Federico, Lorenzo
|
|
|
110 |
11 |
p. 3649
|
article
|
| 3456 |
Overview of Cardiac Status in Thalassemia Intermedia: The Lebanese Experience.
|
Taher, A.
|
|
|
110 |
11 |
p. 3828
|
article
|
| 3457 |
Oxidative Metabolism in Red Cells Deficient in Antioxidant Enzymes.
|
Johnson, Robert M.
|
|
|
110 |
11 |
p. 1716
|
article
|
| 3458 |
Oxidative Stress Contributes to Hemolysis in Hereditary Spherocytosis.
|
Ghoti, Hussam
|
|
|
110 |
11 |
p. 2667
|
article
|
| 3459 |
Oxidative Stress Induces Changes and Shedding of Membrane Phospholipids from Thalassemic RBCs - A NMR Study.
|
Fibach, Eitan
|
|
|
110 |
11 |
p. 1782
|
article
|
| 3460 |
Oxygen Levels and HIV-1 Transcription.
|
Nekhai, Sergei
|
|
|
110 |
11 |
p. 2280
|
article
|
| 3461 |
PAD Given at Relapse Is More Effective Than VAD Given as Induction Therapy - Results of a Phase II Study.
|
Morris, Treen C.
|
|
|
110 |
11 |
p. 2724
|
article
|
| 3462 |
Palmitoylation of Oncogenic NRAS Is Essential for Leukemogenesis.
|
Cuiffo, Benjamin G.
|
|
|
110 |
11 |
p. 826
|
article
|
| 3463 |
P2 and P2′ Residues Are Important for the Efficient Proteolysis of Factor VIIIa at Arg336 Catalyzed by Activated Protein C.
|
Varfaj, Fatbardha
|
|
|
110 |
11 |
p. 2689
|
article
|
| 3464 |
Pan-Histone Deacetylase (HDAC) Inhibitor LBH589 Depletes CXCR4 Levels and Signaling, Exerting Synergistic Anti-Leukemia Activity in Combination with CXCR4 Antagonists.
|
Mandawat, Aditya
|
|
|
110 |
11 |
p. 537
|
article
|
| 3465 |
Paracrine Suppression of VEGF Secretion by Erythropoietin Inhibits Tumor Growth.
|
Smith, Carroll R.
|
|
|
110 |
11 |
p. 3909
|
article
|
| 3466 |
Paraffin-Based 6-Gene Model Predicts Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP.
|
Malumbres, Raquel
|
|
|
110 |
11 |
p. 49
|
article
|
| 3467 |
Parenteral Iron Replacement after Bariatric Surgery.
|
Varma, Seema
|
|
|
110 |
11 |
p. 959
|
article
|
| 3468 |
Parents' Commitment to Participation in Mesenchymal Stem Cell Donation and Research Demonstrates Extensive Altruism to Other Patients.
|
Walraven, Anne-Marie
|
|
|
110 |
11 |
p. 5078
|
article
|
| 3469 |
p19Arf Cooperation in Shp2-Induced Leukemogenesis.
|
Chen, Xiaolan
|
|
|
110 |
11 |
p. 1619
|
article
|
| 3470 |
Partial Efficacy of Bortezomib on Acute Myeloid Leukemia (AML) Cells in a Patient with Concomitant Multiple Myeloma and AML.
|
Joly, Bertrand
|
|
|
110 |
11 |
p. 4379
|
article
|
| 3471 |
Parvovirus B19 Detection by PCR in Patients with Chronic Renal Failure and Resistance to Erythropoietin: An Interim Report.
|
Franco, Hector
|
|
|
110 |
11 |
p. 3773
|
article
|
| 3472 |
Pathogenesis of the Erythroid Failure in Diamond Blackfan Anemia.
|
Sieff, Colin A.
|
|
|
110 |
11 |
p. 424
|
article
|
| 3473 |
Patient Characteristics Associated with Successful Mobilization of Peripheral Blood Stem and Progenitor Cells Following Cytotoxic Chemotherapy and Peg-G-CSF Stimulation.
|
Bruns, Ingmar
|
|
|
110 |
11 |
p. 4920
|
article
|
| 3474 |
Patient-Related Outcomes of Elective Major Orthopedic Surgery in Severe Hemophilia Patients: A Review of the Literature and a Proposed Agenda for Research.
|
Botteman, Marc F.
|
|
|
110 |
11 |
p. 965
|
article
|
| 3475 |
Patient Safety in the Context of Disease Outcome and Effectiveness of Therapy.
|
Van Hoef, Marlies E.H.M.
|
|
|
110 |
11 |
p. 4959
|
article
|
| 3476 |
Patients Receiving IL-2 Activated Donor NK Cells Show Lower Incidence of Severe GvHD after Haploidentical SCT.
|
Gentilini, Chiara
|
|
|
110 |
11 |
p. 354
|
article
|
| 3477 |
Patients with aaIPI 2-3 Diffuse Large B-Cell Lymphoma Achieve 75% Long-Term Survival Following First-Line Rituximab-Supplemented High-Dose Sequential Chemotherapy and Autograft: Final Results of the Prospective Phase II GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) Trial.
|
Tarella, Corrado
|
|
|
110 |
11 |
p. 1889
|
article
|
| 3478 |
Patients with Relapsed or Progressive Multiple Myeloma Treated with Lenalidomide in the Compassionate Use Program. Spanish Registry, Preliminary Analysis.
|
Alegre, Adrian
|
|
|
110 |
11 |
p. 4821
|
article
|
| 3479 |
Pattern of Relapse in Localized Gastric Lymphoma Registered within the Prospective German Multicenter Study GIT NHL 01/92.
|
Liersch, Ruediger
|
|
|
110 |
11 |
p. 1355
|
article
|
| 3480 |
Pattern of Single Agent Rituximab Usage in Indolent Lymphoma and CLL beyond GELF and NCI Criteria.
|
Cohler, Cheryl
|
|
|
110 |
11 |
p. 4508
|
article
|
| 3481 |
Patterns and Prognostic Impact of PI3K-AKT Pathway Activation, Regulation and Downstream Activity in AML Using Reverse Phase Proteins Arrays (RPPA).
|
Kornblau, Steven M.
|
|
|
110 |
11 |
p. 2393
|
article
|
| 3482 |
Patterns of Care in Follicular Lymphoma (FL): Are Minorities Being Treated Differently? Report from the National LymphoCare Study (NLCS).
|
Nabhan, Chadi
|
|
|
110 |
11 |
p. 367
|
article
|
| 3483 |
Patterns of Care in Patients with Chemotherapy Receiving Erythropoiesis Stimulating Agents (ESAs).
|
Naeim, Arash
|
|
|
110 |
11 |
p. 964
|
article
|
| 3484 |
Patterns of Priapism in Sickle Cell Disease.
|
Redding-Lallinger, Rupa
|
|
|
110 |
11 |
p. 3808
|
article
|
| 3485 |
Patulin, a Mycotoxin, Has Potent Cytotoxic Activity on Actue Lymphoblastic Leukemia and Induce Apoptosis through Intrinsic and Extrinsic Pathways.
|
Wang, Fengrong
|
|
|
110 |
11 |
p. 4334
|
article
|
| 3486 |
Paucity of Blood Products Transfused Following the I-35W Bridge Disaster.
|
Gorlin, Jed Baron
|
|
|
110 |
11 |
p. 4026
|
article
|
| 3487 |
Pax5 Activates Oncogenic Transcription Factors of the Ets Family by Repressing the mir-15a/16-1 microRNA Cluster.
|
Chung, Elaine Y.
|
|
|
110 |
11 |
p. 346
|
article
|
| 3488 |
PAX5-Mediated Lineage Conversion and Expression of AID Accelerates Clonal Evolution and Initiates Darwinian Selection of BCR-ABL1-Mutants in Chronic Myeloid Leukemia.
|
Klemm, Lars
|
|
|
110 |
11 |
p. 1005
|
article
|
| 3489 |
PAX5 Mutations Occur Frequently in Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL) and Is Significantly Associated with BCR-ABL1 Fusion Gene.
|
Familiades, Julien
|
|
|
110 |
11 |
p. 2806
|
article
|
| 3490 |
PAX5/TEL Causes Down Modulation of B-Lineage Specific Genes, and Enhances Migration to CXCL12 in preBI Cells.
|
Fazio, Grazia
|
|
|
110 |
11 |
p. 980
|
article
|
| 3491 |
Pbx1 Regulates the Self-Renewal of Long-Term Hematopoietic Stem Cells by Maintaining Their Quiescence.
|
Ficara, Francesca
|
|
|
110 |
11 |
p. 94
|
article
|
| 3492 |
PDE4B Activity Controls Glucorticoid and Rapamycin Effects in DLBCL.
|
Batra, Nidhi
|
|
|
110 |
11 |
p. 3461
|
article
|
| 3493 |
p53 Deletion Yields High Response Rates but Rapid Progression and Poor Overall Survival in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.
|
Mikhael, Joseph R.
|
|
|
110 |
11 |
p. 953
|
article
|
| 3494 |
PD-1 Expression Is Markedly Upregulated on Intratumoral CD4+ and CD8+ T Cells in Follicular Lymphoma and Is Associated with T-Cell Exhaustion.
|
Nattamai, Durgha
|
|
|
110 |
11 |
p. 2749
|
article
|
| 3495 |
PD-1/PD-1-Ligand Interaction Contributes to Immunosuppressive Microenvironment of Hodgkin Lymphoma.
|
Yamamoto, Ryo
|
|
|
110 |
11 |
p. 379
|
article
|
| 3496 |
PD-1 Signaling on Chronic Myeloid Leukemia-Specific T Cells Results in T Cell Exhaustion and Disease Progression.
|
Mumprecht, Sabine
|
|
|
110 |
11 |
p. 2923
|
article
|
| 3497 |
PECAM-1 Is a Negative Regulator of Platelet Activation by Laminin.
|
Crockett Jr., Jimmy
|
|
|
110 |
11 |
p. 3655
|
article
|
| 3498 |
Pediatric Myelodysplastic Syndrome and Juvenile Myelomonocytic Leukemia in Korea: A Nation-Wide, Multicenter, Retrospective Study.
|
Kook, Hoon
|
|
|
110 |
11 |
p. 4630
|
article
|
| 3499 |
Pediatric T-Cell Lymphoblastic Leukemia and T-Cell Lymphoblastic Lymphoma: One and the Same or Two Different Diseases?.
|
Krieger, David
|
|
|
110 |
11 |
p. 1437
|
article
|
| 3500 |
Pegfilgrastim in Congenital Neutropenia: An Observational Survey from the French SCN Registry.
|
Beaupain, B.
|
|
|
110 |
11 |
p. 3308
|
article
|
| 3501 |
Pegfilgrastmin in Children with Severe Aplastic Anemia during Immunosuppressive Therapy.
|
Pawelec, Katarzyna
|
|
|
110 |
11 |
p. 3766
|
article
|
| 3502 |
Pegylated Granulocyte Colony Stimulating Factor (Peg-G-CSF) Enhances Mapatumumab-Mediated Antibody Dependent Cellular Cytotoxicity (ADCC) Against Non-Hodgkin's Lymphoma (NHL) Cell Lines Independent of NADPH Oxidase-Derived Reactive Oxidant Intermediates (ROIs).
|
Derby, Lyudmyla
|
|
|
110 |
11 |
p. 4519
|
article
|
| 3503 |
Pegylated Interferon-alfa-2a (PEG-IFN-α-2A; PEGASYS™) for Essential Thrombocythemia (ET) and Polycythemia Vera (PV): An Update of an Ongoing Phase II Study.
|
Quintás-Cardama, Alfonso
|
|
|
110 |
11 |
p. 3542
|
article
|
| 3504 |
Pegylated Liposomal Doxorubicin (PLD), Dexamethasone and Low Dose Thalidomide (DDt): An Active Regimen in the Frontline Therapy for Multiple Myeloma (MM).
|
Deauna-Limayo, Delva
|
|
|
110 |
11 |
p. 3619
|
article
|
| 3505 |
Pegylated Liposomal Doxorubicin (PLD) in Combination with Bortezomib (B) May Provide Therapeutic Advantage for High-Risk Multiple Myeloma Patients Relapsing within 12 Months of Stem Cell Transplant.
|
Kumar, Shaji
|
|
|
110 |
11 |
p. 2730
|
article
|
| 3506 |
Pegylated Recombinant Human Arginase, Rharg-Peg5,000MW, Targets Cell Cycle Machinery in Multiple Myeloma Cells.
|
Liu, Delong
|
|
|
110 |
11 |
p. 4095
|
article
|
| 3507 |
PEGylation or Polysialylation Reduces FVIII Binding to LRP Resulting in Prolonged Half-Life in Murine Models.
|
Rottensteiner, Hanspeter
|
|
|
110 |
11 |
p. 3150
|
article
|
| 3508 |
Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone (PCRM): A New Highly Active Regimen for Patients with Chronic Lymphocytic Leukemia (CLL) Previously Treated with PCR or FCR.
|
Lamanna, Nicole
|
|
|
110 |
11 |
p. 3115
|
article
|
| 3509 |
Peptide-Dependency of Alloreactive T Cell Clones after HLA-Mismatch Hematopoietic Stem Cell Transplantation.
|
Terakura, Seitaro
|
|
|
110 |
11 |
p. 3268
|
article
|
| 3510 |
Peptide-Major Histocompatibility Complex Class I Tetramers with Enhanced Coreceptor Binding Properties Enable Visualization of Low Avidity Leukemia-Associated Antigen-Specific CD8+ T Cells.
|
Melenhorst, J. Joseph
|
|
|
110 |
11 |
p. 1343
|
article
|
| 3511 |
Percentage of Smudge Cells on Blood Smear Predicts Prognosis in Chronic Lymphocytic Leukemia: A Multicenter Study.
|
Nowakowski, Grzegorz S.
|
|
|
110 |
11 |
p. 745
|
article
|
| 3512 |
Perioperative Outcome of Patients with Acquired Factor X Deficiency Associated with AL Amyloidosis: The Mayo Clinic Experience.
|
Thompson, Carrie
|
|
|
110 |
11 |
p. 3965
|
article
|
| 3513 |
Periostin Is a Previously Uncharacterised Vitamin K Dependent γ-Carboxyglutamic Acid (Gla) Containing Protein Expressed by Marrow-Derived Mesenchymal Stromal Cells.
|
Coutu, Daniel L.
|
|
|
110 |
11 |
p. 1927
|
article
|
| 3514 |
Peripartum Management of Women with Suspected Hereditary Thrombocytopenia.
|
Wu, Cynthia M.
|
|
|
110 |
11 |
p. 3224
|
article
|
| 3515 |
Peripheral Blood CD3+CD4+ and CD3−CD56+ Cell Counts and Circulating Lymphoma Cells Are Significant Predictors of Overall Survival in Newly Diagnosed Follicular Lymphoma.
|
Shafer, Danielle
|
|
|
110 |
11 |
p. 2607
|
article
|
| 3516 |
Peripheral Blood Cytogenetic Studies in Hematological Neoplasms: Predictors of Obtaining Metaphases for Analysis.
|
Hussein, Kebede
|
|
|
110 |
11 |
p. 3504
|
article
|
| 3517 |
Peripheral Blood Cytogenetic Studies in Myelofibrosis: Overall Yield and Comparison with Bone Marrow Cytogenetic Studies
|
Hussein, Kebede
|
|
|
110 |
11 |
p. 1547
|
article
|
| 3518 |
Peripheral Localization and Regulation of the Murine β-Globin Locus.
|
Ragoczy, Tobias
|
|
|
110 |
11 |
p. 4070
|
article
|
| 3519 |
Peripheral Neuropathy (PN) in Multiple Myeloma (MM) Responder Patients during Maintenance Therapy with Low-Intermittent Doses of Thalidomide (TAL).
|
Bibas, Michele
|
|
|
110 |
11 |
p. 4829
|
article
|
| 3520 |
Peripheral T-Cell Lymphomas with Follicular Growth Patterns Are Derived from Follicular Helper T Cells (TFH): A Link with Angioimmunoblastic T-Cell Lymphomas?.
|
Huang, Yenlin
|
|
|
110 |
11 |
p. 3568
|
article
|
| 3521 |
Peroxiredoxin-2 (Prx-2) Shows a Dual Role as Antioxidant and Chaperone in Red Cells from a β Thalassemic Mouse Model.
|
Matte', Alessandro
|
|
|
110 |
11 |
p. 1783
|
article
|
| 3522 |
Peroxisome Proliferator-Activated Receptor Gamma Promotes Lymphocyte Survival Via a Mitochondrial Pathway Mediated by GSK-3 Beta.
|
Miao, Qi
|
|
|
110 |
11 |
p. 3354
|
article
|
| 3523 |
Persistent Monoclonality after Histological Remission in Gastric Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Treated with Chemotherapy and/or Surgery: Influence of t(11;18)(q21;q21).
|
Salar, Antonio
|
|
|
110 |
11 |
p. 1359
|
article
|
| 3524 |
Persistent Recipient Antigen-Presenting Cells in Human Hematopoietic Stem Cell Transplantation: Identification of a New Dermal Subset That Outlives Epidermal Langerhans Cells.
|
Haniffa, Muzlifah
|
|
|
110 |
11 |
p. 66
|
article
|
| 3525 |
Perturbed Endocytosis as a Mechanism of CALM-Dependent Leukemogenesis: Identification of Specific CALM Domains Required for Internalization and Demonstration of Prolonged JAK2 Signaling in Response to GM-CSF.
|
Brooks, Natasha L.
|
|
|
110 |
11 |
p. 1817
|
article
|
| 3526 |
P-Glycoprotein Is Downregulated in KG1a Primitive Leukaemia Cells by LDL Cholesterol Deprivation and by HMG-CoA Reductase Inhibitors.
|
Connelly-Smith, Laura
|
|
|
110 |
11 |
p. 4192
|
article
|
| 3527 |
PHA-739358, an Aurora Kinase Inhibitor, Induces Clinical Responses in Chronic Myeloid Leukemia Harboring T315I Mutations of BCR-ABL.
|
Paquette, Ronald L.
|
|
|
110 |
11 |
p. 1030
|
article
|
| 3528 |
PHA-680626 Exhibits Anti-Proliferative and Pro-Apoptotic Activity on Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines and Primary CD34+ Cells by Inhibition of Both Bcr-Abl Tyrosine Kinase and Aurora Kinases.
|
Gontarewicz, Artur
|
|
|
110 |
11 |
p. 4568
|
article
|
| 3529 |
Pharmacodynamic Analysis of the Anticoagulant Effects of Idraparinuxparinux after Termination of 6 and 12 Months Therapy for Prevention of Recurrent Venous Thromboembolism: Observations after the vanGogh Trials.
|
Harenberg, Job
|
|
|
110 |
11 |
p. 1883
|
article
|
| 3530 |
Pharmacodynamic Differentiation of Generic Low Molecular Weight Heparins.
|
Jeske, Walter P.
|
|
|
110 |
11 |
p. 1871
|
article
|
| 3531 |
Pharmacogenetics of Mycophenolate Mofetil in Patients Undergoing Hematopoietic Cell Transplantation (HCT).
|
Long, Janel
|
|
|
110 |
11 |
p. 3010
|
article
|
| 3532 |
Pharmacogenetic Study of Methotrexate and 6-Mercaptopurine Related Genes in Korean Pediatric Patients with Acute Lymphoblastic Leukemia.
|
Kang, Hyoung Jin
|
|
|
110 |
11 |
p. 4195
|
article
|
| 3533 |
Pharmacogenetic Study on Multiple Myeloma Patients Treated with DAV Regimen and Autologous Stem Cell Transplantation.
|
Buda, Gabriele
|
|
|
110 |
11 |
p. 3468
|
article
|
| 3534 |
Pharmacogenomics Study of Biological Pathways Related to Bortezomib Activity in Myeloma.
|
Mulligan, George
|
|
|
110 |
11 |
p. 392
|
article
|
| 3535 |
Pharmacokinetic Analysis of a von Willebrand Factor/Factor VIII (VWF/FVIII) Concentrate in Adults and Children with von Willebrand Disease (VWD).
|
Di Paola, Jorge
|
|
|
110 |
11 |
p. 2140
|
article
|
| 3536 |
Pharmacokinetic and Pharmacodynamic Effects of PEG-Asparaginase in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: Results from a Single Agent Window Study.
|
Appel, Inge M.
|
|
|
110 |
11 |
p. 860
|
article
|
| 3537 |
Pharmacokinetic and Pharmacodynamic Evaluation of a Biosimilar Rituximab in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP (Rituximab, Cyclophosphamide, Adriamycin, Vincristine, Prednisolone).
|
Viswabandya, Auro
|
|
|
110 |
11 |
p. 4491
|
article
|
| 3538 |
Pharmacokinetic and Pharmacodynamic Properties of SB1317, a Potent and Orally Active Multi-Kinase Inhibitor.
|
Yeo, Pauline
|
|
|
110 |
11 |
p. 4201
|
article
|
| 3539 |
Pharmacokinetic and Toxicological Results of a 28-Day Multiple Dose Study of Starch-Conjugated Deferoxamine (S-DFO, 40SD02) in Iron-Loaded Dogs.
|
Grady, Robert W.
|
|
|
110 |
11 |
p. 2780
|
article
|
| 3540 |
Pharmacokinetics and Dose-Finding of Fragmin in Pediatric Patients at Risk for Thromboembolic Events.
|
Mitchell, Lesley G.
|
|
|
110 |
11 |
p. 1861
|
article
|
| 3541 |
Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects.
|
Mousa, Shaker A.
|
|
|
110 |
11 |
p. 4009
|
article
|
| 3542 |
Pharmacokinetics of Anti-CD22 Antibody Conjugates with Uncleavable and Cleavable Linkers in Rats.
|
Xie, Dong
|
|
|
110 |
11 |
p. 2361
|
article
|
| 3543 |
Pharmacokinetics of Nilotinib in Subjects with Normal or Impaired Hepatic Function.
|
Holland, Jaymes
|
|
|
110 |
11 |
p. 2379
|
article
|
| 3544 |
Pharmacokinetics of Plerixafor (AMD3100) in Volunteers with Renal Impairment.
|
MacFarland, Ronald
|
|
|
110 |
11 |
p. 2878
|
article
|
| 3545 |
Pharmacological Chaperone Therapy for the Treatment of Gaucher Disease: Results of Phase 1 Clinical Trials and a Clinical Ex Vivo Response Study with a Survey of Blood Markers for 53 Gaucher Patients.
|
Weinreb, Neal J.
|
|
|
110 |
11 |
p. 2404
|
article
|
| 3546 |
Pharmacologic Inhibition of Src Family Kinases Differentially Affects T Cell Cytokine Production and Proliferation: Implications for Novel Immunomodulatory Therapies.
|
Schade, Andrew E.
|
|
|
110 |
11 |
p. 1349
|
article
|
| 3547 |
Pharmacologic Replacement of BIM BH3 Reactivates Apoptosis in Hematologic Cancer and Lymphoproliferative Disease.
|
LaBelle, James L.
|
|
|
110 |
11 |
p. 524
|
article
|
| 3548 |
Phase 1 Assessment of an Orally Bioavailable Formulation of Gallium Nitrate (G4544).
|
Julian, Thomas
|
|
|
110 |
11 |
p. 4455
|
article
|
| 3549 |
Phase 1 Clinical Trial of a Novel Proteasome Inhibitor (NPI-0052) in Patients with Lymphomas and Solid Tumors.
|
Kurzrock, Razelle
|
|
|
110 |
11 |
p. 4504
|
article
|
| 3550 |
Phase 1 Dose Escalation Study of the Monoclonal Antibody Against the Insulin Like Growth Factor I Receptor CP-751,871 in Patients with Multiple Myeloma.
|
Lacy, Martha Q.
|
|
|
110 |
11 |
p. 1171
|
article
|
| 3551 |
Phase 1 Dose Escalation Study of TLK199 Tablets (Telintra), a Novel Glutathione Analog, in Myelodysplastic Syndrome.
|
Raza, Azra
|
|
|
110 |
11 |
p. 1454
|
article
|
| 3552 |
Phase 1 Human Trial of Autologous Mesenchymal Stem Cell Transplantation for the Treatment of Decompensated Cirrhosis.
|
Alimoghaddam, Kamran
|
|
|
110 |
11 |
p. 4864
|
article
|
| 3553 |
Phase IA/II Study of Oral LBH589, a Novel Deacetylase Inhibitor (DACi), Administered on 2 Schedules, in Patients with Advanced Hematologic Malignancies.
|
Spencer, Andrew
|
|
|
110 |
11 |
p. 907
|
article
|
| 3554 |
Phase I Clinical Trial of a Novel, Long-Acting Antithrombotic Drug: A Human Monoclonal Antibody Partially Inhibiting FVIII Activity.
|
Verhamme, Peter
|
|
|
110 |
11 |
p. 312
|
article
|
| 3555 |
Phase I Clinical Trial of Haplotype Mismatched Myeloablative Stem Cell Transplantation: Higher Doses of Donor Lymphocyte Infusions Depleted of Alloreactive Cells Using ATIR May Improve Outcome without Causing GVHD.
|
Roy, Denis-Claude
|
|
|
110 |
11 |
p. 2976
|
article
|
| 3556 |
Phase II Evaluation of Sunitinib Malate, a Multi-Targeted Inhibitor of Receptor Tyrosine Kinases, in Patients with Myelofibrosis.
|
Tam, Constantine S.
|
|
|
110 |
11 |
p. 3552
|
article
|
| 3557 |
Phase I/II Gene Therapy Study for Chronic Granulomatous Disease: Results, Lessons and Perspectives.
|
Ott, Marion G.
|
|
|
110 |
11 |
p. 503
|
article
|
| 3558 |
Phase I/II Report from a Multicenter Trial of Perifosine (KRX-0401) + Bortezomib in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma Previously Treated with Bortezomib.
|
Richardson, Paul
|
|
|
110 |
11 |
p. 1170
|
article
|
| 3559 |
Phase I/II Study of Clofarabine Plus Cyclophosphamide in Adults with Relapsed and Refractory Acute Lymphoblastic Leukemia (ALL).
|
Faderl, Stefan
|
|
|
110 |
11 |
p. 4335
|
article
|
| 3560 |
Phase I/II Study of MGCD0103, an Oral Isotype-Selective Histone Deacetylase (HDAC) Inhibitor, in Combination with 5-Azacitidine in Higher-Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML).
|
Garcia-Manero, Guillermo
|
|
|
110 |
11 |
p. 444
|
article
|
| 3561 |
Phase I/II Study of Rituxan (R) in Combination with Doxil (D) in Patients (pts) with Relapsing or Refractory B-Cell Lymphoma: Clinical Efficacy without Cardiac Toxicity.
|
Czuczman, Myron S.
|
|
|
110 |
11 |
p. 1369
|
article
|
| 3562 |
Phase I/II Study of the P-Glycoprotein (Pgp) Inhibitor Zosuquidar Administered by Continuous Infusion (CIV) with Daunorubicin (DNR) and Cytarabine (ARA-C) as Primary Therapy in Older Patients with Pgp-Positive Acute Myeloid Leukemia (AML).
|
Lancet, Jeffrey E.
|
|
|
110 |
11 |
p. 299
|
article
|
| 3563 |
Phase I-II Trial of Adoptive Immunotherapy with Haploidentical KIR Ligand-Mismatched Natural Killer Cells in High Risk Acute Myeloblastic Leukemia Patients.
|
Curti, Antonio
|
|
|
110 |
11 |
p. 2857
|
article
|
| 3564 |
Phase I/II Trial of Bortezomib Maintenance in Order To Prolong Remission-Duration Following Autologous Peripheral Blood Progenitor Cell Transplantation as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma.
|
Schiller, Gary J.
|
|
|
110 |
11 |
p. 3617
|
article
|
| 3565 |
Phase I/II Trial of High-Dose Melphalan (M) and Topotecan (T) Followed by Autologous Stem Cell Rescue in Patients ≤ 60 and > 60 Years of Age with Multiple Myeloma (MM).
|
Sullivan, Daniel
|
|
|
110 |
11 |
p. 943
|
article
|
| 3566 |
Phase III Trial of Immunotherapy with Recombinant Interleukin-2 (rIL-2) Versus Observation in Patients < 60 Years with Acute Myeloid Leukemia (AML) in First Remission (CR1): Preliminary Results from Cancer and Leukemia Group B (CALGB) 19808.
|
Kolitz, Jonathan E.
|
|
|
110 |
11 |
p. 157
|
article
|
| 3567 |
Phase II Multicenter Trial To Evaluate the Safety and Efficacy of Low-Toxicity Treosulfan/Fludarabine Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.
|
Holowiecki, Jerzy
|
|
|
110 |
11 |
p. 621
|
article
|
| 3568 |
Phase II Pilot Study of Rituximab + CHOP in Patients with Newly Diagnosed Waldenström's Macroglobulinemia, an Eastren Cooperative Oncology Group Trial (Study E1A02).
|
Abonour, Rafat
|
|
|
110 |
11 |
p. 3616
|
article
|
| 3569 |
Phase II Studies of Different Schedules and Doses of the Farnesyl Transferase Inhibitor Tipifarnib (R115777, Zarnestra, NSC-702818) for Patients of Age 70 or Older with Previously Untreated Acute Myeloid Leukemia (AML): A North American Intergroup Study (S0432).
|
Erba, Harry P.
|
|
|
110 |
11 |
p. 440
|
article
|
| 3570 |
Phase II Study of CEP701, an Orally Available JAK2 Inhibitor, in Patients with Primary Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis.
|
Verstovsek, Srdan
|
|
|
110 |
11 |
p. 3543
|
article
|
| 3571 |
Phase II Study of Combination of the HyperCVAD Regimen with Dasatinib in Patients with Philadelphia Chromosome (Ph) or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL) and Lymphoid Blast Phase Chronic Myeloid Leukemia (CML-LB).
|
Ravandi, Farhad
|
|
|
110 |
11 |
p. 2814
|
article
|
| 3572 |
Phase II Study of Dasatinib (SPRYCEL™) in Philadelphia Chromosome-Negative Acute and Chronic Myeloid Diseases, Including Systemic Mastocytosis.
|
Verstovsek, Srdan
|
|
|
110 |
11 |
p. 3551
|
article
|
| 3573 |
Phase II Study of High Dose Lenalidomide as Initial Treatment for Older Acute Myeloid Leukemia Patients: Early Results Show a Significant Reduction of Bone Marrow Blasts after 14 Days of Therapy.
|
Fehniger, Todd A.
|
|
|
110 |
11 |
p. 916
|
article
|
| 3574 |
Phase II Study of Lenalidomide and Prednisone for Patients with Myelofibrosis.
|
Quintás-Cardama, Alfonso
|
|
|
110 |
11 |
p. 3545
|
article
|
| 3575 |
Phase II Study of Oral Fludarabine (FAMP) in Combination with Rituximab in Indolent B-Cell Non-Hodgkin Lymphoma (B-NHL)
|
Ishizawa, Kenichi
|
|
|
110 |
11 |
p. 1287
|
article
|
| 3576 |
Phase II Study of R-CHOP Followed by 90Y-Ibritumomab Tiuxetan in Untreated Mantle Cell Lymphoma: Eastern Cooperative Oncology Group Study E1499.
|
Smith, Mitchell R.
|
|
|
110 |
11 |
p. 389
|
article
|
| 3577 |
Phase II Study of RCHOP with Pegylated Liposomal Doxorubicin (DRCOP) for Patients > 60 Years Old with Untreated Diffuse Large B Cell Lymphoma (DLBCL).
|
Rodriguez, Maria Alma
|
|
|
110 |
11 |
p. 4468
|
article
|
| 3578 |
Phase II Study of VNP40101M (Cloretazine®) in Elderly Patients with De Novo Poor Risk Acute Myelogenous Leukemia (AML).
|
Schiller, Gary J.
|
|
|
110 |
11 |
p. 917
|
article
|
| 3579 |
Phase II Study of 2-Weekly CHOP+Rituximab Followed by Yttrium 90 Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Diffuse Large B Cell Lymphoma (DLBCL).
|
Venugopal, Parameswaran
|
|
|
110 |
11 |
p. 4507
|
article
|
| 3580 |
Phase II Testing of Lenalidomide Plus Melphalan for Previously Untreated Older Patients with Multiple Myeloma: Toxicity Data from the NCIC CTG MY.11 Trial.
|
White, Darrell J.
|
|
|
110 |
11 |
p. 189
|
article
|
| 3581 |
Phase II Trial of a Chemotherapy-Only Regimen of Busulfan, Melphalan, Fludarabine and R-ATG Followed by Allogeneic T-Cell Depleted (TCD) Hematopoietic Stem Cell Transplants (HSCT) for the Treatment of Myeloid Malignancies.
|
Boulad, Farid
|
|
|
110 |
11 |
p. 2991
|
article
|
| 3582 |
Phase II Trial of Bevacizumab Combined with Low Dose Dexamethasone and Lenalidomide (BEV/REV/DEX) for Relapsed or Refractory Myeloma (MM).
|
Raschko, Martha
|
|
|
110 |
11 |
p. 1173
|
article
|
| 3583 |
Phase II Trial of Combination of Bortezomib and Rituximab in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: Preliminary Results.
|
Ghobrial, Irene M.
|
|
|
110 |
11 |
p. 4494
|
article
|
| 3584 |
Phase II Trial of Lenalidomide, Cyclophosphamide, and Dexamethasone (CRd) for Newly Diagnosed Myeloma.
|
Kumar, Shaji
|
|
|
110 |
11 |
p. 190
|
article
|
| 3585 |
Phase II Trial of Perifosine (KRX-0401) in Relapsed and/or Refractory Waldenström Macroglobulinemia: Preliminary Results.
|
Ghobrial, Irene M.
|
|
|
110 |
11 |
p. 4493
|
article
|
| 3586 |
Phase II Trial of the Oral mTOR Inhibitor RAD001 (Everolimus) in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: Preliminary Results.
|
Ghobrial, Irene M.
|
|
|
110 |
11 |
p. 4496
|
article
|
| 3587 |
Phase I Study Demonstrates Activity and Tolerability of Diphtheria Toxin Interleukin-3 Fusion Protein in Patients with AML and MDS.
|
Frankel, Arthur E.
|
|
|
110 |
11 |
p. 894
|
article
|
| 3588 |
Phase I Study of a Liposomal Carrier (CPX-351) Containing an Optimized, Synergistic, Fixed Molar Ratio of Cytarabine (Ara-C) and Daunorubicin (DNR) in Advanced Leukemias and Myelodysplastic Syndromes (MDS).
|
Feldman, Eric J.
|
|
|
110 |
11 |
p. 900
|
article
|
| 3589 |
Phase I Study of AVE1642 Anti IGF-1R Monoclonal Antibody in Patients with Advanced Multiple Myeloma.
|
Moreau, Philippe
|
|
|
110 |
11 |
p. 1166
|
article
|
| 3590 |
Phase I Study of 5-aza-2′-Deoxycitidine, Alone or in Combination with Hyper-CVAD, in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL).
|
Garcia-Manero, Guillermo
|
|
|
110 |
11 |
p. 2826
|
article
|
| 3591 |
Phase I Study of Bortezomib, (BTZ) Followed by High-Dose Melphalan, (HD Mel) and BTZ as Conditioning Regimen for Tandem Peripheral Blood Stem Cell Transplants (TanPSCT) in Patients with Primary Refractory Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL).
|
Alekshun, Todd
|
|
|
110 |
11 |
p. 5131
|
article
|
| 3592 |
Phase I Study of Clofarabine with Standard-Dose Infusional Cytarabine (Ara-C) as Intensive Induction Therapy for Newly-Diagnosed De Novo Acute Myeloid Leukemia in Older Adults Age ≥60 Years.
|
Foran, James
|
|
|
110 |
11 |
p. 1831
|
article
|
| 3593 |
Phase I Study of huN901-DM1 (BB-10901) in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma.
|
Chanan-Khan, Asher A.
|
|
|
110 |
11 |
p. 1174
|
article
|
| 3594 |
Phase I Study of KW-0761, a Humanized Anti-CCR4 Antibody, in Patients (Pts) with Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma (ATLL) and Peripheral T-Cell Lymphoma (PTCL): Preliminary Results.
|
Uike, Naokuni
|
|
|
110 |
11 |
p. 4492
|
article
|
| 3595 |
Phase I Study of Sapacitabine, an Oral Nucleoside Analogue, in Patients with Advanced Leukemias or Myelodysplastic Syndromes (MDS).
|
Kantarjian, Hagop
|
|
|
110 |
11 |
p. 884
|
article
|
| 3596 |
Phase I Study of S-trans, Trans-farnesylthiosalicylic Acid (FTS), a Novel Oral Ras Inhibitor, in Patients with Refractory Hematologic Malignancies.
|
Borthakur, Gautam
|
|
|
110 |
11 |
p. 1600
|
article
|
| 3597 |
Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA) and Decitabine in Patients with Relapsed, Refractory or Poor Prognosis Leukemia.
|
Ravandi, Farhad
|
|
|
110 |
11 |
p. 897
|
article
|
| 3598 |
Phase I Study of Triciribine Phosphate Monohydrate, a Specific Inhibitor of AKt Phosphorylation, in Adult Patients with Advanced Hematologic Malignancies.
|
Ravandi, Farhad
|
|
|
110 |
11 |
p. 913
|
article
|
| 3599 |
Phase I Study of Vaccination with Dendritic Cell Myeloma Fusions.
|
Avigan, David
|
|
|
110 |
11 |
p. 284
|
article
|
| 3600 |
Phase I Trial of Combination Therapy with 90Y Ibritumomab Tiuxetan (Zevalin) and Gemicitabine in Patients with Non-Hodgkin's Lymphoma.
|
Borghaei, Hossein
|
|
|
110 |
11 |
p. 4485
|
article
|
| 3601 |
Phase I Trial of Fenretinide (4-HPR) Intravenous Emulsion for Hematologic Malignancies.
|
Mohrbacher, Ann
|
|
|
110 |
11 |
p. 2581
|
article
|
| 3602 |
Phase I Trial of HuLuc63 in Multiple Myeloma.
|
Bensinger, William
|
|
|
110 |
11 |
p. 1180
|
article
|
| 3603 |
Phase I Trial of Multiple Infusions of Autologous Activated T Cells with Anti-CD3 x Anti-CD20 Bispecific Antibody (CD20Bi) after Autologous Peripheral Blood Stem Cell Transplant for NonHodgkins Lymphoma To Improve Graft-vs-Lymphoma Effects.
|
Lum, Lawrence G.
|
|
|
110 |
11 |
p. 4488
|
article
|
| 3604 |
Phase I Trial of Oral Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Combination with Bortezomib in Patients with Advanced Multiple Myeloma.
|
Weber, Donna M.
|
|
|
110 |
11 |
p. 1172
|
article
|
| 3605 |
Phase I Trial of Suberoylanilide Hydroxamic Acid (SAHA) + Bortezomib (Bort) in Relapsed Multiple Myeloma (MM) Patients (pts).
|
Badros, Ashraf
|
|
|
110 |
11 |
p. 1168
|
article
|
| 3606 |
Phase I Trial of the 131I-Labelled Anti-CD25 Antibody Basiliximab in the Treatment of Patients with Relapsed or Refractory Lymphoma.
|
Dancey, Gairin
|
|
|
110 |
11 |
p. 648
|
article
|
| 3607 |
Phase I Trial of the Targeted Alpha-Particle Nano-Generator Actinium-225 (225Ac)-HuM195 (Anti-CD33) in Acute Myeloid Leukemia (AML).
|
Rosenblat, Todd L.
|
|
|
110 |
11 |
p. 910
|
article
|
| 3608 |
Phase 1 Single Agent Antitumor Activity of Twice Weekly Consecutive Day Dosing of the Proteasome Inhibitor Carfilzomib (PR-171) in Hematologic Malignancies.
|
Alsina, Melissa
|
|
|
110 |
11 |
p. 411
|
article
|
| 3609 |
Phase 1/2 Study of AMG 531 in Thrombocytopenic Patients (pts) with Low-Risk Myelodysplastic Syndrome (MDS): Update Including Extended Treatment.
|
Kantarjian, Hagop
|
|
|
110 |
11 |
p. 250
|
article
|
| 3610 |
Phase-2 Study of R-MACLO-IVAM-T in Newly Diagnosed Mantle Cell Lymphoma.
|
Lossos, Izidore S.
|
|
|
110 |
11 |
p. 1363
|
article
|
| 3611 |
Phenotypic Analysis of Plasma Cells in Monoclonal Gammopathy and Multiple Myeloma Subjects.
|
Kovarova, Lucie
|
|
|
110 |
11 |
p. 4755
|
article
|
| 3612 |
Phenotypic and Functional Characterization of Mesenchymal Stromal Cells Derived from CD271+- Bone Marrow Mononuclear Cells and Mesenchymal Stromal Cells Derived through Plastic Adherence.
|
Kuci, Selim
|
|
|
110 |
11 |
p. 1921
|
article
|
| 3613 |
Phenotypic and Functional Effects of Perifosine on Dendritic Cells.
|
Song, Weihua
|
|
|
110 |
11 |
p. 4803
|
article
|
| 3614 |
Phenotypic and Functional Features of Vγ9/Vδ2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells.
|
Coscia, Marta
|
|
|
110 |
11 |
p. 1131
|
article
|
| 3615 |
Phenotypic Correction of Adamts13-Deficient Mice by Early Intra-Amniotic Gene Transfer of Lentiviral Vector Encoding ADAMTS13 Genes.
|
Niiya, Masami
|
|
|
110 |
11 |
p. 197
|
article
|
| 3616 |
2-Phenylacetylenesulfonamide Upregulates Noxa and Induces p53-Independent Apoptosis of CLL Cells.
|
Steele, Andrew J.
|
|
|
110 |
11 |
p. 1609
|
article
|
| 3617 |
PHF23: A Novel Erythropoietin-Induced Gene Associated with AML and MDS.
|
Hodges, Vivien M.
|
|
|
110 |
11 |
p. 3178
|
article
|
| 3618 |
Philadelphia Chromosome-Positive Leukemia Patients Who Harbor Imatinib-Resistant Mutations Have a Higher Likelihood of Developing Additional Mutations Associated with Resistance to Novel Tyrosine Kinase Inhibitors.
|
Soverini, Simona
|
|
|
110 |
11 |
p. 322
|
article
|
| 3619 |
Philadelphia Negative BCR/ABL1 Positive CML: FISH Mapping and aCGH Reveal Breakpoint Hotspots.
|
Virgili, Anna
|
|
|
110 |
11 |
p. 2924
|
article
|
| 3620 |
Phlebotomy and Bolus Subcutaneous Deferoxamine in Algerian Patients with Thalassemia Major or Intermedia or Sickle Cell Disease Treated with Hydroxyurea.
|
Bradai, Mohamed
|
|
|
110 |
11 |
p. 3812
|
article
|
| 3621 |
Phospho- AKT Is Not Sufficient To Delay Neutrophil Apoptosis.
|
Souza, Liliana R.
|
|
|
110 |
11 |
p. 3366
|
article
|
| 3622 |
Phosphodiesterase Inhibition Increases Fetal Hemoglobin in Sickle Cell Disease; L-Arginine Supplementation Does Not.
|
Little, Jane A.
|
|
|
110 |
11 |
p. 3396
|
article
|
| 3623 |
Phospho-IkappaB Is Abnormally Expressed in Bone Marrow of CMML Patients.
|
Peerwani, Ziad
|
|
|
110 |
11 |
p. 2450
|
article
|
| 3624 |
Phospholipase D Activity Is Essential for PKC-Mediated Phosphatidylserine Exposure.
|
DeJong, Kitty
|
|
|
110 |
11 |
p. 1715
|
article
|
| 3625 |
Phosphorylation of AML1/Runx1 Is Essential for T Cell Differentiation and Early Hematopoietic Development.
|
Yoshimi, Mayumi
|
|
|
110 |
11 |
p. 2189
|
article
|
| 3626 |
Photopheresis in HIV-1 Infected Patients Utilizing (Benzoporphyrin Derivative Verteporfin/BPD-MA) and Light.
|
Bernstein, Zale P.
|
|
|
110 |
11 |
p. 2275
|
article
|
| 3627 |
Photo-Reactive and Non-Natural Amino Acid Epitopes of Human WT1 Enhance Immunogenicity and Allow Kinetic Study of Antigen Processing.
|
Haro, Kurtis J.
|
|
|
110 |
11 |
p. 2311
|
article
|
| 3628 |
Physiologically Significant Genetic Interaction between STAT5 and Gab2 during Normal and Pathologic Hematopoiesis.
|
Li, Geqiang
|
|
|
110 |
11 |
p. 87
|
article
|
| 3629 |
Physiological Non-Responsiveness and Absence of Activation Induced Cell Death of T Cells Rapidly Re-Expressing Retrovirally Introduced TCRs after T Cell Activation.
|
van Loenen, Marleen
|
|
|
110 |
11 |
p. 2301
|
article
|
| 3630 |
PI-103, a Dual Inhibitor of Class I Phosphatidylinositide 3-Kinase and mTOR, Has Anti-Leukemic Activity in Acute Myeloid Leukemia.
|
Park, Sophie
|
|
|
110 |
11 |
p. 876
|
article
|
| 3631 |
Pifithrin α, a Selective Inhibitor of p53-Mediated Transcription, Augments Apoptotic Killing of Chronic Lymphocytic Leukemia Cells by Nutlin 3a and Cytotoxic Drugs.
|
Steele, Andrew J.
|
|
|
110 |
11 |
p. 1590
|
article
|
| 3632 |
Pilot Results: Pre-Treatment with Deferasirox Increases the Chances of Rapid Viral Response in Patients with Chronic Hepatitis C Infection Treated with PEG-Interferon/Ribavirin.
|
Goubran, Hadi A.
|
|
|
110 |
11 |
p. 2281
|
article
|
| 3633 |
Pilot Study of a Wilms Tumor Protein (WT1) Heteroclitic Peptide Vaccine in Patients with Myeloid and Thoracic Neoplasms.
|
Maslak, Peter G.
|
|
|
110 |
11 |
p. 903
|
article
|
| 3634 |
Pimozide Inhibits STAT5 Signaling in Chronic Myelogenous Leukemia and Reduces the Viability of Both Imatinib Sensitive and Imatinib Resistant Cells.
|
Nelson, Erik A.
|
|
|
110 |
11 |
p. 2953
|
article
|
| 3635 |
p53 Inactivation in CLL: Pattern of 110 TP53 Mutations.
|
Zenz, Thorsten
|
|
|
110 |
11 |
p. 2064
|
article
|
| 3636 |
p53 in B Cell Chronic Lymphocytic Leukemia (CLL) and Lymphoma with Peripheral Blood Expression along Treatment with Fludarabine and Other Treatment Regimens.
|
Barragan, Carlos Sergio
|
|
|
110 |
11 |
p. 4673
|
article
|
| 3637 |
Piperacillin Induced Thrombocytopenia in Critical Care Patients as Compared to Non Critical Patients.
|
Naik, Seema
|
|
|
110 |
11 |
p. 3916
|
article
|
| 3638 |
Pipkiia and Beta-Globin: Transcripts Differentially Expressed in Reticulocytes and Associated with High Levels of Hb H in Two Siblings with Hb H Disease.
|
Sonati, Maria F.
|
|
|
110 |
11 |
p. 3821
|
article
|
| 3639 |
PI-PLCbeta1 Expression in Patients with High-Risk Myelodysplastic Syndromes Is Affected by Azacitidine Treatment.
|
Finelli, Carlo
|
|
|
110 |
11 |
p. 2448
|
article
|
| 3640 |
PIR-B-Deficient Mice Are Susceptible to Salmonella Infection.
|
Oka, Satoshi
|
|
|
110 |
11 |
p. 2420
|
article
|
| 3641 |
Pivotal Role of FoxO3 and mTORC1 in the Opposite Effects of SDF-1 and TGF-β on Cell Cycle Progression in CD34+ Stem/Progenitor Cells.
|
Chabanon, Aurelie
|
|
|
110 |
11 |
p. 3363
|
article
|
| 3642 |
PKCδ Regulates Retinoic Acid-Induced Myeloid Cell Differentiation through Eukaryotic Initiation Factor Alpha (eIF2α).
|
Ozpolat, Bulent
|
|
|
110 |
11 |
p. 1814
|
article
|
| 3643 |
PKC zeta-mTOR Pathway: A New Target for Rituximab Therapy in Follicular Lymphoma.
|
Laurent, Guy
|
|
|
110 |
11 |
p. 804
|
article
|
| 3644 |
Placenta Derived Adherent Cells Modulate the Allogenic Mixed Lymphocyte Reaction Partially via an Indoleamine 2,3-Dioxygenase Mediated Mechanism.
|
Liang, Bitao
|
|
|
110 |
11 |
p. 4112
|
article
|
| 3645 |
Planned First Efficacy and Safety Analysis of De-Intensified Induction with Fludarabine, Cyclophosphamide Plus Rituximab (FCR) Followed by Fludarabine Plus Rituximab (FR) and Remission Maintenance Therapy with Rituximab in Previously Untreated B-Chronic Lymphocytic Leukemia (B-CLL): The Chairos Study.
|
Egle, Alexander
|
|
|
110 |
11 |
p. 2045
|
article
|
| 3646 |
Plasma ADAMTS13 Activity Markedly Decreases in Patients with Severe Acute Pancreatitis: Its Potential Role on the Development of Multiorgan Failure.
|
Morioka, Chie
|
|
|
110 |
11 |
p. 2160
|
article
|
| 3647 |
Plasma Cell Dyscrasia in Human Immunodefficiency Disease.
|
Jajeh, Ahmad
|
|
|
110 |
11 |
p. 3858
|
article
|
| 3648 |
Plasmacytoid Dendritic Cells Induce Growth and Survival of Multiple Myeloma Cells: Therapeutic Application.
|
Chauhan, Dharminder
|
|
|
110 |
11 |
p. 3507
|
article
|
| 3649 |
Plasma Endothelin-1 and Leukocyte Microparticles Increase during Pain Episode in Patients with Sickle Cell Disease.
|
Alvarez, Ofelia
|
|
|
110 |
11 |
p. 3807
|
article
|
| 3650 |
Plasmatic Levels of FLT-3 Ligand and SDF-1 and Expression of FLT-3 and CXCR4 in CD34+ Cells Population Prior and Post Mobilization of Peripheral Blood Stem Cell.
|
Cecyn, Karin Z.
|
|
|
110 |
11 |
p. 4922
|
article
|
| 3651 |
Plasmin Enhances Cell Surface Tissue Factor Activity without Increasing Tissue Factor Antigen Levels at the Cell Surfaces of Mesothelial and Endothelial Cells.
|
Kothari, Hema
|
|
|
110 |
11 |
p. 1758
|
article
|
| 3652 |
Platelet Apoptosis in Fluid-Phase and Adherent Platelets and Thrombi-Like Platelet Aggregates.
|
Leytin, Valery
|
|
|
110 |
11 |
p. 2102
|
article
|
| 3653 |
Platelet Count Is an IPSS-Independent Risk Factor Predicting Survival in Refractory Anemia with Ringed Sideroblasts.
|
Palmer, Shanique R.
|
|
|
110 |
11 |
p. 2455
|
article
|
| 3654 |
Platelet Counts Remain Elevated in Two Patients with Idiopathic Thrombocytopenic Purpura after Cessation of Oral Eltrombopag.
|
Cheng, Gregory
|
|
|
110 |
11 |
p. 3927
|
article
|
| 3655 |
Platelet-Dependent Activity of GlycoPEGylated rFVIIa.
|
Sorensen, Brit B.
|
|
|
110 |
11 |
p. 3140
|
article
|
| 3656 |
Platelet-Derived Microparticles Induce Angiogenesis In Vitro and In Vivo.
|
Chen, Bao-An
|
|
|
110 |
11 |
p. 3901
|
article
|
| 3657 |
Platelet Gene/Protein Expression Analyses Using an Integrated Platform.
|
Gnatenko, Dmitri V.
|
|
|
110 |
11 |
p. 3645
|
article
|
| 3658 |
Platelet Pathology in Carriers of X-Linked GATA-1 Macrothrombocyopenia.
|
White, James G.
|
|
|
110 |
11 |
p. 3198
|
article
|
| 3659 |
Platelet-Platelet Fusion Results from Fusing of Plasma Membranes and Is Augmented by Stimulation through PAR1 or CCR4.
|
Woronowicz, Kamil
|
|
|
110 |
11 |
p. 137
|
article
|
| 3660 |
Platelet Production Rate Predicts the Response to Prednisone Therapy in Patients with Idiopathic Thrombocytopenic Purpura.
|
Houwerzijl, Ewout
|
|
|
110 |
11 |
p. 1325
|
article
|
| 3661 |
Platelets and Heparin Induced Thrombocytopenia Antibodies Do Not Influence the Inhibitory Activity of Argatroban on Thrombin Generation.
|
Gerotziafas, Grigoris T.
|
|
|
110 |
11 |
p. 929
|
article
|
| 3662 |
Platelet Septins: Interaction of the Human Septins SEPT5, SEPT7 and SEPT11.
|
Zieger, Barbara
|
|
|
110 |
11 |
p. 3891
|
article
|
| 3663 |
Platelet vWF, ADAMTS-13, and Neutrophil Activation in Patients with Essential Thrombocythemia (ET)
|
Falanga, Anna
|
|
|
110 |
11 |
p. 1548
|
article
|
| 3664 |
Pleural Effusions Associated with Use of Dasatinib in Chronic Myeloid Leukemia May Have an Auto-Immune Pathogenesis.
|
Punnialingam, Sinthiya
|
|
|
110 |
11 |
p. 2945
|
article
|
| 3665 |
Pluripotent SSEA-1+ OCT-4+ CXCR4+ Sca-1+ lin− CD45− Very Small Embryonic Like (VSEL) Stem Cells Reside in Multiple Murine Organs - Are VSEL Epiblast-Derived Functional Pluripotent Precursors for Tissue Committed Stem Cells or Merely Quesiscent Remants from Embryonic Development?.
|
Kucia, Magda
|
|
|
110 |
11 |
p. 3698
|
article
|
| 3666 |
PML Protects HIPK2 and p300 from SCF-Mediated Ubiquitin-Dependent Degradation To Activate Transcription.
|
Shima, Yutaka
|
|
|
110 |
11 |
p. 2653
|
article
|
| 3667 |
PNAS-2's Subcullar Location in Leukemic Cell Is Abnormal and Its Relation with Leukemogenesis.
|
Wang, Hai-Rong
|
|
|
110 |
11 |
p. 4299
|
article
|
| 3668 |
PNH-Affected RBC's Mean Life Span Estimated by Reticulocyte-Gated Flow Cytometry Reflects In Vivo Hemolysis in PNH.
|
Ninomiya, Haruhiko
|
|
|
110 |
11 |
p. 3679
|
article
|
| 3669 |
Podocalyxin Is a Selective Marker of Erythroid Progenitors but Is Dispensable for Anemia Recovery.
|
Hughes, Michael R.
|
|
|
110 |
11 |
p. 1731
|
article
|
| 3670 |
Polyclonal Hypergammaglobulinemia in a Randomized Sample of Ghanaian Adult Males.
|
Buadi, Francis
|
|
|
110 |
11 |
p. 960
|
article
|
| 3671 |
Polymorphic Variation at the STAT5 Locus Is Associated with the Response of CML Patients to Interferon Alpha.
|
Kreil, Sebastian
|
|
|
110 |
11 |
p. 2913
|
article
|
| 3672 |
Polymorphism in the IFN-γ Gene Is Associated with Severe Acute Graft Versus Host Disease in β Thalassemia Major Patients Undergoing Matched Related Hematopoietic Stem Cell Transplantation (HSCT).
|
Sellathamby, Shanmugaapriya
|
|
|
110 |
11 |
p. 1105
|
article
|
| 3673 |
Polymorphisms in Detoxification and DNA Repair Genes in Myelodysplastic Syndromes.
|
Seedhouse, Claire H.
|
|
|
110 |
11 |
p. 2440
|
article
|
| 3674 |
Polymorphisms in Multidrug Resistance-Associated Protein Genes Are Associated with Worse Outcome in Childhood Acute Lymphoblastic Leukemia.
|
Ansari, Marc
|
|
|
110 |
11 |
p. 1443
|
article
|
| 3675 |
Polymorphisms in One-Carbon Metabolism Genes and Overall Survival in Diffuse Large B-Cell Lymphoma (DLBCL).
|
Cerhan, James R.
|
|
|
110 |
11 |
p. 1568
|
article
|
| 3676 |
Polymorphisms in the BLyS Gene Are Associated with an Increased Risk of Developing B-Cell Non-Hodgkin Lymphoma.
|
Novak, Anne J.
|
|
|
110 |
11 |
p. 564
|
article
|
| 3677 |
Polymorphisms in the MGMT Gene as Predictors of Leukemia Risk and Response to Therapy in Children with AML.
|
George, Alex
|
|
|
110 |
11 |
p. 1444
|
article
|
| 3678 |
Polymorphisms of NOS3 and FCGR2A Genes Contribute to Thrombotic Risk in Essential Thrombocythemia
|
Olcaydu, Damla
|
|
|
110 |
11 |
p. 1537
|
article
|
| 3679 |
Polymorphisms of the Transforming Growth Factor Beta 1 (TGFB1) Gene Define a Subgroup of Patients with Late Onset of Disease and Poor Outcome in Multiple Myeloma.
|
Neben, Kai
|
|
|
110 |
11 |
p. 1491
|
article
|
| 3680 |
Polyphosphate Enhances Fibrin Clot Structure.
|
Smith, Stephanie A.
|
|
|
110 |
11 |
p. 403
|
article
|
| 3681 |
Polyphosphate Shortens the Clotting Time of Hemophilic and Anticoagulated Plasma.
|
Smith, Stephanie A.
|
|
|
110 |
11 |
p. 1760
|
article
|
| 3682 |
Poor Outcome after Allogeneic Hematopoietic Stem Cell Transplantation for De Novo AML with Chromosome 7 Abnormalities: A Report for the ALWP of the European Group for Blood and Marrow Transplantation.
|
Buzyn, Agnes
|
|
|
110 |
11 |
p. 325
|
article
|
| 3683 |
Poor Survival of CD34 Positive and CD13/33 Positive Patients in Pediatric T-Cell Acute Lymphoblastic Leukemia Is Not Explained by Expression of Multidrug Resistance Genes.
|
van Grotel, Martine
|
|
|
110 |
11 |
p. 4219
|
article
|
| 3684 |
Population-Based Prevalence of Anemia, Iron, Folic Acid and Vitamin B12 Deficiency among Young Adults in Israel.
|
Merkel, Drorit
|
|
|
110 |
11 |
p. 3754
|
article
|
| 3685 |
Population Pharmacokinetics (PK) of Oral Posaconazole (POS) for Antifungal Prophylaxis in Neutropenic Patients with Hematologic Malignancies.
|
AbuTarif, Malaz A.
|
|
|
110 |
11 |
p. 2287
|
article
|
| 3686 |
Positional Cloning: Regulation of Hematopoietic Stem and Progenitor Cell Mobilization through EGF Receptor Signaling.
|
Ryan, Marnie A.
|
|
|
110 |
11 |
p. 1252
|
article
|
| 3687 |
Positive Impact of Iron Chelation Therapy (CT) on Survival in Regularly Transfused MDS Patients. A Prospective Analysis by the GFM.
|
Rose, Christian
|
|
|
110 |
11 |
p. 249
|
article
|
| 3688 |
Positron Emission Tomography (PET) Scanning in the Setting of Post-Transplant Lymphoproliferative Disorders (PTLD).
|
Blaes, Anne H.
|
|
|
110 |
11 |
p. 4411
|
article
|
| 3689 |
Possible Advantage of Twice-Daily 6-Mercaptopurine Dosing in Children with Acute Lymphoblastic Leukemia (ALL).
|
Carson, Thaddeus Y.
|
|
|
110 |
11 |
p. 851
|
article
|
| 3690 |
Possible Involvement of Heparin-Binding Protein in Antibody-Mediated Non-Hemolytic Transfusion Reaction.
|
Furuta, Rika A.
|
|
|
110 |
11 |
p. 4014
|
article
|
| 3691 |
Possible Involvement of γδ-T Cells in the Development of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
|
Koh, Ki-Ryang
|
|
|
110 |
11 |
p. 1971
|
article
|
| 3692 |
Post Allogeneic Stem Cell Transplant Complications - Single Centre Experience from Pakistan.
|
Raza, Shahid
|
|
|
110 |
11 |
p. 4955
|
article
|
| 3693 |
Post-Consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML: Long Term Follow-Up of Leukemia-Free Survival and Overall Survival.
|
Brune, Mats L.
|
|
|
110 |
11 |
p. 1846
|
article
|
| 3694 |
Post Thaw Colony Forming Units (CFU) Is a Strong Independent Predictor of Engraftment after Unrelated Donor Umbilical Cord Blood Transplantation (UCBT).
|
Page, Kristin M.
|
|
|
110 |
11 |
p. 3282
|
article
|
| 3695 |
Post Transplant Autoimmune Hemolytic Anemia and Other Cytopenias Are Increased in Very Young Babies after Unrelated Donor Umbilical Cord Blood Transplantation.
|
Page, Kristin M.
|
|
|
110 |
11 |
p. 1054
|
article
|
| 3696 |
Post-Transplant Lymphoproliferative Diseases after Renal Transplantation. Long Term Experience over 35 Years in Peru.
|
Beltran, Brady
|
|
|
110 |
11 |
p. 4420
|
article
|
| 3697 |
Posttransplant Lymphoproliferative Disorder in Adult Lung Transplant Recipients: A Report on Twenty-Seven Patients.
|
Stein, Sophie D.
|
|
|
110 |
11 |
p. 4425
|
article
|
| 3698 |
Post Transplant Lymphoproliferative Disorders (PTLD): Prevalence, Clinical Features and Outcome.
|
Colorio, Cecilia
|
|
|
110 |
11 |
p. 5029
|
article
|
| 3699 |
Potency Adjusted Generic Versions of Argatroban Can Be Differentiated from Branded Argatroban in Thrombin Generation and Platelet Activation Assays.
|
Adiguzel, Cafer
|
|
|
110 |
11 |
p. 4007
|
article
|
| 3700 |
Potent and Durable Neutrophil Stimulation and Progenitor Stem Cell Mobilization by Maxy-G34 a Next Generation G-CSF.
|
Vetticaden, Santosh J.
|
|
|
110 |
11 |
p. 4053
|
article
|
| 3701 |
Potent Anti-Leukemic Activity of a Cationic Lipid-DNA Complex.
|
Herse, Zachary
|
|
|
110 |
11 |
p. 4891
|
article
|
| 3702 |
Potent Antitumor Activity of AP24534, an Orally Active Inhibitor of Bcr-Abl Variants Including T315I, in In Vitro and In Vivo Models of Chronic Myeloid Leukemia (CML).
|
Rivera, Victor M.
|
|
|
110 |
11 |
p. 1032
|
article
|
| 3703 |
Potential for Cure by Chemotherapy Only, without Allogeneic Stem Cell Transplantation, in Pediatric Relapsed Acute Myeloid Leukemia?.
|
Kaspers, Gertjan J.
|
|
|
110 |
11 |
p. 2865
|
article
|
| 3704 |
Potential Increase in Graft Failure Risk after Reduced Intensity Conditioning Stem Cell Transplant (RIT) Using Umbilical Cord Blood for Children with Primary Immunodeficiency.
|
Guarino, Jessica
|
|
|
110 |
11 |
p. 2006
|
article
|
| 3705 |
Potential of Angeli's Salt To Reduce Nitric Oxide Scavenging in Hemolysis.
|
Kim-Shapiro, Daniel B.
|
|
|
110 |
11 |
p. 3788
|
article
|
| 3706 |
Potential Role of a Mismatched HLA-Specific Cytotoxic T Lymphocyte Clone Developed Pre-Transplant in Graft Rejection Following Cord Blood Transplantation.
|
Narimatsu, Hiroto
|
|
|
110 |
11 |
p. 3269
|
article
|
| 3707 |
Potential Role of Dual NF-κB and Oxidative Stress Pathway Inhibitor, OT-304 as a Novel Drug Resistance-Reversing Agent.
|
Mousa, Shaker A.
|
|
|
110 |
11 |
p. 4211
|
article
|
| 3708 |
Potentiated Phospho-Protein Network Profiling of Multiple Myeloma Cell Lines and Primary Patient Samples by Multi-Parameter Flow Cytometry.
|
Li, Zhi Hua
|
|
|
110 |
11 |
p. 1505
|
article
|
| 3709 |
Potentiation of Melphalan-Induced Cytotoxicity through Targeting of the Base Excision Repair Pathway in Multiple Myeloma.
|
Reed, April M.
|
|
|
110 |
11 |
p. 4799
|
article
|
| 3710 |
Potentiation of Reactive Oxygen Species Is a Marker for Synergistic Cytotoxicity of MS-275 and 5-Azacytidine in Leukemic Cells.
|
Gao, Shan
|
|
|
110 |
11 |
p. 4343
|
article
|
| 3711 |
Potentiation of Topoisomerase II Inhibitor-Mediated Myeloid Leukemia Cell Kill by Farnesyltransferase Inhibitor L-744,832.
|
Onono, Fredrick O.
|
|
|
110 |
11 |
p. 3479
|
article
|
| 3712 |
P53 Protein Expression Levels Are Prognostic in AML and Predict for Mutational Status.
|
Kornblau, Steven M.
|
|
|
110 |
11 |
p. 2397
|
article
|
| 3713 |
Practical Implications of Non-Invasive MRI-Based Liver and Cardiac Iron Assessments in Children and Adults with Transfusion-Dependent Anemias.
|
Chirnomas, S. Deborah
|
|
|
110 |
11 |
p. 2666
|
article
|
| 3714 |
Practice Patterns in the Diagnosis of Follicular Lymphoma (FL): Report from the National Lymphocare Study (NLCS).
|
Matasar, Matthew J.
|
|
|
110 |
11 |
p. 2613
|
article
|
| 3715 |
Pre-B Cell Receptor Signaling Prevents Leukemic Transformation by BCR-ABL1.
|
Trageser, Daniel
|
|
|
110 |
11 |
p. 2795
|
article
|
| 3716 |
Pre-Clinical Activity of a Novel FcγRIIIa Engineered CD19 Monoclonal Antibody in B Cell Chronic Lymphocytic Leukemia and Acute Lymphoblastic Leukemia.
|
Roda, Julie M.
|
|
|
110 |
11 |
p. 2351
|
article
|
| 3717 |
Pre-Clinical Data and Preliminary Patient Results of Intravenous MV-NIS To Treat Relapsed, Refractory Multiple Myeloma.
|
Dispenzieri, Angela
|
|
|
110 |
11 |
p. 1181
|
article
|
| 3718 |
Pre-Clinical Development of a Subunit Vaccine Expressing an IE1-IE2 Fusion Protein of HCMV.
|
Wang, Zhongde
|
|
|
110 |
11 |
p. 165
|
article
|
| 3719 |
Preclinical Evaluation of CBP/β-catenin Inhibition as a New Strategy for Drug Resistant Acute Lymphoblastic Leukemia.
|
Kim, Yong-Mi
|
|
|
110 |
11 |
p. 1596
|
article
|
| 3720 |
Preclinical Evaluation of Sorafenib in Combination with Cytarabine and Clofarabine in Acute Myeloid Leukemia (AML).
|
Hu, Shuiying
|
|
|
110 |
11 |
p. 4202
|
article
|
| 3721 |
Pre-Clinical Evaluation of the Anti-CD22 Immunotoxin CAT-8015 in Combination with Chemotherapy Agents for Childhood B-Precursor Acute Lymphoblastic Leukemia (Pre-B ALL).
|
Ahuja, Yachna
|
|
|
110 |
11 |
p. 865
|
article
|
| 3722 |
Preclinical Results of the Camptothecin-Polymer Conjugate IT-101 in Multiple Human Lymphoma Xenografts.
|
Numbenjapon, Tontanai
|
|
|
110 |
11 |
p. 1376
|
article
|
| 3723 |
Preclinical Validation of a Clinical Grade Novel Specific Small Molecule Cyclin D1 Inhibitor, P276-00 for the Treatment of Multiple Myeloma.
|
Raje, Noopur
|
|
|
110 |
11 |
p. 256
|
article
|
| 3724 |
Pre-Clinical Validation of Polo-Like Kinase 1 as a Therapeutic Target in Multiple Myeloma with the Selective Inhibitor BI2536.
|
Sidhu, Roger
|
|
|
110 |
11 |
p. 2514
|
article
|
| 3725 |
Predicting Acute Chest Syndrome in Sickle Cell Disease Patients Hospitalized for Acute Vasoocclusive Events.
|
Dworkis, Daniel A.
|
|
|
110 |
11 |
p. 3390
|
article
|
| 3726 |
Predicting Response and Survival for Severe Aplastic Anemia Patients Treated with Immunosuppression.
|
Scheinberg, Phillip
|
|
|
110 |
11 |
p. 1691
|
article
|
| 3727 |
Predicting Response to Therapy for Graft-vs-Host Disease (GvHD) with a Rapid Immune Function Assay.
|
Anaissie, Elias J.
|
|
|
110 |
11 |
p. 5012
|
article
|
| 3728 |
Predicting Structural and Serologic Modifications in Blood Group Antigens by Homology Modeling.
|
Westhoff, Connie M.
|
|
|
110 |
11 |
p. 451
|
article
|
| 3729 |
Prediction of Heparin Induced Thrombocytopenia: Validation of an Experience-Based Computer Model.
|
Whitlatch, Nicole L.
|
|
|
110 |
11 |
p. 3226
|
article
|
| 3730 |
Prediction of Survival in Patients with Myelodysplastic Syndrome According to WHO Classification-Based Prognostic Scoring System (WPSS).
|
Jang, Jun Ho
|
|
|
110 |
11 |
p. 4617
|
article
|
| 3731 |
Predictive Factors to Hypogammaglobulinemia and Non-Neutropenic Infection Complications after Rituximab/Chemotherapy Treatment
|
Filanovsky, Kalman
|
|
|
110 |
11 |
p. 1288
|
article
|
| 3732 |
Predictive Potential of Minimal Residual Disease Level after the First Imatinib Cycle on the Outcome of Allogeneic Stem Cell Transplantation in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
|
Lee, Seok
|
|
|
110 |
11 |
p. 1098
|
article
|
| 3733 |
Predictive Role of Flow Cytometry in Assessing Very Early Treatment Response in Childhood ALL.
|
Motwani, J.
|
|
|
110 |
11 |
p. 4266
|
article
|
| 3734 |
Predictive Value of Flow Cytometric MRD Analysis in Childhood Acute Lymphoblastic Leukaemia at the End of Remission Induction Therapy.
|
Motwani, J.
|
|
|
110 |
11 |
p. 4267
|
article
|
| 3735 |
Predictive Value of the Pre-Operative CT Scan for Splenectomy in Patients with Primary, and Post Essential Thrombocythemia/Post Polycythemia Vera Myelofibrosis.
|
Mesa, Ruben A.
|
|
|
110 |
11 |
p. 4632
|
article
|
| 3736 |
Predictive Value of the Psychosocial Assessment of Candidates for Transplantation (PACT) Scale in Allogeneic BMT.
|
McLellan, Linda
|
|
|
110 |
11 |
p. 3330
|
article
|
| 3737 |
Predictors for Skeletal-Related Events in Patients with Advanced Multiple Myeloma.
|
Terpos, Evangelos
|
|
|
110 |
11 |
p. 1482
|
article
|
| 3738 |
Predictors of Diagnosis Delay and Complications for Newly-Diagnosed Myeloma Patients.
|
Friese, Christopher R.
|
|
|
110 |
11 |
p. 368
|
article
|
| 3739 |
Predictors of In-Hospital Mortality and Charges in Sickle Cell Disease: Results from the California Discharge Databases 1998–2005.
|
Strouse, John J.
|
|
|
110 |
11 |
p. 432
|
article
|
| 3740 |
Predictors of Mortality in Patients Undergoing Autologous Stem Cell Transplant (ASCT) Admitted to the Intensive Care Unit: An Institutional Review of 1013 Transplant Patients over Five Years.
|
Trinkaus, Martina A.
|
|
|
110 |
11 |
p. 2876
|
article
|
| 3741 |
Predictors of Survival in De Novo Cardiac Amyloidosis.
|
Comenzo, Raymond L.
|
|
|
110 |
11 |
p. 2870
|
article
|
| 3742 |
Predictors of Transformation to Myelodysplasia/Acute Myelogenous Leukemia (MDS/AML) in Severe Congenital Neutropenia (SCN).
|
Boxer, Laurence A.
|
|
|
110 |
11 |
p. 3307
|
article
|
| 3743 |
Preemptive Management of Epstein-Barr Virus Reactivation after Hematopoietic Stem Cell Transplantation.
|
Ahmad, Imran
|
|
|
110 |
11 |
p. 5000
|
article
|
| 3744 |
Pre-Engraftment Serum C-Reactive Protein (CRP) Value as a Predictor of Acute Graft-Versus-Host Disease and Non-Relapse Mortality.
|
Fuji, Shigeo
|
|
|
110 |
11 |
p. 1968
|
article
|
| 3745 |
Preferential Hypermethylation of the DKK-1 Promoter in Core-Binding Factor Leukaemia.
|
Suzuki, Rikio
|
|
|
110 |
11 |
p. 4136
|
article
|
| 3746 |
Preferentially Expressed Antigen of Melanoma (PRAME)-Specific Cytotoxic T-Lymphocytes (CTLs) and Transgenic T Cells To Target Chronic Myelogenous Leukemia (CML).
|
Quintarelli, C.
|
|
|
110 |
11 |
p. 2761
|
article
|
| 3747 |
Preferential Proliferation of T Effectors and Tumor Protection by Adoptive Transfer of Primed Anti-Lymphoma Splenocytes into Lymphodepleted Hosts.
|
Brody, Joshua D.
|
|
|
110 |
11 |
p. 2753
|
article
|
| 3748 |
Pregnancy Associated Thrombotic Thrombocytopenic Purpura: A Case Report.
|
Ye, Xu
|
|
|
110 |
11 |
p. 3221
|
article
|
| 3749 |
Preliminary Pharmacokinetic (PK) Analysis of Eastern Cooperative Oncology Group Protocol E4402: Rituximab Extended Schedule or Re-Treatment Trial (RESORT).
|
Kahl, Brad S.
|
|
|
110 |
11 |
p. 3420
|
article
|
| 3750 |
Preliminary Results from a Phase I Study of Revlimid® (Lenalidomide) in Combination with Vidaza® (Azacitidine) in Patients with Advanced Myelodysplastic Syndromes (MDS).
|
Sekeres, Mikkael A.
|
|
|
110 |
11 |
p. 1458
|
article
|
| 3751 |
Preliminary Results of a Phase I/II Study of Weekly or Twice Weekly Bortezomib in Combination with Rituximab, in Patients with Follicular Lymphoma, Mantle Cell Lymphoma and Waldenström's Macroglobulinaemia.
|
Agathocleous, A.
|
|
|
110 |
11 |
p. 2559
|
article
|
| 3752 |
Preliminary Results of a Phase II Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults with Myelodysplastic Syndrome (MDS).
|
Steensma, David P.
|
|
|
110 |
11 |
p. 1450
|
article
|
| 3753 |
Preliminary Results of a Phase II Study of Flavopiridol (Alvocidib) in Relapsed Chronic Lymphocytic Leukemia (CLL): Confirmation of Clinical Activity in High-Risk Patients and Achievement of Complete Responses (CR).
|
Lin, Thomas S.
|
|
|
110 |
11 |
p. 3104
|
article
|
| 3754 |
Preliminary Results of a Phase II Study of HCVIDDoxil Alternated with Methotrexate-Cytarabine in Patients with Newly Diagnosed T-Cell Lymphoma.
|
Pro, Barbara
|
|
|
110 |
11 |
p. 3456
|
article
|
| 3755 |
Preliminary Results of a Prospective Multicenter Phase III Trial Comparing High-Dose and Standard-Dose Daunorubicin for Induction of Complete Remission (CR) in Acute Myeloid Leukemia (AML).
|
Lee, Je-Hwan
|
|
|
110 |
11 |
p. 1833
|
article
|
| 3756 |
Preliminary Results of CNTO 328, an Anti-Interleukin (IL)-6 Monoclonal Antibody (mAb), in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma.
|
Manges, Robert F.
|
|
|
110 |
11 |
p. 1183
|
article
|
| 3757 |
Preliminary Results of Phase II Trial of Clofarabine with Parenteral Busulfan Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies and Diseases.
|
Agura, Edward D.
|
|
|
110 |
11 |
p. 4954
|
article
|
| 3758 |
Preliminary Results of the Combination Rituximab, Fludarabine, Cyclophosphamide and Mitoxantrone (R-FCM) Followed by Rituximab Maintenance in Previously Untreated Chronic Lymphocytic Leukemia (CLL).
|
Bosch, Francesc
|
|
|
110 |
11 |
p. 626
|
article
|
| 3759 |
Preliminary Study on Effects of Marsdenia Tenacissima Injection on NB4 Cells.
|
Li, Dong
|
|
|
110 |
11 |
p. 4310
|
article
|
| 3760 |
Preliminary Study on the Leukemia Targeting by a CD19 Antibody Conjugated with Saline Extracts from Mylabris Phalerata Pallas.
|
Tang, Yongmin
|
|
|
110 |
11 |
p. 4189
|
article
|
| 3761 |
Premature Aging of Hematopoietic Cells in Long Term Survivors after HSCT with Chronic GVHD and a Female Donor.
|
Baerlocher, Gabriela M.
|
|
|
110 |
11 |
p. 829
|
article
|
| 3762 |
Preparation of Platelet Membrane Microparticles with High Pressure Homogenization Method.
|
Li, Cui-ping
|
|
|
110 |
11 |
p. 4022
|
article
|
| 3763 |
Presence of DRB1*01 Allele in Multiple Myeloma Patients Is Associated with Indolent Disease.
|
Alcoceba, M.
|
|
|
110 |
11 |
p. 1481
|
article
|
| 3764 |
Presence of Immunoglobulin Heavy Chain Gene (IGH) Translocations in Chronic Lymphocytic Leukemia Is Related to Poor Prognosis.
|
Nowakowski, Grzegorz S.
|
|
|
110 |
11 |
p. 2067
|
article
|
| 3765 |
Presence of JAK2 V617F Mutation in Peripheral Blood of Blood Donors with Upper-Limit Hematocrit and Platelet Values.
|
Bianchi, Paola
|
|
|
110 |
11 |
p. 2533
|
article
|
| 3766 |
Preservation of Beneficial TAFI Functions by an Activated Protein C Variant with Normal Cytoprotective Functions but Minimal Anticoagulant Activity.
|
Mosnier, Laurent O.
|
|
|
110 |
11 |
p. 268
|
article
|
| 3767 |
Pre Transplantation MGUS and Transformation to Multiple Myeloma in Kidney Transplantation: A Single Center Experience.
|
Naina, Harris V.K.
|
|
|
110 |
11 |
p. 4779
|
article
|
| 3768 |
Pre-Transplant Hypogammaglobulinemia Influences Survival after Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).
|
Sobecks, Ronald
|
|
|
110 |
11 |
p. 1979
|
article
|
| 3769 |
Pre-Transplant Infusion of Donor CD4+ CD25+ T Cells Suppresses Host Anti-Donor MiHA-Specific CD8 T Cells and Facilitates Stable Mixed Chimerism Following MHC-Matched Allogeneic Marrow Transplant.
|
Shatry, Alwi M.
|
|
|
110 |
11 |
p. 3254
|
article
|
| 3770 |
Pre-Transplant Rituximab Therapy Is Associated with Improved Progression-Free and Overall Survival in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma (DLBCL).
|
Fenske, Timothy S.
|
|
|
110 |
11 |
p. 19
|
article
|
| 3771 |
Pre-Transplant Test Dose vs. PK Studies during Conditioning Regimen To Target iv Busulfan in Allogeneic Hematopoietic Stem Cell Transplantation.
|
Chunduri, Sandeep
|
|
|
110 |
11 |
p. 3006
|
article
|
| 3772 |
Pre Transplant Values of C Reactive Protein (CRP) and Brain Natriuretic Peptide (BNP) as Predictors of Transplant Outcomes in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndromes (AML/MDS) Undergoing Allogeneic Stem Cell Transplantation (AlloSCT).
|
Giralt, Sergio
|
|
|
110 |
11 |
p. 1984
|
article
|
| 3773 |
Pre-Treatment p27 and Bcl-6 Staining Levels Correlate with Response to Bortezomib in Non-Hodgkin Lymphoma: Results from a Tissue Microarray Analysis
|
Gerecitano, John
|
|
|
110 |
11 |
p. 1294
|
article
|
| 3774 |
Prevalence and Prognostic Impact of KIT Mutations in Acute Myeloid Leukaemia with Inv(16). A Retrospective Study.
|
Cairoli, Roberto
|
|
|
110 |
11 |
p. 3488
|
article
|
| 3775 |
Prevalence and Prognostic Implications of CEBPα Mutations in Pediatric AML.
|
Ho, Phoenix A.
|
|
|
110 |
11 |
p. 1441
|
article
|
| 3776 |
Prevalence and Prognostic Significance of c-KIT Mutations in Pediatric CBF AML Patients Enrolled on Serial CCG/COG Protocols.
|
Pollard, Jessica
|
|
|
110 |
11 |
p. 1442
|
article
|
| 3777 |
Prevalence and Trend of Hematopoietic Stem Cell Transplantation for Adult Aplastic Anemia/Pure Red Cell Aplasia in Korea.
|
Kim, Hawk
|
|
|
110 |
11 |
p. 3757
|
article
|
| 3778 |
Prevalence Estimates of Adult Chronic Idiopathic Thrombocytopenic Purpura (ITP) in the United States.
|
Feudjo-Tepie, Maurilee A.
|
|
|
110 |
11 |
p. 3202
|
article
|
| 3779 |
Prevalence of Abnormal Serum Free Light Chain Ratio in Monoclonal Gammopathies at Presentation and Sensitivity for Bence Jones Proteinuria.
|
Holding, Stephen
|
|
|
110 |
11 |
p. 1495
|
article
|
| 3780 |
Prevalence of Polycythemia Vera and Essential Thrombocythemia.
|
Ma, Xiaomei
|
|
|
110 |
11 |
p. 4667
|
article
|
| 3781 |
Prevalence of Post-Transplant Lymphoproliferative Disorder with Monoclonal Gammopathy of Unknown Significance in Patients Undergoing Kidney Transplantation.
|
Naina, Harris V.K.
|
|
|
110 |
11 |
p. 4778
|
article
|
| 3782 |
Prevalence of Thrombophilia Genes in Patients with Idiopathic Thromboembolic Disease.
|
Mandala, Eudokia
|
|
|
110 |
11 |
p. 1644
|
article
|
| 3783 |
Prevention of Complete TTP Relapses by Immediate Initiation of Rituximab Treatment.
|
von Auer, Charis
|
|
|
110 |
11 |
p. 3203
|
article
|
| 3784 |
Prevention of Graft-Versus-Host Disease in Mouse Model Using Anti-Mouse C5 Antibody.
|
Nishimura, Jun-ichi
|
|
|
110 |
11 |
p. 3245
|
article
|
| 3785 |
Prevention of Ph+ Acute Lymphoblastic Leukemia by Nanoparticulate Delivery of a DNA Vaccine in Syngeneic Mice.
|
Koechling, Joachim
|
|
|
110 |
11 |
p. 5135
|
article
|
| 3786 |
Prevention of Transfusion-Associated Graft Versus Host Disease (TA-GVHD) by Photochemical Treatment of Platelet Components: Clinical Experience in Routine Use.
|
Osselaer, Jean Claude
|
|
|
110 |
11 |
p. 2885
|
article
|
| 3787 |
P-REX1: A Novel RAC Activing Guanine-Nucleotide Exchange Factor in Human Platelets.
|
Morgan-Spencer, Alex
|
|
|
110 |
11 |
p. 3639
|
article
|
| 3788 |
Primary Cell Experiments with TG101348, a JAK2-Selective Inhibitor, in the Presence of Myeloproliferative Disorder-Associated JAK2V617F, MPLW515L/K, and JAK2 Exon 12 Mutations.
|
Lasho, Terra L.
|
|
|
110 |
11 |
p. 3541
|
article
|
| 3789 |
Primary Central Nervous System Lymphoma (PCNSL): Intent-to-Treat Analysis of Monocenter Long-Term Experience.
|
Korfel, Agnieszka
|
|
|
110 |
11 |
p. 1365
|
article
|
| 3790 |
Primary Diffuse Large B-Cell Lymphoma of the Colon: Surgery for Local Disease Control Does Not Improve Outcome.
|
Katipamula, Rajini
|
|
|
110 |
11 |
p. 3444
|
article
|
| 3791 |
Primary Fibrinolysis as the Presenting Sign of Metastatic Prostate Cancer: One Case Report and Literature Review.
|
Zhou, Rongfu
|
|
|
110 |
11 |
p. 3966
|
article
|
| 3792 |
Primary Non-Hodgkin's Lymphoma of the Lung.
|
Fong, Thomas
|
|
|
110 |
11 |
p. 4402
|
article
|
| 3793 |
Primary Plasma Cell Leukaemia and Autologous Stem Cell Transplantation.
|
Drake, Mary B.
|
|
|
110 |
11 |
p. 731
|
article
|
| 3794 |
Primary Study on the Reconstitution of CD4+CD25high Regulatory T Cells Early after Allogeneic Hematopoietic Stem Cell Transplantation.
|
Sun, Daoping
|
|
|
110 |
11 |
p. 3252
|
article
|
| 3795 |
Primary Thyroid Lymphoma: A Retrospective IELSG and IIL Analysis of Clinical Characteristics, Prognostic Factors, Treatment Outcome and Somatic Hypermutation for Localized Diffuse Large B-Cell Lymphoma (DLBCL).
|
Cortelazzo, Sergio
|
|
|
110 |
11 |
p. 3432
|
article
|
| 3796 |
Primary Treatment for Acute Graft-Versus-Host Disease (GVHD): A Single-Center Analysis of 458 Japanese Patients.
|
Fukuda, Takahiro
|
|
|
110 |
11 |
p. 4976
|
article
|
| 3797 |
Priming Effect with G-CSF Enhances In Vitro Apoptosis by Treatment with Ara-C and VP-16 in Leukemic Cell Line.
|
Kitagawa, Jun-ichi
|
|
|
110 |
11 |
p. 4333
|
article
|
| 3798 |
Primitive Quiescent CD34+ Cells in Chronic Myeloid Leukemia Are Targeted by In Vitro Expanded Allogeneic Natural Killer Cells, Which Are Functionally Enhanced by Bortezomib Treatment.
|
Yong, Agnes S.M.
|
|
|
110 |
11 |
p. 1008
|
article
|
| 3799 |
Prior High Dose Chemotherapy and a Higher “Intensity” of the Preparative Regimen Can Influence Outcome after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).
|
Mohty, Mohamad
|
|
|
110 |
11 |
p. 2001
|
article
|
| 3800 |
Prior Therapy with Rituximab Correlates with Less Acute Graft-Versus-Host Disease and Better Survival in B-Cell Lymphoma Patients Who Received Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT).
|
Ratanatharathorn, Voravit
|
|
|
110 |
11 |
p. 1063
|
article
|
| 3801 |
PRL3 Is a Mediator of IL6/STAT3 Signaling and Defines a Population of Multiple Myeloma Patients Distinct from Those That Activate NFkB.
|
Sebag, Michael
|
|
|
110 |
11 |
p. 671
|
article
|
| 3802 |
Procoagulant Activity in Sickle Cell Anemia.
|
Vicari, Perla
|
|
|
110 |
11 |
p. 3789
|
article
|
| 3803 |
Procoagulant Assessment of Topical Battlefield Hemostats Using a Novel Semi-Automated Whole Blood Clotting Assay System.
|
Moskowitz, Keith A.
|
|
|
110 |
11 |
p. 3161
|
article
|
| 3804 |
Procoagulant Function and Phosphatidylserine Distribution on Immortalized Acute Promyelocytic Leukemia Cells.
|
Shi, Jialan
|
|
|
110 |
11 |
p. 2155
|
article
|
| 3805 |
Production of Inflammatory Mediators by Nanoparticle Stimulated Macrophages.
|
Hall, David J.
|
|
|
110 |
11 |
p. 3837
|
article
|
| 3806 |
Profound Shut-Down of Antigen Specific T-Cell Effector Functions by Dasatinib.
|
Weichsel, Ralf
|
|
|
110 |
11 |
p. 1348
|
article
|
| 3807 |
Prognostic Analysis of Pre-Transplant CD26-Positive Lymphocytes and CD26bright/CD45RO-Positive Memory T-Cell Levels in Patients Receiving an Autologous Hematopoietic Progenitor-Cell Transplant.
|
Hildebrandt, Martin
|
|
|
110 |
11 |
p. 1653
|
article
|
| 3808 |
Prognostic Analysis of Refractory Anemia in Adult Patients with Myelodysplasric Syndrome in China.
|
Wang, Xiao-qin
|
|
|
110 |
11 |
p. 2465
|
article
|
| 3809 |
Prognostic Assessment of BCL2 C938A Polymorphism in Chronic Lymphocytic Leukemia (CLL).
|
Rossi, Davide
|
|
|
110 |
11 |
p. 2072
|
article
|
| 3810 |
Prognostic Assessment of Three Single Nucleotide Polymorphisms (BCL2–938C>A, MTHFR 677C>T, GNAS1 T393C) in Chronic Lymphocytic Leukemia.
|
Zenz, Thorsten
|
|
|
110 |
11 |
p. 2080
|
article
|
| 3811 |
Prognostic Factors for Myelodysplastic Syndrome in the Veteran Population: Single Institution Experience.
|
Axelson, Michael
|
|
|
110 |
11 |
p. 4622
|
article
|
| 3812 |
Prognostic Factors in Adult Patients up to 60 Years with AML and Translocations of Chromosome 11q23: Individual Patient Data Based Analysis of the German AML-Intergroup.
|
Krauter, Jürgen
|
|
|
110 |
11 |
p. 759
|
article
|
| 3813 |
Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma: Clinical and Molecular Characterization of a Subset with Worse Outcome.
|
Woo, Denise
|
|
|
110 |
11 |
p. 3573
|
article
|
| 3814 |
Prognostic Factors in Treatment-Related Myelodysplastic Syndromes (t-MDS) and Acute Myeloid Leukemia (t-AML).
|
Kuendgen, Andrea
|
|
|
110 |
11 |
p. 2451
|
article
|
| 3815 |
Prognostic Factors Predicting Survival in De Novo AML Patients Requiring Intensive Care.
|
Schellongowski, Peter
|
|
|
110 |
11 |
p. 2860
|
article
|
| 3816 |
Prognostic Impact of BAALC Expression in the Context of Other Molecular Markers in Cytogenetically Normal Acute Myeloid Leukemia.
|
Dohner, Konstanze
|
|
|
110 |
11 |
p. 3485
|
article
|
| 3817 |
Prognostic Impact of Cancer Testis Antigens Expression in Advanced Stage Multiple Myeloma Patients.
|
Andrade, Valéria C.C.
|
|
|
110 |
11 |
p. 4733
|
article
|
| 3818 |
Prognostic Impact of Chromosomal Abnormalities in Elderly Patients with Multiple Myeloma Treated with High-Dose Melphalan (MEL140) and Autologous Stem Cell Transplantation.
|
Liebisch, Peter
|
|
|
110 |
11 |
p. 992
|
article
|
| 3819 |
Prognostic Impact of Clinical and Molecular Markers in Normal Karyotype AML-Results from the AMLCG 2000 Trial.
|
Schneider, Friederike
|
|
|
110 |
11 |
p. 3482
|
article
|
| 3820 |
Prognostic Impact of Cytogenetic Abnormalities in Elderly Patients with Acute Myeloid Leukemia (AML) Enrolled in the ALFA-9803 Trial.
|
Terré, Christine
|
|
|
110 |
11 |
p. 4233
|
article
|
| 3821 |
Prognostic Impact of Deletions of Derivative Chromosome 9 on Patients (pts) with Chronic Myelogenous Leukemia (CML) in Chronic Phase Treated with Nilotinib or Dasatinib.
|
Quintás-Cardama, Alfonso
|
|
|
110 |
11 |
p. 1955
|
article
|
| 3822 |
Prognostic Impact of Elevated Pretransplant Serum Ferritin in Allogeneic Hematopoietic Stem Cell Transplantation.
|
Mahindra, Anuj
|
|
|
110 |
11 |
p. 1109
|
article
|
| 3823 |
Prognostic Impact of Minimal Residual Disease (MRD) in Children Is Different in B or T Lineage Acute Lymphoblastic Leukemia: Results of Trial AIEOP-BFM ALL 2000.
|
Schrappe, Martin
|
|
|
110 |
11 |
p. 1425
|
article
|
| 3824 |
Prognostic Impact of Tumor Infiltrating FOXP3 Positive Regulatory T Cells in Diffuse Large B-Cell Lymphoma at Diagnosis.
|
Kwak, Jae-Yong
|
|
|
110 |
11 |
p. 1565
|
article
|
| 3825 |
Prognostic Implications and Biological Roles of RhoH in Acute Myeloid Leukemia.
|
Iwasaki, Toshihiro
|
|
|
110 |
11 |
p. 4246
|
article
|
| 3826 |
Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience.
|
Plesa, Claudiu
|
|
|
110 |
11 |
p. 4352
|
article
|
| 3827 |
Prognostic Role of Glutathione S-Transferase (GST) Polymorphisms in Acute Myeloid Leukemia.
|
Voso, Maria Teresa
|
|
|
110 |
11 |
p. 1446
|
article
|
| 3828 |
Prognostic Significance of ABCB1 (MDR1) Gene Polymorphisms in De Novo Acute Myeloid Leukemia with t(8;21) or inv(16).
|
Kim, Yeo-Kyeoung
|
|
|
110 |
11 |
p. 4271
|
article
|
| 3829 |
Prognostic Significance of CD33, CD34 and CD117 Expression on Bone Marrow Blasts of Patients with Myelodysplastic Syndromes.
|
Nador, Guido
|
|
|
110 |
11 |
p. 4604
|
article
|
| 3830 |
Prognostic Significance of CD20 Expression in Adult B-Cell Precursor Acute Lymphoblastic Leukemia.
|
Maury, Sébastien
|
|
|
110 |
11 |
p. 2829
|
article
|
| 3831 |
Prognostic Significance of Early Treatment Response in Pediatric Relapsed Acute Myeloid Leukemia: Results from the International Study Relapsed AML 2001/01.
|
Kaspers, Gertjan J.
|
|
|
110 |
11 |
p. 1843
|
article
|
| 3832 |
Prognostic Significance of EVI1 Defects in MDS/AML with 3q21q26 Abnormalities.
|
Bernasconi, Paolo
|
|
|
110 |
11 |
p. 4224
|
article
|
| 3833 |
Prognostic Significance of FLT3/ITD Mutation in AML1/ETO-Associated Acute Myeloid Leukemia.
|
Kim, Yeo-Kyeoung
|
|
|
110 |
11 |
p. 3493
|
article
|
| 3834 |
Prognostic Significance of Molecular-Cytogenetic Abnormalities in Pediatric T-ALL Is Not Explained by Immunophenotypic Differences.
|
van Grotel, Martine
|
|
|
110 |
11 |
p. 4220
|
article
|
| 3835 |
Prognostic Significance of Molecular Cytogenetics in Chinese Patients with Chronic Lymphocytic Leukemia: A Prospective Unicentric Analysis.
|
Xu, Wei
|
|
|
110 |
11 |
p. 4690
|
article
|
| 3836 |
Prognostic Significance of Prior Best Response to Imatinib in Patients (pts) with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs).
|
Jabbour, Elias
|
|
|
110 |
11 |
p. 1942
|
article
|
| 3837 |
Prognostic Significance of Tissue Necrosis Factor-Alpha in Newly Diagnosed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes.
|
Tsimberidou, Apostolia-Maria
|
|
|
110 |
11 |
p. 4263
|
article
|
| 3838 |
Prognostic Significance of VEGF, VEGF Receptors, and Microvessel Density in Diffuse Large B Cell Lymphoma Treated with Anthracycline-Based Chemotherapy.
|
Gratzinger, Dita
|
|
|
110 |
11 |
p. 53
|
article
|
| 3839 |
Prognostic Utility of Extranodal Disease Involvement in Diffuse Large B-Cell Lymphoma in Patients Treated with R-CHOP.
|
Hui, David
|
|
|
110 |
11 |
p. 1563
|
article
|
| 3840 |
Prognostic Value of BCR-ABL Transcript Amount for Early Relapse Detection in Chronic Myeloid Leukemia Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation.
|
Solarska, Iwona
|
|
|
110 |
11 |
p. 5032
|
article
|
| 3841 |
Prognostic Value of CXCR4, Adhesion Molecules and Heat Shock Proteins (HSP) in Acute Myelogenous Leukemia.
|
Tavernier, Emmanuelle
|
|
|
110 |
11 |
p. 2848
|
article
|
| 3842 |
Prognostic Value of Cytogenetics in Patients with Acute Myeloid Leukemia Aged More Than 60 Years at Diagnosis: Identification of Subgroups Taking Benefit from Intensive Chemotherapy. Results from a Large Single Center Retrospective Study.
|
Blin, Nicolas
|
|
|
110 |
11 |
p. 3503
|
article
|
| 3843 |
Prognostic Value of Immunophenotype in Patients with Non-Promyelocytic Acute Myeloid Leukemia Treated with Intensive Chemotherapy. A Single Centre Study.
|
Montesinos, Pau
|
|
|
110 |
11 |
p. 2391
|
article
|
| 3844 |
Prognostic Value of Immunophenotyping in Elderly Patients with Acute Myeloid Leukemia: A Single Institution Experience.
|
Plesa, Claudiu
|
|
|
110 |
11 |
p. 4353
|
article
|
| 3845 |
Prognostic Value of Immunophenotyping of Multiple Myeloma: A Study on 685 Patients Uniformly Treated with High-Dose Therapy.
|
Mateo, Gema
|
|
|
110 |
11 |
p. 1472
|
article
|
| 3846 |
Prognostic Value of Minimal Residual Disease by Real-Time Quantitative PCR in AML with CBFB-MYH11 Rearrangement: The French Experience.
|
Guièze, Romain
|
|
|
110 |
11 |
p. 3496
|
article
|
| 3847 |
Prognostic Value of Positron Emission Tomography (PET) Scan in Patients with Relapsed Hodgkin Lymphoma or Aggressive Non-Hodgkin Lymphoma Receiving Salvage Chemotherapy Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation.
|
Dodero, Anna
|
|
|
110 |
11 |
p. 3039
|
article
|
| 3848 |
Prognostic Value of Serum Lactate Dehydrogenase (LDH) in Patients with Primary Systemic Amyloidosis Undergoing Stem Cell Transplantation.
|
Kumar, Shaji
|
|
|
110 |
11 |
p. 2871
|
article
|
| 3849 |
Prognostic Value of Serum Soluble IL2 Receptor (sIL2R) Level in Patients with Diffuse Large B Cell Lymphoma (DLBCL), Treated with CHOP or R-CHOP Based Therapy.
|
Oki, Yasuhiro
|
|
|
110 |
11 |
p. 1569
|
article
|
| 3850 |
Prognostic Value of the Serum Free Light Chain Ratio in Patients with Newly Diagnosed Myeloma: Proposed Incorporation into the International Staging System.
|
Snozek, Christine L.H.
|
|
|
110 |
11 |
p. 659
|
article
|
| 3851 |
Prognostic Value of Tumor-Infiltrating TIA-1+ Cytotoxic T Cells (TIA1-CTCs) and FOXP3+ Regulatory T Cells (Tregs) in Post-Transplant Lymphoproliferative Disorder (PTLD) Following Solid Organ Transplant (SOT).
|
Tsao, Raymond E.
|
|
|
110 |
11 |
p. 54
|
article
|
| 3852 |
Progression Free Survival (PFS) in Alemtuzumab Based RIC Allogeneic Transplantation for Myeloma Is Improved with Use of Pre-Emptive DLI (pDLI).
|
Ramasamy, Karthik
|
|
|
110 |
11 |
p. 3034
|
article
|
| 3853 |
Progressive Multifocal Leukoencephalopathy Associated with Rituximab Treatment of B-Cell Lymphoproliferative Disorders: A Report of 29 Cases from the RADAR Project.
|
Carson, Kenneth R.
|
|
|
110 |
11 |
p. 370
|
article
|
| 3854 |
Pro-Inflammatory and Pro-Coagulant Effects of Gemtuzumab Ozogamicin (Mylotarg®); Implications for the Development of VOD-Like Syndrome.
|
Bruneau, Johanna C.
|
|
|
110 |
11 |
p. 2156
|
article
|
| 3855 |
Proinflammatory Lipids in Sickle Cell Disease-Associated Pulmonary Hypertension.
|
Ataga, Kenneth I.
|
|
|
110 |
11 |
p. 3801
|
article
|
| 3856 |
Projecting the Long-Term Quality-Adjusted Survival of Patients with Imatinib-Resistant Chronic Myelogenous Leukemia in Chronic Phase Receiving Nilotinib, Dasatinib, Dose Escalation Imatinib, or Palliative Care: An Essential Element for Cost-Effectiveness Analysis.
|
Botteman, M.
|
|
|
110 |
11 |
p. 4585
|
article
|
| 3857 |
Proliferation of Acute Lymphoblastic Leukemic (ALL) Cells Is Dependent on Exogenous Purine Administration.
|
Goselink, Henriette M.
|
|
|
110 |
11 |
p. 3466
|
article
|
| 3858 |
Proline-Rich Tyrosine Kinase-2 (PYK2): A New Target for the Treatment of Hematopoietic Neoplasms with TEL-FGFR3 Fusion or FGFR3 Active Mutation.
|
Okamura, Daisuke
|
|
|
110 |
11 |
p. 3360
|
article
|
| 3859 |
Prolongation of QTc Intervals and Risk of Sudden Death among Patients with Sickle Cell Diseases.
|
Upadhya, Bharathi
|
|
|
110 |
11 |
p. 2249
|
article
|
| 3860 |
Prolonged Clinical and Molecular Remissions Following High-Dose Therapy/Autologous Stem Cell Transplantation (HDT/ASCT) and Rituximab and Interferon-alpha Maintenance for Relapsed High-Risk Follicular Lymphoma.
|
Cheung, Matthew C.
|
|
|
110 |
11 |
p. 1902
|
article
|
| 3861 |
Prolonged In-Vivo Half-Life of FVIIa by Fusion to Albumin.
|
Schulte, Stefan
|
|
|
110 |
11 |
p. 3142
|
article
|
| 3862 |
Prolonged Monthly Myelosuppressive Maintenance Chemotherapy in Acute Myeloid Leukemia: The AMLCG Experience.
|
Krug, Utz O.
|
|
|
110 |
11 |
p. 1856
|
article
|
| 3863 |
Prolonged Overall Survival with Lenalidomide Plus Dexamethasone Compared with Dexamethasone Alone in Patients with Relapsed or Refractory Multiple Myeloma.
|
Weber, Donna
|
|
|
110 |
11 |
p. 412
|
article
|
| 3864 |
Prolonged Progression Free Survival Does Not Relate to Quality of Response to Treatment with Thalidomide in Patients with Relapsed Multiple Myeloma (MM).
|
Quach, Hang
|
|
|
110 |
11 |
p. 2718
|
article
|
| 3865 |
Promoter Methylation of Multiple Genes in Diffuse Large Cell Lymphoma (DLCL), Follicular Lymphoma (FL) and Bening Follicular Hyperplasia (BFH).
|
Paz-Carreira, Jose M.
|
|
|
110 |
11 |
p. 2608
|
article
|
| 3866 |
Promoting Patient (pt) Adherence (PA) with Imatinib Treatment (IMRx) in Chronic Myeloid Leukemia (CML): Physicians (MD) Perceptions of Utility (Effectiveness [FX], Feasibility [FB], Cost [CO]) and Rankings of Clinical Applicability (CAPL) of 13 Adherence-Enhancing Strategies (AESs) - Results from the ADAGIO Study.
|
van Lierde, Marie-Anne
|
|
|
110 |
11 |
p. 5165
|
article
|
| 3867 |
Pronounced Reduction in ADAMTS13 Activity Occurs in Heparin Induced Thrombocytopenia but Is Not Due to IgG ANTI-ADAMTS13.
|
Austin, Steven K.
|
|
|
110 |
11 |
p. 2085
|
article
|
| 3868 |
Properties of CD34+ CML Cells That Predict Clinical Response to Tyrosine Kinase Inhibitors.
|
Jiang, Xiaoyan
|
|
|
110 |
11 |
p. 324
|
article
|
| 3869 |
Prophylaxis of Graft-Versus-Host Disease (GVHD) with Pentostatin, Tacrolimus, and “Mini”-Methotrexate (MTX): A Phase I/II Controlled, Randomized Study in Unrelated Donor (UD) Transplantation.
|
de Lima, Marcos
|
|
|
110 |
11 |
p. 40
|
article
|
| 3870 |
Proportions of T-Cell CD8+ Subsets Lacking CD28 Expression at Day 30 after Myeloablative Allogeneic Stem Cell Transplantation Are Predictive for Relapse and Chronic GVHD.
|
Yakoub-Agha, Ibrahim
|
|
|
110 |
11 |
p. 2979
|
article
|
| 3871 |
Prospecitve Quantitative PCR Monitoring of Allogeneic Stem Cell Transplant (SCT) Patients at High Risk for EBV Associated PTLD.
|
Omar, Hamdy
|
|
|
110 |
11 |
p. 2969
|
article
|
| 3872 |
Prospective Assessment of Pulmonary Hypertension in Children with Chuvash Polycythemia.
|
Dham, Niti
|
|
|
110 |
11 |
p. 3665
|
article
|
| 3873 |
Prospective Evaluation of FDG-PET Imaging of Treatment Response in Relapsed Follicular Lymphoma.
|
Brown, Jennifer R.
|
|
|
110 |
11 |
p. 2331
|
article
|
| 3874 |
Prospective Evaluation of MRD-Kinetics in 274 Children with High-Risk ALL Treated in Trial ALL-BFM 2000: Insights into Development of Resistance and Impact on Further Refinement of Treatment Stratification Strategies.
|
Schrauder, André
|
|
|
110 |
11 |
p. 585
|
article
|
| 3875 |
Prospective Evaluation of Prognostic Parameters in Early Stage Chronic Lymphocytic Leukemia (CLL): Results of the CLL1-Protocol of the German CLL Study Group (GCLLSG).
|
Bergmann, Manuela A.
|
|
|
110 |
11 |
p. 625
|
article
|
| 3876 |
Prospective Evaluation of the Bone Anabolic Effect of Bortezomib in Relapsed Multiple Myeloma (MM) Patients.
|
Zangari, Maurizio
|
|
|
110 |
11 |
p. 2719
|
article
|
| 3877 |
Prospective Evaluation of the NIH Staging Criteria in Chronic GVHD and Correlation to Quality of Life - Results of a German Multicenter Validation Trial.
|
Wolff, Daniel
|
|
|
110 |
11 |
p. 42
|
article
|
| 3878 |
Prospective Evaluation of the Prevalence of Elevated Tricuspid Regurgitant Jet Velocity and Associated Clinical and Echocardiographic Factors in Children and Adolescents with Sickle Cell Disease.
|
Campbell, Andrew D.
|
|
|
110 |
11 |
p. 3388
|
article
|
| 3879 |
Prospective Identification of Resistance Mutants to the JAK2 Inhibitor TG101348.
|
Hood, John D.
|
|
|
110 |
11 |
p. 2528
|
article
|
| 3880 |
Prospective In Vivo Identification of Osteogenic Stem/Progenitor Cells from Bone Marrow-Derived Lin−/Sca-1+/CD45− Cells.
|
Wang, Zhuo
|
|
|
110 |
11 |
p. 1409
|
article
|
| 3881 |
Prospective Measurement of BK Virus Blood and Urine Levels, and Associations with Morbidity, in Recipients of Allogeneic Hematopoetic Stem Cell Transplants.
|
O'Donnell, Peter H.
|
|
|
110 |
11 |
p. 1973
|
article
|
| 3882 |
Prospective Study of Direct Thrombin Inhibition with Argatroban in Pediatric Patients Requiring Nonheparin Anticoagulation.
|
Young, Guy
|
|
|
110 |
11 |
p. 1868
|
article
|
| 3883 |
Prostaglandin E2 Stimulates Human Brain Endothelial Cell Migration Via a Signaling Pathway Involving Activation of Rho-Kinase II
|
Khan, Gausal
|
|
|
110 |
11 |
p. 3729
|
article
|
| 3884 |
Protease-Activated Receptor 3 Negatively Regulates Plasmin-Mediated Protease-Activated Receptor 4 Activation in Platelets.
|
Mao, Yingying
|
|
|
110 |
11 |
p. 3636
|
article
|
| 3885 |
Proteasome Chymotrypsin-Like Activity in Plasma Is a Major Predictor of Outcome in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Normal Karyotype.
|
Ma, Wanlong
|
|
|
110 |
11 |
p. 2837
|
article
|
| 3886 |
Proteasome Inhibitor/Imatinib Combinations Exert Potentiated Antileukemia Efficacy but Not Cardiotoxicity in Chronic Myeloid Leukemia.
|
Zhou, Guangbiao
|
|
|
110 |
11 |
p. 4572
|
article
|
| 3887 |
Protection of CML Progenitors from Bcr-Abl Tyrosine Kinase Inhibitor Mediated Apoptosis by the Bone Marrow Stromal Microenvironment.
|
Zhang, Bin
|
|
|
110 |
11 |
p. 3378
|
article
|
| 3888 |
Protective Abilities of Interleukin-10 in Blood-Induced Joint Damage.
|
Jansen, Nathalie W.D.
|
|
|
110 |
11 |
p. 494
|
article
|
| 3889 |
Protective Role of Connexin 32 in Experimental Leukemogenesis.
|
Hirabayashi, Yoko
|
|
|
110 |
11 |
p. 2239
|
article
|
| 3890 |
ProteinChip Array Profiling and Markers of Inflammation and Thrombin Generation in Plasma Samples from Lung Cancer Patients and Their Modulation by Chemotherapy with or without Warfarin Anticoagulation.
|
Demir, Muzaffer
|
|
|
110 |
11 |
p. 3978
|
article
|
| 3891 |
Protein Disulfide Isomerase Is Required for Fibrin Generation and Platelet Thrombus Formation In Vivo.
|
Cho, Jaehyung
|
|
|
110 |
11 |
p. 292
|
article
|
| 3892 |
Protein Expression of p15 and p21 Plays an Unfavorable Prognostic Role in Adult Acute Lymphoblastic Leukemia (ALL) Patients Independently of Their Gene Promoter Methylation Status.
|
De Cave, Fabiana
|
|
|
110 |
11 |
p. 2802
|
article
|
| 3893 |
Protein Expression Profiling of Cytokines and Cytokine Receptors on Purified Chronic Lymphocytic Leukemia Cells.
|
Yu, Zhifeng
|
|
|
110 |
11 |
p. 4709
|
article
|
| 3894 |
Protein Expression Signatures Determined by Reverse Phase Proteins Arrays (RPPA) Accurately Predict FLT3-ITD Mutation Status in AML.
|
Kornblau, Steven M.
|
|
|
110 |
11 |
p. 2398
|
article
|
| 3895 |
Protein Kinase C α Is Critically Involved in MyD88-Dependent Toll-Like Receptor 2-Mediated Activation of Dendritic Cells.
|
Springael, Cecile
|
|
|
110 |
11 |
p. 2418
|
article
|
| 3896 |
Protein Phosphatase 2B Inhibitor, Cyclosporine A, Stimulates Endothelial Cell Exocytosis of Ultra-Large VWF Multimeric Strings by Regulating Munc18c Phosphorylation.
|
Nolasco, Lettica
|
|
|
110 |
11 |
p. 3910
|
article
|
| 3897 |
Protein Phosphatase1 gamma (PP1cγ) Is Required for Thrombin-Induced Integrin αIIbβ3 Activation.
|
Gushiken, Francisca C.
|
|
|
110 |
11 |
p. 135
|
article
|
| 3898 |
Protein Profiling in Myeloma In Vivo; Effects of Bortezomib in a Mouse Model of Myeloma.
|
Edwards, Claire M.
|
|
|
110 |
11 |
p. 255
|
article
|
| 3899 |
Proteins of the Calnexin Cycle Regulate αIIbβ3 Surface Expression in Human Megakaryocyte-Lineage Cells.
|
Yazdani-Abyaneh, Mahmoud
|
|
|
110 |
11 |
p. 3227
|
article
|
| 3900 |
Protein Tyrosine Phosphatase Receptor Type O (PTPRO) Exhibits Tumor Suppressor Properties in K562 Cells by Dephosphorylating Bcr-Abl.
|
Majumder, Sarmila
|
|
|
110 |
11 |
p. 2914
|
article
|
| 3901 |
Proteomic Analysis of RBC Ghosts from the Beta-Adducin and Protein 4.2 Knock-Out Mouse Models of Inherited Hemolytic Anemia.
|
Wooden, Jason M.
|
|
|
110 |
11 |
p. 1728
|
article
|
| 3902 |
Proteomic and mRNA Expression Chip Analysis of Acquired TRAIL-Resistance in Human HL60 Myeloid Leukemia Cells.
|
Zivny, Jan
|
|
|
110 |
11 |
p. 4155
|
article
|
| 3903 |
Proteomics Analysis of Naturally Occurring CD4+/CD25+ Regulatory T Cells.
|
Garin, Marina I.
|
|
|
110 |
11 |
p. 3883
|
article
|
| 3904 |
Proteomics in the Study of Qualitative Platelet Defects: Validation of the Approach in the Gray Platelet Syndrome and Quebec Platelet Disorder.
|
Kasthuri, Raj S.
|
|
|
110 |
11 |
p. 3900
|
article
|
| 3905 |
Proteomics To Identify Novel Immune-Targeted CML Stem Cell Antigens.
|
Biernacki, Melinda A.
|
|
|
110 |
11 |
p. 1799
|
article
|
| 3906 |
Prothrombotic Platelet Signaling by the Scavenger Receptor, CD36.
|
Chen, Kan
|
|
|
110 |
11 |
p. 3642
|
article
|
| 3907 |
PR1 Peptide Vaccine-Induced Immune Response Is Associated with Better Event-Free Survival in Patients with Myeloid Leukemia.
|
Qazilbash, Muzaffar H.
|
|
|
110 |
11 |
p. 283
|
article
|
| 3908 |
p90RSK2 as a Therapeutic Target in Treatment of FGFR3-Expressing t(4;14) Multiple Myeloma.
|
Kang, Sumin
|
|
|
110 |
11 |
p. 253
|
article
|
| 3909 |
Pruritus in Polycythemia Vera Is More Prevalent in Non-Smokers and Is Independently Associated with a Lower Risk of Arterial Thrombosis.
|
Gangat, Naseema
|
|
|
110 |
11 |
p. 2550
|
article
|
| 3910 |
PR1 Vaccine Elicited Immunological Response after Hematopoietic Stem Cell Transplantation Is Associated with Better Clinical Response and Event-Free Survival.
|
Qazilbash, Muzaffar H.
|
|
|
110 |
11 |
p. 577
|
article
|
| 3911 |
P-Selectin Glycoprotein Ligand-1 VNTR Polymorphisms in Systemic Sclerosis.
|
Taranoglu, Ozer
|
|
|
110 |
11 |
p. 3914
|
article
|
| 3912 |
p53 Signaling in Response to Increased DNA Damage Sensitizes AML1-ETO Cells to Stress-Induced Death.
|
Krejci, Ondrej
|
|
|
110 |
11 |
p. 3176
|
article
|
| 3913 |
p62 Signaling Is Increased in Multiple Myeloma Microenvironment.
|
Hiruma, Yuko
|
|
|
110 |
11 |
p. 669
|
article
|
| 3914 |
PTP1B, Distinctively Expressed in GCB-Like and ABC-Like DLBCL, Is a New Regulator of IL-4-STAT6 Intracellular Signaling.
|
Lu, XiaoQing
|
|
|
110 |
11 |
p. 1558
|
article
|
| 3915 |
Puberty, Gonadal Function and Pregnancy in Female Patients Following Hematopoietic Cell Transplantation (HCT).
|
Sanders, Jean E.
|
|
|
110 |
11 |
p. 1663
|
article
|
| 3916 |
PU.1 Cooperates with SOX4 in Myeloid Cells.
|
Aue, Georg
|
|
|
110 |
11 |
p. 2633
|
article
|
| 3917 |
PU.1 Dose-Dependently Induces Granulocyte or Macrophage Commitment by Targeting Lineage Restricted Genes and by Regulating Transcription Factors Egr2, Nab2, Cebpa and Gfi1.
|
Pospisil, Vit
|
|
|
110 |
11 |
p. 661
|
article
|
| 3918 |
Puerto Rican Child with Combined Heterozygocity for Hemoglobin S and Porto Alegre.
|
Lojo, Liliana
|
|
|
110 |
11 |
p. 3800
|
article
|
| 3919 |
Pulmonary Function Tests and Their Correlation with Tricuspid Regurgitant Jet Velocity in Pediatric Sickle Cell Disease Patients.
|
Arteta, Manuel
|
|
|
110 |
11 |
p. 2262
|
article
|
| 3920 |
Pulmonary Hypertension after Thalidomide Administration in Multiple Myeloma Patients. Pilot Study.
|
Lafaras, Christos
|
|
|
110 |
11 |
p. 4846
|
article
|
| 3921 |
Pulmonary Hypertension in Adults and Children with Sickle Cell Disease in Nigeria: Prevalence, Clinical Characteristics and Role of Endemic Tropical Infections.
|
Aliyu, Zakari Y.
|
|
|
110 |
11 |
p. 3793
|
article
|
| 3922 |
Punch Biopsy Model To Evaluate the Impact of Anticoagulation or Antiplatelet Therapy-Induced Bleeding Episodes: Model Validation.
|
Mathews, David
|
|
|
110 |
11 |
p. 3157
|
article
|
| 3923 |
Pure Hematopoietic Stem Cells Reconstitute Immunity in Allogeneic Hosts Superior to Bone Marrow: Immunosuppression by Subclinical Graft-Versus-Host Disease.
|
Tsao, Gabriel J.
|
|
|
110 |
11 |
p. 4869
|
article
|
| 3924 |
Purified MHC-Matched Hematopoietic Stem Cell Transplantation Following Total Lymphoid Irradiation and Anti-Thymocyte Globulin (TLI+ATG) Blocks EAE Pathogenesis.
|
Lee, Li-Fen
|
|
|
110 |
11 |
p. 3259
|
article
|
| 3925 |
P2X7 Receptor Polymorphisms and Clinical Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation.
|
Lee, Kyung-Hun
|
|
|
110 |
11 |
p. 1962
|
article
|
| 3926 |
14q32 Abnormalities and 13q Deletions Are Common in Primary Systemic Amyloidosis Using Cytoplasmic Immunoglobulin Fluorescence In Situ Hybridization (cIg-FISH).
|
Bryce, Alan H.
|
|
|
110 |
11 |
p. 2477
|
article
|
| 3927 |
Qualitative and Quantitative PCR Monitoring of MRD: Practical Implications of a Surrogate Marker for GVL Effect after RIC Allogeneic Transplantation in Relapsed Chronic Lymphocytic Leukemia.
|
Farina, Lucia
|
|
|
110 |
11 |
p. 1659
|
article
|
| 3928 |
Quality Analysis of a Multidisciplinary Program Project in Radioimmunotherapy.
|
Recasens, Valle
|
|
|
110 |
11 |
p. 5152
|
article
|
| 3929 |
Quality of Leukemia-Derived Dendritic Cells (DC) and T-Cells Are Predictive for the Specific Anti-Leukemic Potential of DC-Trained T-Cells.
|
Schmetzer, Helga
|
|
|
110 |
11 |
p. 4883
|
article
|
| 3930 |
Quality of Life after High Dose Chemotherapy with Autologous Hematopoietic Progenitor Cell Support Long Term Follow-Up.
|
Nesbitt, Marylou
|
|
|
110 |
11 |
p. 3331
|
article
|
| 3931 |
Quality of Life in Patients with B-Cell Lymphoma during Maintenance Therapy with the Anti-CD20 Antibody Rituximab.
|
Witzens-Harig, Mathias
|
|
|
110 |
11 |
p. 4471
|
article
|
| 3932 |
Quantifying Capsid Peptide:MHC I Complexes Following Adeno-Associated Virus (AAV) Transduction
|
Pien, Gary C.
|
|
|
110 |
11 |
p. 3737
|
article
|
| 3933 |
Quantitation of Bleeding Symptoms in Children with von Willebrand Disease (VWD) or a Platelet Function Disorder: Use of a Standardized Pediatric Bleeding Score.
|
Biss, T.T.
|
|
|
110 |
11 |
p. 2137
|
article
|
| 3934 |
Quantitative Analysis of Angiogenesis Inhibition by Cleaved High Molecular Weight Kininogen Using VESGEN.
|
Ribita, Daniela
|
|
|
110 |
11 |
p. 3907
|
article
|
| 3935 |
Quantitative Analysis of Gene Expression for Vascular Endothelial Growth Factor and Its Application.
|
Bai, Xia
|
|
|
110 |
11 |
p. 3912
|
article
|
| 3936 |
Quantitative and Functional Alterations of the Gamma Delta T-Cell Subset within Follicular Lymphoma Microenvironment.
|
de Guibert, Sophie
|
|
|
110 |
11 |
p. 2601
|
article
|
| 3937 |
Quantitative Assessment of DNA Editing Enzymes in B-Cell Lymphomas.
|
Wang, Y. Lynn
|
|
|
110 |
11 |
p. 4687
|
article
|
| 3938 |
Quantitative Bioluminescent Method Appropriate for Bimodality Analysis To Improve and Follow a Syngenic Murine Model of B-Cell Lymphoma Expressing Human CD20.
|
Daydé, David
|
|
|
110 |
11 |
p. 1400
|
article
|
| 3939 |
Quantitative Flow Cytometric Assessment of CD36 (Platelet Glycoprotein IV) Expression on Monocytes and Platelets: Assay Development, Role in Plasmodium falciparum Risk Assessment, and Relationship to Sickle Hemoglobin.
|
Cserti, Christine M.
|
|
|
110 |
11 |
p. 3857
|
article
|
| 3940 |
Quantitative Measurement of CD52 Expression and Alemtuzumab Binding in Adult Acute Lymphoblastic Leukemia (ALL): Correlation with Immunophenotype and Cytogenetics in Patients (Pts) Enrolled on a Phase I/II Trial from the Cancer and Leukemia Group B (CALGB 10102).
|
Lozanski, Gerard
|
|
|
110 |
11 |
p. 2386
|
article
|
| 3941 |
Quantitative Molecular Expression of the Immunoregulatory Enzyme Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia Cells as a Possible Marker for Minimal Residual Disease Detection.
|
Aluigi, Michela
|
|
|
110 |
11 |
p. 4229
|
article
|
| 3942 |
Quantitative Monitoring of BCR-ABL mRNA Harboring the T315I Mutation in Chronic Myeloid Leukemia (CML).
|
Chomel, Jean-Claude
|
|
|
110 |
11 |
p. 2919
|
article
|
| 3943 |
Quantitative Monitoring of T315I BCR-ABL Mutation by the Invader Assay.
|
Kakihana, Kazuhiko
|
|
|
110 |
11 |
p. 4543
|
article
|
| 3944 |
Quick, Cheap, and Easy Method for HIV-1 Human Blood Screening.
|
Rozmyslowicz, Tomasz
|
|
|
110 |
11 |
p. 2902
|
article
|
| 3945 |
Rabbit Antithymocyte Globulin in Treatment of Children with Severe Aplastic Anemia.
|
Pawelec, Katarzyna
|
|
|
110 |
11 |
p. 3767
|
article
|
| 3946 |
Rabbit ATG but Not Horse ATG Promotes Expansion of Functional CD4+CD25highFoxP3 Regulatory T Cells In Vitro.
|
Feng, Xingmin
|
|
|
110 |
11 |
p. 2312
|
article
|
| 3947 |
Rab38 Expression in Platelet Dense Granule Storage Pool Disease.
|
Ninkovic, Ivana
|
|
|
110 |
11 |
p. 2112
|
article
|
| 3948 |
Rac1, but Not Rac2, Mediates Osteoclast Gain-of-Function Induced by Nf1 Haploinsufficiency.
|
Chen, Shi
|
|
|
110 |
11 |
p. 237
|
article
|
| 3949 |
Race and Non-Hodgkin's Lymphoma: Adverse Impact of Race and Treatment Delays on Survival. A SEER-Medicare Population Study (1995–2003).
|
Vance, Katisha T.
|
|
|
110 |
11 |
p. 3578
|
article
|
| 3950 |
Rac GTPases Are Potential Therapeutic Targets in p210-BCR-ABL-Induced Myeloproliferative Disease (MPD).
|
Thomas, Emily K.
|
|
|
110 |
11 |
p. 465
|
article
|
| 3951 |
Rac GTPases Modulate Migration of Hematopoietic Progenitor Cells in an SDF-1α Dependent Manner in a Tumor Model.
|
Goettig, Stephan
|
|
|
110 |
11 |
p. 222
|
article
|
| 3952 |
Rac GTPases Regulate Erythropoiesis Both in the Early Steps of Differentiation and in Enucleation.
|
Kalfa, Theodosia A.
|
|
|
110 |
11 |
p. 1714
|
article
|
| 3953 |
Radiation, Mylotarg, and DLI for Extramedullary Relapse from AML Post-Allogeneic Transplant.
|
Sharma, Manish
|
|
|
110 |
11 |
p. 5024
|
article
|
| 3954 |
Radioimmunotherapy for Myeloablation Before SCT in Paediatric Patients with Malignant and Non-Malignant Diseases.
|
Schulz, Ansgar S.
|
|
|
110 |
11 |
p. 624
|
article
|
| 3955 |
Radioimmunotherapy (RIT) of Refractory or Relapsed Hodgkin's Lymphoma (HL) with 90Yttrium-Labelled Antiferritin Antibody.
|
Decaudin, Didier
|
|
|
110 |
11 |
p. 4473
|
article
|
| 3956 |
Radioimmunotherapy (RIT) with 90Y-Ibritumomab Tiuxetan (Zevalin) for the Treatment of Relapsed or Resistant Aggressive Diffuse Large B-Cell Lymphoma (DLBCL) Heavily Pretreated with Rituximab + Chemotherapy: A GIMURELL Experience.
|
Botto, Barbara
|
|
|
110 |
11 |
p. 4478
|
article
|
| 3957 |
Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan (Zevalin®) as Consolidation of First Remission in Patients with Advanced Stage Follicular Lymphoma: A 'Real-Time' MBR RQ-PCR Analysis.
|
Goff, Lindsey
|
|
|
110 |
11 |
p. 3412
|
article
|
| 3958 |
Radioimmunotherapy with Yttrium-90-Ibritumomab Tiuxetan as Part of a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Non-Hodgkin Lymphoma: A Phase I/II Study.
|
Bethge, Wolfgang A.
|
|
|
110 |
11 |
p. 3059
|
article
|
| 3959 |
Randomised Study on Prophylactic Pamidronate 30 mg vs. 90 mg in Multiple Myeloma (Nordic Myeloma Study Group).
|
Gimsing, Peter
|
|
|
110 |
11 |
p. 533
|
article
|
| 3960 |
Randomized Comparison of Standard Induction with Daunorubicin (DNR) for 3 Days vs Idarubicin (IDA) for 3 or 4 Days in AML pts Aged 50 to 70 and of Maintenance with Interleukin 2. Final Analysis of the ALFA 9801 Study.
|
Pautas, Cecile
|
|
|
110 |
11 |
p. 162
|
article
|
| 3961 |
Randomized Study of Decitabine Versus Observation or Continued Cytotoxic Chemotherapy in Patients with Intermediate and Poor Risk Acute Myeloid Leukemia in First or Subsequent Complete Remission.
|
Ravandi, Farhad
|
|
|
110 |
11 |
p. 2859
|
article
|
| 3962 |
Randomized Study of Double Cord Blood Transplantation (CBT) with Versus without Ex-Vivo Expansion (EXP).
|
de Lima, Marcos
|
|
|
110 |
11 |
p. 2014
|
article
|
| 3963 |
R935788: A Phase II, Single Center, Open Label, Efficacy and Safety, Ascending Dose, Pilot Study for the Treatment of Adult Immune Thrombocytopenic Purpura (ITP).
|
Bussel, James B.
|
|
|
110 |
11 |
p. 1310
|
article
|
| 3964 |
Rapid and Sensitive Single Tube Screen for Paroxysmal Nocturnal Hemoglobinuria (PNH) Clones in Aplastic Anemia, Myelodysplastic Syndrome and Bone Marrow Failure Syndromes by Multiparameter Flow Cytometry.
|
Movalia, Mayur K.
|
|
|
110 |
11 |
p. 3680
|
article
|
| 3965 |
Rapid Control of Previously Untreated Multiple Myeloma with Bortezomib-Lenalidomide-Dexamethasone (BLD).
|
Wang, Michael
|
|
|
110 |
11 |
p. 3611
|
article
|
| 3966 |
Rapid Detection and Isolation of Viable Virus-Reactive CD4+ and CD8+ T Cells Based on Activation-Induced CD137 Expression.
|
Wehler, Thomas C.
|
|
|
110 |
11 |
p. 1972
|
article
|
| 3967 |
Rapid Duffy Genotyping in Sickle Cell Disease Patients Using PCR-SSP Is a Valuable Tool for Blood Component Selection.
|
Novaretti, Marcia C.Z.
|
|
|
110 |
11 |
p. 2901
|
article
|
| 3968 |
Rapid Identification of Hematology-Associated Serious Adverse Drug Reactions (sADRS) with Small Datasets: Findings from the Research on Adverse Drug Events and Reports (RADAR) Project.
|
Undevia, Nina
|
|
|
110 |
11 |
p. 3339
|
article
|
| 3969 |
Rapid Infusion of Rituximab (RIR) Is Well Tolerated and Can Safely Be Delivered in Patients with Lymphoproliferative Diseases.
|
Milone, Jorge
|
|
|
110 |
11 |
p. 4503
|
article
|
| 3970 |
Rapid In Vivo Consumption and Ex Vivo Phagocytosis of WASP(−) Platelets.
|
Prislovsky, Amanda
|
|
|
110 |
11 |
p. 2103
|
article
|
| 3971 |
Rapid Remission Induction by VTD (Velcade, Thalidomide, Dexamethason) in Patients with Multiple Myeloma and High Tumor Burden at Diagnosis.
|
Odelga, Viktoria
|
|
|
110 |
11 |
p. 4845
|
article
|
| 3972 |
Rapid T Cell Recovery and Possible Auto-GVHD Following Adoptive Transfer of Ex-Vivo Costimulated Autologous T Cells at Day +2 Post-Transplant.
|
Rapoport, Aaron P.
|
|
|
110 |
11 |
p. 769
|
article
|
| 3973 |
Rapid Transport and Infusion of Hematopoietic Stem Cells Can Improve Outcome after Unrelated Donor Transplant.
|
Lazarus, Hillard M.
|
|
|
110 |
11 |
p. 3063
|
article
|
| 3974 |
RARα-Specific Retinoid Am-80 Prevents SDF-1-Mediated Chemotaxis in CXCR4 Expressing Tumor Cells.
|
Matsumoto, Taichi
|
|
|
110 |
11 |
p. 4194
|
article
|
| 3975 |
RARS-T without Thrombocytosis?.
|
Ravoet, Christophe
|
|
|
110 |
11 |
p. 4607
|
article
|
| 3976 |
RAS and SYK Mediate cAMP Inhibition of PI3K/AKT in Mature B-Cells.
|
Batra, Nidhi
|
|
|
110 |
11 |
p. 796
|
article
|
| 3977 |
Rates of Guideline-Recommended Venous Thromboembolism Prophylaxis in Surgical Patients among US Hospitals: A Real-World Analysis.
|
Amin, Alpesh N.
|
|
|
110 |
11 |
p. 1865
|
article
|
| 3978 |
Rational for a Combination of Bortezomib and Doxorubicin in the Treatment of Multiple Myeloma: A Pivotal Role for Mcl-1.
|
Le Gouill, Steven
|
|
|
110 |
11 |
p. 1501
|
article
|
| 3979 |
Ratio of Mutant JAK2-V617F to Wild Type Jak2 Determines the MPD Phenotypes in Transgenic Mice.
|
Tiedt, Ralph
|
|
|
110 |
11 |
p. 674
|
article
|
| 3980 |
RB1 Haploinsufficiency Confers a Proliferation Advantage in Myeloma Cell Lines.
|
Henry, Travis J.
|
|
|
110 |
11 |
p. 2489
|
article
|
| 3981 |
Rb Intrinsically Promotes Erythropoiesis by Coupling Cell Cycle Exit with Mitochondrial Biogenesis.
|
Sankaran, Vijay G.
|
|
|
110 |
11 |
p. 638
|
article
|
| 3982 |
R-CHOP Modified with Pegilated Lyposomal Adriamycin in Elderly Diffuse Large B-Cell Non Hodgkin's Lymphoma (DLBC-NHL) Therapy: An Attempt To Reduce Toxicity in Patients with Comorbidity.
|
Giordano, Giulio
|
|
|
110 |
11 |
p. 4469
|
article
|
| 3983 |
R-CHOP vs R-MiniCEOP in Elderly Patients with Diffuse Large B-Cell Lymphoma (B-DLCL) Prospectively Selected by a Multidimensional Evaluation Scale: Preliminary Results of a Randomized Study Performed by Intergruppo Italiano Linfomi (IIL).
|
Merli, Francesco
|
|
|
110 |
11 |
p. 3429
|
article
|
| 3984 |
R-COMP 21 (Prednisone, Cyclophosphamide, Vincristine, Myocettm and Rituximab) for Frail and Elderly Patients with Aggressive B-Cell Non-Hodgkin Lymphoma: A Pilot Study.
|
Isidori, Alessandro
|
|
|
110 |
11 |
p. 4442
|
article
|
| 3985 |
Reactive Oxygen Species Target the Degradation of the EVI1 Oncoprotein.
|
Shackelford, David
|
|
|
110 |
11 |
p. 651
|
article
|
| 3986 |
Real-Life Rates of Disease Monitoring in Clinical Practice in Europe: The “Unmet Needs in CML and Ph+ALL” (UNIC) Study.
|
Morra, Enrica
|
|
|
110 |
11 |
p. 1959
|
article
|
| 3987 |
Real-Time Quantitative PCR (RQ-PCR) Detection of Minimal Residual Disease (MRD) by Optimized WT1 Assay To Enhance Risk Stratification in Acute Myeloid Leukemia (AML): A European LeukemiaNet Study.
|
Cilloni, Daniela
|
|
|
110 |
11 |
p. 542
|
article
|
| 3988 |
Rearrangement and Deletion of the PAX5 Gene in Pediatric Acute B-Cell Lineage Lymphoblastic Leukemia.
|
Kawamata, Norihiko
|
|
|
110 |
11 |
p. 981
|
article
|
| 3989 |
Recent Decrease in Acute GVHD and Increased Relapse in Children with Leukemia Receiving Unrelated Donor Bone Marrow Transplants.
|
Davies, Stella M.
|
|
|
110 |
11 |
p. 1081
|
article
|
| 3990 |
Receptor-Based Identification of Novel Peptide Ligands as Inhibitors of Blood Stage Malaria.
|
Li, Xuerong
|
|
|
110 |
11 |
p. 139
|
article
|
| 3991 |
Recipient Genotype for the IL-10 -1064 Promoter Gene STR Polymorphism Influences the Risk of Graft Failure/Rejection after HLA Matched Allogeneic Hematopoietic Stem Cell Transplant in a Chimerism Mediated Fashion.
|
Manzano, Cintia
|
|
|
110 |
11 |
p. 1983
|
article
|
| 3992 |
Reciprocal Activation of GATA-1 and PU.1 Marks Initial Specification of Hematopoietic Stem Cells into Myelo-Erythroid and Myelo-Lymphoid Lineages.
|
Arinobu, Yojiro
|
|
|
110 |
11 |
p. 1228
|
article
|
| 3993 |
Reciprocal Regulation of DSCR1 (Down Syndrome Critical Region 1) Expression and NFAT (Nuclear Factor of Activated T Cells) Activation in Megakaryocytes.
|
Kyttaelae, Satu
|
|
|
110 |
11 |
p. 2204
|
article
|
| 3994 |
Recombinant Activated Factor VII (rFVIIa) in the Treatment of Non-Hemophilia Patients: Physician Underreporting of Thromboembolic Adverse Events.
|
Hsia, Cyrus C.
|
|
|
110 |
11 |
p. 3143
|
article
|
| 3995 |
Recombinant Chimeric IgA1 and IgA2 Antibodies for Tumor Immunotherapy.
|
Dechant, Michael
|
|
|
110 |
11 |
p. 4892
|
article
|
| 3996 |
Recombinant Human Erythropoietin Administration Decreases the Frequency of Excessive Apoptosis in Erythroid Progenitors in the Model Mouse of Anemia Due to Chronic Renal Failure.
|
Oyake, Tatsuo
|
|
|
110 |
11 |
p. 3668
|
article
|
| 3997 |
Recombinant Human Erythropoietin May Negatively Influence Survival in Newly Diagnosed Patients with Multiple Myeloma: A Single Center Experience in 246 Patients.
|
Katodritou, Eirini
|
|
|
110 |
11 |
p. 4814
|
article
|
| 3998 |
Recombinant Interleukin-21 Plus Rituximab: Clinical Activity in a Phase 1, Dose-Finding Trial in Relapsed Low-Grade B Cell Lymphoma.
|
Timmerman, John M.
|
|
|
110 |
11 |
p. 2577
|
article
|
| 3999 |
Recombinant Thrombin Has a Superior Immunogenicity Profile Compared with Bovine Thrombin in a Well-Controlled, Randomized, Double-Blind, Phase 3 Study of Topically Applied Thrombins in Four Surgical Settings.
|
Zuckerman, Linda A.
|
|
|
110 |
11 |
p. 3156
|
article
|
| 4000 |
Recovery of Donor Peripheral Blood Platelet Count Following Platelet Apheresis.
|
Dumont, Larry J.
|
|
|
110 |
11 |
p. 2892
|
article
|
Journal description